Skip Navigation LinksHome > ADCS > Publications  
 

ADCS SELECTED PUBLICATIONS

   

Search ADCS Publications

 
 
         
AuthorYearPublicationAbstract
Burnham SC, Faux NG, Wilson W, Laws SM, Ames D, Bedo J, Bush AI, Doecke JD, Ellis KA, Head R, Jones G, Kiiveri H, Martins RN, Rembach A, Rowe CC, Salvado O, Macaulay SL, Masters CL, Villemagne VL; Alzheimer’s Disease Neuroimaging Initiative; Australian Imaging, Biomarkers and Lifestyle Study Research Group.2013A blood-based predictor for neocortical Aβ burden in Alzheimer's disease: results from the AIBL study. Mol Psychiatry. 2013 Apr 30. doi: 10.1038/mp.2013.40. [Epub ahead of print] PMID: 23628985 [PubMed - as supplied by publisher]view
Casanova R, Hsu FC, Espeland MA; Alzheimer's Disease Neuroimaging Initiative.2013Classification of structural MRI images in Alzheimer's disease from the perspective of ill-posed problems. PLoS One. 2012;7(10):e44877. doi: 10.1371/journal.pone.0044877. Epub 2012 Oct 10. PMID: 23071501 [PubMed - indexed for MEDLINE] Free PMC Article view
Charles D. Smith, Anders H. Andersen, Brian T. Gold, Alzheimer’s Disease Neuroimaging Initiative2013Structural Brain Alterations before Mild Cognitive Impairment in ADNI: Validation of Volume Loss in a Predefined Antero-Temporal Region J Alzheimers Dis. Author manuscript; available in PMC 2013 May 13. Published in final edited form as: J Alzheimers Dis. 2012; 31(0 3): S49–S58. doi: 10.3233/JAD-2012-120157 PMCID: PMC3652624 view
Cruchaga C, Kauwe JS, Harari O, Jin SC, Cai Y, Karch CM, Benitez BA, Jeng AT, Skorupa T, Carrell D, Bertelsen S, Bailey M, McKean D, Shulman JM, De Jager PL, Chibnik L, Bennett DA, Arnold SE, Harold D, Sims R, Gerrish A, Williams J, Van Deerlin VM, Lee VM, Shaw LM, Trojanowski JQ, Haines JL, Mayeux R, Pericak-Vance MA, Farrer LA, Schellenberg GD, Peskind ER, Galasko D, Fagan AM, Holtzman DM, Morris JC; GERAD Consortium; Alzheimer’s Disease Neuroimaging Initiative (ADNI); Alzheimer Disease Genetic Consortium (ADGC), Goate AM2013GWAS of Cerebrospinal Fluid Tau Levels Identifies Risk Variants for Alzheimer's Disease. Neuron. 2013 Apr 3. doi:pii: S0896-6273(13)00184-0. 10.1016/j.neuron.2013.02.026. [Epub ahead of print] PMID: 23562540 [PubMed - as supplied by publisher] view
Ewers M, Insel PS, Stern Y, Weiner MW; Alzheimer's Disease Neuroimaging Initiative (ADNI).2013Cognitive reserve associated with FDG-PET in preclinical Alzheimer disease. Neurology. 2013 Mar 26;80(13):1194-201. doi: 10.1212/WNL.0b013e31828970c2. Epub 2013 Mar 13. PMID: 23486873 [PubMed - indexed for MEDLINE]view
Galasko DR, Aisen P.2013Antioxidants for Alzheimer disease-reply. JAMA Neurol. 2013 Feb 1;70(2):270-1. doi: 10.1001/jamaneurol.2013.935. No abstract available. PMID: 23400724 [PubMed - in process]view
Guffanti G, Torri F, Rasmussen J, Clark AP, Lakatos A, Turner JA, Fallon JH, Saykin AJ, Weiner M; ADNI the Alzheimer’s Disease Neuroimaging Initiative, Vawter MP, Knowles JA, Potkin SG, Macciardi F.2013Increased CNV-Region Deletions in Mild Cognitive Impairment (MCI) and Alzheimer's disease (AD) Subjects in the ADNI Sample. Genomics. 2013 Apr 11. doi:pii: S0888-7543(13)00066-9. 10.1016/j.ygeno.2013.04.004. [Epub ahead of print] PMID: 23583670 [PubMed - as supplied by publisher] Related citations view
Guzman VA, Carmichael OT, Schwarz C, Tosto G, Zimmerman ME, Brickman AM; Alzheimer's Disease Neuroimaging Initiative.2013White matter hyperintensities and amyloid are independently associated with entorhinal cortex volume among individuals with mild cognitive impairment. Alzheimers Dement. 2013 Jan 30. doi:pii: S1552-5260(12)02571-X. 10.1016/j.jalz.2012.11.009. [Epub ahead of print] PMID: 23375566 [PubMed - as supplied by publisher]view
Hostage CA, Roy Choudhury K, Doraiswamy PM, Petrella JR; zheimer’s Disease Neuroimaging Initiative.2013Dissecting the Gene Dose-Effects of the APOE ε4 and ε2 Alleles on Hippocampal Volumes in Aging and Alzheimer's Disease. PLoS One. 2013;8(2):e54483. doi: 10.1371/journal.pone.0054483. Epub 2013 Feb 6. PMID: 23405083 [PubMed - in process] Free Article view
Jack CR Jr, Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS, Shaw LM, Vemuri P, Wiste HJ, Weigand SD, Lesnick TG, Pankratz VS, Donohue MC, Trojanowski JQ.2013Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 2013 Feb;12(2):207-16. doi: 10.1016/S1474-4422(12)70291-0. PMID: 23332364 [PubMed - in process]view
Kantarci K, Gunter JL, Tosakulwong N, Weigand SD, Senjem MS, Petersen RC, Aisen PS, Jagust WJ, Weiner MW, Jack CR Jr; Alzheimer's Disease Neuroimaging Initiative.2013Focal hemosiderin deposits and β-amyloid load in the ADNI cohort. Alzheimers Dement. 2013 Jan 30. doi:pii: S1552-5260(12)02573-3. 10.1016/j.jalz.2012.10.011. [Epub ahead of print] PMID: 23375568 [PubMed - as supplied by publisher]view
Koppel J, Sunday S, Goldberg TE, Davies P, Christen E, Greenwald BS; Alzheimer's Disease Neuroimaging Initiative.2013Psychosis in Alzheimer's Disease Is Associated With Frontal Metabolic Impairment and Accelerated Decline in Working Memory: Findings From the Alzheimer's Disease Neuroimaging Initiative. Am J Geriatr Psychiatry. 2013 Mar 15. doi:pii: S1064-7481(12)00102-9. 10.1016/j.jagp.2012.10.028. [Epub ahead of print] PMID: 23672944 [PubMed - as supplied by publisher] view
Landau SM, Lu M, Joshi AD, Pontecorvo M, Mintun MA, Trojanowski JQ, Shaw LM, Jagust WJ; Alzheimer's Disease Neuroimaging Initiative.2013Comparing PET imaging and CSF measurements of Aß Ann Neurol. 2013 Mar 28. doi: 10.1002/ana.23908. [Epub ahead of print] PMID: 23536396 [PubMed - as supplied by publisher]view
Liu M, Zhang D, Shen D; the Alzheimer's Disease Neuroimaging Initiative.2013Hierarchical fusion of features and classifier decisions for Alzheimer's disease diagnosis. Hum Brain Mapp. 2013 Feb 18. doi: 10.1002/hbm.22254. [Epub ahead of print] PMID: 23417832 [PubMed - as supplied by publisher]view
Lowe VJ, Peller PJ, Weigand SD, Montoya Quintero C, Tosakulwong N, Vemuri P, Senjem ML, Jordan L, Jack CR Jr, Knopman D, Petersen RC.2013Application of the National Institute on Aging-Alzheimer's Association AD criteria to ADNI. Neurology. 2013 May 3. [Epub ahead of print] PMID: 23645596 [PubMed - as supplied by publisher]view
Mackin RS, Insel P, Tosun D, Mueller SG, Schuff N, Truran-Sacrey D, Raptentsetsang ST, Lee JY, Jack CR Jr, Aisen PS, Petersen RC, Weiner MW; Alzheimer's Disease Neuroimaging Initiative.2013The Effect of Subsyndromal Symptoms of Depression and White Matter Lesions on Disability for Individuals With Mild Cognitive Impairment. Am J Geriatr Psychiatry. 2013 Feb 6. doi:pii: S1064-7481(13)00026-2. 10.1016/j.jagp.2013.01.021. [Epub ahead of print] PMID: 23567388 [PubMed - as supplied by publisher] view
Murphy KR, Landau SM, Choudhury KR, Hostage CA, Shpanskaya KS, Sair HI, Petrella JR, Wong TZ, Doraiswamy PM; Alzheimer's Disease Neuroimaging Initiative.2013Mapping the effects of ApoE4, age and cognitive status on 18F-florbetapir PET measured regional cortical patterns of beta-amyloid density and growth. Neuroimage. 2013 Apr 23. doi:pii: S1053-8119(13)00395-9. 10.1016/j.neuroimage.2013.04.048. [Epub ahead of print] PMID: 23624169 [PubMed - as supplied by publisher] view
Pillai JA, McEvoy LK, Hagler DJ Jr, Holland D, Dale AM, Salmon DP, Galasko D, Fennema-Notestine C; Alzheimer's Disease Neuroimaging Initiative.2013Higher education is not associated with greater cortical thickness in brain areas related to literacy or intelligence in normal aging or mild cognitive impairment. J Clin Exp Neuropsychol. 2012;34(9):925-35. doi: 10.1080/13803395.2012.702733. Epub 2012 Aug 21. PMID: 22905705 [PubMed - indexed for MEDLINE]view
Posner HB, Cano S, Carrillo MC, Selnes O, Stern Y, Thomas RG, Zajicek J, Hobart J; zheimer's Disease Neuroimaging Initiative.2013Establishing the psychometric underpinning of cognition measures for clinical trials of Alzheimer's disease and its precursors: A new approach. Alzheimers Dement. 2013 Feb;9(1 Suppl):S56-60. doi: 10.1016/j.jalz.2012.10.008. PMID: 23391006 [PubMed - in process]view
Ramanan VK, Risacher SL, Nho K, Kim S, Swaminathan S, Shen L, Foroud TM, Hakonarson H, Huentelman MJ, Aisen PS, Petersen RC, Green RC, Jack CR, Koeppe RA, Jagust WJ, Weiner MW, Saykin AJ.2013APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study. Mol Psychiatry. 2013 Feb 19. doi: 10.1038/mp.2013.19. [Epub ahead of print] PMID: 23419831 [PubMed - as supplied by publisher]view
Reitz C, Jun G, Naj A, Rajbhandary R, Vardarajan BN, Wang LS, Valladares O, Lin CF, Larson EB, Graff-Radford NR, Evans D, De Jager PL, Crane PK, Buxbaum JD, Murrell JR, Raj T, Ertekin-Taner N, Logue M, Baldwin CT, Green RC, Barnes LL, Cantwell LB, Fallin MD, Go RC, Griffith P, Obisesan TO, Manly JJ, Lunetta KL, Kamboh MI, Lopez OL, Bennett DA, Hendrie H, Hall KS, Goate AM, Byrd GS, Kukull WA, Foroud TM, Haines JL, Farrer LA, Pericak-Vance MA, Schellenberg GD, Mayeux R; Alzheimer Disease Genetics Consortium.2013Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans. JAMA. 2013 Apr 10;309(14):1483-92. doi: 10.1001/jama.2013.2973. PMID: 23571587 [PubMed - indexed for MEDLINE]view
Risacher SL, Kim S, Shen L, Nho K, Foroud T, Green RC, Petersen RC, Jack CR Jr, Aisen PS, Koeppe RA, Jagust WJ, Shaw LM, Trojanowski JQ, Weiner MW, Saykin AJ; Alzheimer's Disease Neuroimaging Initiative (ADNI)†.2013The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI). Front Aging Neurosci. 2013;5:11. doi: 10.3389/fnagi.2013.00011. Epub 2013 Apr 1. PMID: 23554593 [PubMed] Free PMC Article view
Roussotte FF, Jahanshad N, Hibar DP, Sowell ER, Kohannim O, Barysheva M, Hansell NK, McMahon KL, de Zubicaray GI, Montgomery GW, Martin NG, Wright MJ, Toga AW, Jack CR Jr, Weiner MW, Thompson PM; and the ADNI.2013A commonly carried genetic variant in the delta opioid receptor gene, OPRD1, is associated with smaller regional brain volumes: Replication in elderly and young populations. Hum Brain Mapp. 2013 Feb 21. doi: 10.1002/hbm.22247. [Epub ahead of print]view
Shi J, Thompson PM, Gutman B, Wang Y; the Alzheimer’s Disease Neuroimaging Initiative.2013Surface fluid registration of conformal representation: Application to detect disease burden and genetic influence on hippocampus. Neuroimage. 2013 Apr 12. doi:pii: S1053-8119(13)00345-5. 10.1016/j.neuroimage.2013.04.018. [Epub ahead of print] PMID: 23587689 [PubMed - as supplied by publisher] view
Smith CD, Andersen AH, Gold BT; Alzheimer's Disease Neuroimaging Initiative.2013Structural brain alterations before mild cognitive impairment in ADNI: validation of volume loss in a predefined antero-temporal region. J Alzheimers Dis. 2012;31 Suppl 3:S49-58. PMID: 22460332 [PubMed - indexed for MEDLINE] view
Swaminathan S, Risacher SL, Yoder KK, West JD, Shen L, Kim S, Inlow M, Foroud T, Jagust WJ, Koeppe RA, Mathis CA, Shaw LM, Trojanowski JQ, Soares H, Aisen PS, Petersen RC, Weiner MW, Saykin AJ; Alzheimer's Disease Neuroimaging Initiative.2013Association of plasma and cortical amyloid beta is modulated by APOE ε4 status. Alzheimers Dement. 2013 Mar 26. doi:pii: S1552-5260(13)00039-3. 10.1016/j.jalz.2013.01.007. [Epub ahead of print] PMID: 23541187 [PubMed - as supplied by publisher]view
Toledo JB, Da X, Bhatt P, Wolk DA, Arnold SE, Shaw LM, Trojanowski JQ, Davatzikos C; zheimer’s Disease Neuroimaging Initiative.2013Relationship between Plasma Analytes and SPARE-AD Defined Brain Atrophy Patterns in ADNI. PLoS One. 2013;8(2):e55531. doi: 10.1371/journal.pone.0055531. Epub 2013 Feb 8. PMID: 23408997 [PubMed - in process] Free Article view
Toledo JB, Toledo E, Weiner MW, Jack CR Jr, Jagust W, Lee VM, Shaw LM, Trojanowski JQ; Alzheimer's Disease Neuroimaging Initiative.2013Cardiovascular risk factors, cortisol, and amyloid-β deposition in Alzheimer's Disease Neuroimaging Initiative. Alzheimers Dement. 2012 Nov;8(6):483-9. doi: 10.1016/j.jalz.2011.08.008. PMID: 23102118 [PubMed - indexed for MEDLINE]view
Tong T, Wolz R, Coupé P, Hajnal JV, Rueckert D; The Alzheimer's Disease Neuroimaging Initiative.2013Segmentation of MR images via discriminative dictionary learning and sparse coding: Application to hippocampus labeling. Neuroimage. 2013 Mar 21. doi:pii: S1053-8119(13)00224-3. 10.1016/j.neuroimage.2013.02.069. [Epub ahead of print] PMID: 23523774 [PubMed - as supplied by publisher]view
Trzepacz PT, Saykin A, Yu P, Bhamditipati P, Sun J, Dennehy EB, Willis B, Cummings JL; Alzheimer's Disease Neuroimaging Intiative.2013Subscale Validation of the Neuropsychiatric Inventory Questionnaire: Comparison of Alzheimer's Disease Neuroimaging Initiative and National Alzheimer's Coordinating Center Cohorts. Am J Geriatr Psychiatry. 2013 Apr 18. doi:pii: S1064-7481(12)00095-4. 10.1016/j.jagp.2012.10.027. [Epub ahead of print] PMID: 23602309 [PubMed - as supplied by publisher]view
Zahodne LB, Gongvatana A, Cohen RA, Ott BR, Tremont G; Alzheimer's Disease Neuroimaging Initiative.2013Are Apathy and Depression Independently Associated With Longitudinal Trajectories of Cortical Atrophy in Mild Cognitive Impairment? Am J Geriatr Psychiatry. 2013 Apr 28. doi:pii: S1064-7481(13)00048-1. 10.1016/j.jagp.2013.01.043. [Epub ahead of print] PMID: 23636003 [PubMed - as supplied by publisher]view
Zhou J, Liu J, Narayan VA, Ye J; Alzheimer's Disease Neuroimaging Initiative.2013Modeling Disease Progression via Multi-task Learning. Neuroimage. 2013 Apr 11. doi:pii: S1053-8119(13)00326-1. 10.1016/j.neuroimage.2013.03.073. [Epub ahead of print] PMID: 23583359 [PubMed - as supplied by publisher] view
Zhu CW, Sano M, Ferris SH, Whitehouse PJ, Patterson MB, Aisen PS.2013Health-Related Resource Use and Costs in Elderly Adults with and without Mild Cognitive Impairment. J Am Geriatr Soc. 2013 Feb 15. doi: 10.1111/jgs.12132. [Epub ahead of print] PMID: 23414481 [PubMed - as supplied by publisher]view
Zhu CW, Sano M, Ferris SH, Whitehouse PJ, Patterson MB, Aisen PS.2013Health-related resource use and costs in elderly adults with and without mild cognitive impairment. J Am Geriatr Soc. 2013 Mar;61(3):396-402. doi: 10.1111/jgs.12132. Epub 2013 Feb 15. PMID: 23414481 [PubMed - indexed for MEDLINE]view
Aisen PS, Cummings J, Schneider LS.2012Symptomatic and nonamyloid/tau based pharmacologic treatment for Alzheimer disease. Cold Spring Harb Perspect Med. 2012 Mar;2(3):a006395. PMID: 22393531 [PubMed - in process]view
Bakken TE, Roddey JC, Djurovic S, Akshoomoff N, Amaral DG, Bloss CS, Casey BJ, Chang L, Ernst TM, Gruen JR, Jernigan TL, Kaufmann WE, Kenet T, Kennedy DN, Kuperman JM, Murray SS, Sowell ER, Rimol LM, Mattingsdal M, Melle I, Agartz I, Andreassen OA, Schork NJ, Dale AM; Alzheimer's Disease Neuroimaging Initiative; Pediatric Imaging, Neurocognition, and Genetics Study, Weiner M, Aisen P, et.al.2012Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans. Proc Natl Acad Sci U S A. 2012 Mar 6;109(10):3985-90. Epub 2012 Feb 16. PMID: 22343285 [PubMed - indexed for MEDLINE]view
Bernick C, Cummings J, Raman R, Sun X, Aisen P.2012Age and rate of cognitive decline in Alzheimer disease: implications for clinical trials. Arch Neurol. 2012 Jul;69(7):901-5. PMID: 22431834 [PubMed - indexed for MEDLINE] Related citations view
Bonner-Jackson A, Okonkwo O, Tremont G; Alzheimerʼs Disease Neuroimaging Initiative.2012Apolipoprotein E ε2 and functional decline in amnestic mild cognitive impairment and Alzheimer disease. Am J Geriatr Psychiatry. 2012 Jul;20(7):584-93. doi: 10.1097/JGP.0b013e3182203c32. PMID: 21685781 [PubMed - indexed for MEDLINE]view
Carmichael O, Xie J, Fletcher E, Singh B, DeCarli C; Alzheimer's Disease Neuroimaging Initiative.2012Localized hippocampus measures are associated with Alzheimer pathology and cognition independent of total hippocampal volume. Neurobiol Aging. 2012 Jun;33(6):1124.e31-41. doi: 10.1016/j.neurobiolaging.2011.08.016. Epub 2011 Dec 14. PMID: 22169204 [PubMed - indexed for MEDLINE]view
Carrillo MC, Bain LJ, Frisoni GB, Weiner MW.2012Worldwide Alzheimer's disease neuroimaging initiative. Alzheimers Dement. 2012 Jul;8(4):337-42. PMID: 22748939 [PubMed - in process]view
Cedarbaum JM, Jaros M, Hernandez C, Coley N, Andrieu S, Grundman M, Vellas B; Alzheimer's Disease Neuroimaging Initiative.2012Rationale for use of the Clinical Dementia Rating Sum of Boxes as a primary outcome measure for Alzheimer's disease clinical trials. Alzheimers Dement. 2012 May 31. [Epub ahead of print] PMID: 22658286 [PubMed - as supplied by publisher]view
Chu C, Hsu AL, Chou KH, Bandettini P, Lin C; Alzheimer's Disease Neuroimaging Initiative.2012Does feature selection improve classification accuracy? Impact of sample size and feature selection on classification using anatomical magnetic resonance images. Neuroimage. 2012 Mar;60(1):59-70. Epub 2011 Dec 1. PMID: 22166797 [PubMed - indexed for MEDLINE]view
Crane PK, Carle A, Gibbons LE, Insel P, Mackin RS, Gross A, Jones RN, Mukherjee S, Curtis SM, Harvey D, Weiner M, Mungas D; for the Alzheimer’s Disease Neuroimaging Initiative.2012Development and assessment of a composite score for memory in the Alzheimer's Disease Neuroimaging Initiative (ADNI). Brain Imaging Behav. 2012 Jul 11. [Epub ahead of print] PMID: 22782295 [PubMed - as supplied by publisher]view
Damoiseaux JS, Seeley WW, Zhou J, Shirer WR, Coppola G, Karydas A, Rosen HJ, Miller BL, Kramer JH, Greicius MD; Alzheimer's Disease Neuroimaging Initiative.2012Gender modulates the APOE ε4 effect in healthy older adults: convergent evidence from functional brain connectivity and spinal fluid tau levels. J Neurosci. 2012 Jun 13;32(24):8254-62. PMID: 22699906 [PubMed - indexed for MEDLINE] view
Daoqiang Zhang, Dinggang Shen, Alzheimer's Disease Neuroimaging Initiative2012Predicting Future Clinical Changes of MCI Patients Using Longitudinal and Multimodal Biomarkers PLoS One. 2012; 7(3): e33182. Epub 2012 March 22. PMC3310854view
Desikan RS, McEvoy LK, Thompson WK, Holland D, Brewer JB, Aisen PS, Sperling RA, Dale AM; for the Alzheimer's Disease Neuroimaging Initiative.2012Amyloid-β--associated clinical decline occurs only in the presence of elevated P-tau. Arch Neurol. 2012 Jun;69(6):709-13. PMID: 22529247 [PubMed - indexed for MEDLINE] Free PMC Article view
Devanand DP, Liu X, Brown PJ, Huey ED, Stern Y, Pelton GH.2012A two-study comparison of clinical and MRI markers of transition from mild cognitive impairment to Alzheimer's disease. Int J Alzheimers Dis. 2012;2012:483469. Epub 2012 Feb 1. PMID: 22482070 [PubMed - in process]view
Doecke JD, Laws SM, Faux NG, Wilson W, Burnham SC, Lam CP, Mondal A, Bedo J, Bush AI, Brown B, De Ruyck K, Ellis KA, Fowler C, Gupta VB, Head R, Macaulay SL, Pertile K, Rowe CC, Rembach A, Rodrigues M, Rumble R, Szoeke C, Taddei K, Taddei T, Trounson B, Ames D, Masters CL, Martins RN; for the Alzheimer's Disease Neuroimaging Initiative and Australian Imaging Biomarker and Lifestyle Research Group2012Blood-Based Protein Biomarkers for Diagnosis of Alzheimer Disease. Arch Neurol. 2012 Jul 16:1-8. doi: 10.1001/archneurol.2012.1282. [Epub ahead of print] PMID: 22801742 [PubMed - as supplied by publisher]view
Domoto-Reilly K, Sapolsky D, Brickhouse M, Dickerson BC; Alzheimer's Disease Neuroimaging Initiative.2012Naming impairment in Alzheimer's disease is associated with left anterior temporal lobe atrophy. Neuroimage. 2012 Oct 15;63(1):348-55. Epub 2012 Jun 21. PMID: 22728617 [PubMed - indexed for MEDLINE] view
Dukart J, Mueller K, Barthel H, Villringer A, Sabri O, Schroeter ML; for the Alzheimer's Disease Neuroimaging Initiative.2012Meta-analysis based SVM classification enables accurate detection of Alzheimer's disease across different clinical centers using FDG-PET and MRI. Psychiatry Res. 2012 Nov 10. doi:pii: S0925-4927(12)00085-6. 10.1016/j.pscychresns.2012.04.007. [Epub ahead of print] PMID: 23149027 [PubMed - as supplied by publisher]view
Escudero J, Ifeachor E, Zajicek J, Green C, Shearer J, Pearson S.2012Machine Learning-Based Method for Personalized and Cost-Effective Detection of Alzheimer's Disease. IEEE Trans Biomed Eng. 2012 Aug 8. [Epub ahead of print] PMID: 22893371 [PubMed - as supplied by publisher]view
Ewers M, Insel P, Jagust WJ, Shaw L, Trojanowski JQ, Aisen P, Petersen RC, Schuff N, Weiner MW; Alzheimer’s Disease Neuroimaging Initiative (ADNI).2012CSF biomarker and PIB-PET-derived beta-amyloid signature predicts metabolic, gray matter, and cognitive changes in nondemented subjects. Cereb Cortex. 2012 Sep;22(9):1993-2004. Epub 2011 Oct 29. PMID: 22038908 [PubMed - indexed for MEDLINE]view
Ewers M, Schmitz S, Hansson O, Walsh C, Fitzpatrick A, Bennett D, Minthon L, Trojanowski JQ, Shaw LM, Faluyi YO, Vellas B, Dubois B, Blennow K, Buerger K, Teipel SJ, Weiner M, Hampel H; Alzheimer's Disease Neuroimaging Initiative.2012Body mass index is associated with biological CSF markers of core brain pathology of Alzheimer's disease. Neurobiol Aging. 2012 Aug;33(8):1599-608. doi: 10.1016/j.neurobiolaging.2011.05.005. Epub 2011 Jun 17. PMID: 21684041 [PubMed - indexed for MEDLINE]view
Farlow M, Arnold SE, van Dyck CH, Aisen PS, Snider BJ, Porsteinsson AP, Friedrich S, Dean RA, Gonzales C, Sethuraman G, DeMattos RB, Mohs R, Paul SM, Siemers ER.2012Safety and biomarker effects of solanezumab in patients with Alzheimer's disease. Alzheimers Dement. 2012 Jul;8(4):261-71. doi: 10.1016/j.jalz.2011.09.224. Epub 2012 Jun 5. PMID: 22672770 [PubMed - indexed for MEDLINE]view
Galasko DR, Peskind E, Clark CM, Quinn JF, Ringman JM, Jicha GA, Cotman C, Cottrell B, Montine TJ, Thomas RG, Aisen P; Alzheimer’s Disease Cooperative Study2012Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures. Arch Neurol. 2012 Jul;69(7):836-41. PMID: 22431837 [PubMed - indexed for MEDLINE]view
Gibbons LE, Carle AC, Mackin RS, Harvey D, Mukherjee S, Insel P, Curtis SM, Mungas D, Crane PK; for the Alzheimer’s Disease Neuroimaging Initiative.2012A composite score for executive functioning, validated in Alzheimer's Disease Neuroimaging Initiative (ADNI) participants with baseline mild cognitive impairment. Brain Imaging Behav. 2012 May 27. [Epub ahead of print] PMID: 22644789 [PubMed - as supplied by publisher]view
Gray KR, Aljabar P, Heckemann RA, Hammers A, Rueckert D; for the Alzheimer's Disease Neuroimaging Initiative.2012Random forest-based similarity measures for multi-modal classification of Alzheimer's disease. Neuroimage. 2012 Oct 4. pii: S1053-8119(12)00983-4. doi: 10.1016/j.neuroimage.2012.09.065. [Epub ahead of print] PMID: 23041336 [PubMed - as supplied by publisher] view
Grill JD, Di L, Lu PH, Lee C, Ringman J, Apostolova LG, Chow N, Kohannim O,Cummings JL, Thompson PL, Elashoff D, Alzheimer's Disease Neuroimaging Initiative2012Estimating sample sizes for predementia Alzheimer's trials based on the Alzheimer's Disease Neuroimaging Initiative.2012.Neurobiology of Aging.PMID: 22503160.view
Grill JD, Raman R, Ernstrom K, Aisen P, Karlawish J.2012Effect of study partner on the conduct of Alzheimer disease clinical trials. Neurology. 2012 Dec 19. [Epub ahead of print] PMID: 23255824 [PubMed - as supplied by publisher]view
Gross AL, Inouye SK, Rebok GW, Brandt J, Crane PK, Parisi JM, Tommet D, Bandeen-Roche K, Carlson MC, Jones RN, For The Alzheimer's Disease Neuroimaging Initiative.2012Parallel but not equivalent: Challenges and solutions for repeated assessment of cognition over time. J Clin Exp Neuropsychol. 2012 Apr 30. [Epub ahead of print] PMID: 22540849 [PubMed - as supplied by publisher]view
Gross AL, Manly JJ, Pa J, Johnson JK, Park LQ, Mitchell MB, Melrose RJ, Inouye SK, McLaren DG; for the Alzheimer’s Disease Neuroimaging Initiative2012Cortical signatures of cognition and their relationship to Alzheimer's disease. Brain Imaging Behav. 2012 Jun 21. [Epub ahead of print] PMID: 22718430 [PubMed - as supplied by publisher]view
Guo LH, Alexopoulos P, Wagenpfeil S, Kurz A, Perneczky R; Alzheimer's Disease Neuroimaging Initiative.2012Brain size and the compensation of Alzheimer's disease symptoms: A longitudinal cohort study. Alzheimers Dement. 2012 Dec 8. doi:pii: S1552-5260(12)02464-8. 10.1016/j.jalz.2012.10.002. [Epub ahead of print] PMID: 23232272 [PubMed - as supplied by publisher]view
Gutman BA, Hua X, Rajagopalan P, Chou YY, Wang Y, Yanovsky I, Toga AW, Jack CR Jr, Weiner MW, Thompson PM; for the Alzheimer's Disease Neuroimaging Initiative.2012Maximizing Power to Track Alzheimer's Disease and MCI Progression by LDA-Based Weighting of Longitudinal Ventricular Surface Features. Neuroimage. 2013 Jan 4. doi:pii: S1053-8119(12)01238-4. 10.1016/j.neuroimage.2012.12.052. [Epub ahead of print] PMID: 23296188 [PubMed - as supplied by publisher]view
Habeck C, Risacher S, Lee GJ, Glymour MM, Mormino E, Mukherjee S, Kim S, Nho K, Decarli C, Saykin AJ, Crane PK; for the Alzheimer’s Disease Neuroimaging Initiative.2012Relationship between baseline brain metabolism measured using [(18)F]FDG PET and memory and executive function in prodromal and early Alzheimer's disease. Brain Imaging Behav. 2012 Nov 21. [Epub ahead of print] PMID: 23179062 [PubMed - as supplied by publisher] view
Han SD, Gruhl J, Beckett L, Dodge HH, Stricker NH, Farias S, Mungas D; for the Alzheimer’s Disease Neuroimaging Initiative.2012Beta amyloid, tau, neuroimaging, and cognition: sequence modeling of biomarkers for Alzheimer's Disease. Brain Imaging Behav. 2012 May 31. [Epub ahead of print] PMID: 22648764 [PubMed - as supplied by publisher]view
Hibar DP, Stein JL, Ryles AB, Kohannim O, Jahanshad N, Medland SE, Hansell NK, McMahon KL, de Zubicaray GI, Montgomery GW, Martin NG, Wright MJ, Saykin AJ, Jack CR Jr, Weiner MW, Toga AW, Thompson PM; the Alzheimer’s Disease Neuroimaging Initiative.2012Genome-wide association identifies genetic variants associated with lentiform nucleus volume in N = 1345 young and elderly subjects. Brain Imaging Behav. 2012 Aug 18. [Epub ahead of print] PMID: 22903471 [PubMed - as supplied by publisher]view
Holland D, Desikan RS, Dale AM, McEvoy LK; Alzheimer’s Disease Neuroimaging Initiative.2012Rates of decline in Alzheimer disease decrease with age. PLoS One. 2012;7(8):e42325. Epub 2012 Aug 2. PMID: 22876315 [PubMed - indexed for MEDLINE] Free PMC Article view
Honea RA, Vidoni ED, Swerdlow RH, Burns JM.2012Maternal Family History is Associated with Alzheimer's Disease Biomarkers. J Alzheimers Dis. 2012 Jun 4. [Epub ahead of print] PMID: 22669011 [PubMed - as supplied by publisher]view
Hu WT, Holtzman DM, Fagan AM, Shaw LM, Perrin R, Arnold SE, Grossman M, Xiong C, Craig-Schapiro R, Clark CM, Pickering E, Kuhn M, Chen Y, Van Deerlin VM, McCluskey L, Elman L, Karlawish J, Chen-Plotkin A, Hurtig HI, Siderowf A, Swenson F, Lee VM, Morris JC, Trojanowski JQ, Soares H; For the Alzheimer's Disease Neuroimaging Initiative.2012Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease. Neurology. 2012 Aug 1. [Epub ahead of print] PMID: 22855860 [PubMed - as supplied by publisher]view
Hua X, Hibar DP, Ching CR, Boyle CP, Rajagopalan P, Gutman BA, Leow AD, Toga AW, Jack CR Jr, Harvey D, Weiner MW, Thompson PM; the Alzheimer's Disease Neuroimaging Initiative.2012Unbiased Tensor-Based Morphometry: Improved Robustness and Sample Size Estimates for Alzheimer's Disease Clinical Trials. Neuroimage. 2012 Nov 12. doi:pii: S1053-8119(12)01090-7. 10.1016/j.neuroimage.2012.10.086. [Epub ahead of print] PMID: 23153970 [PubMed - as supplied by publisher]view
Irizarry MC, Jin S, He F, Emond JA, Raman R, Thomas RG, Sano M, Quinn JF, Tariot PN, Galasko DR, Ishihara LS, Weil JG, Aisen PS.2012Incidence of new-onset seizures in mild to moderate Alzheimer disease. Arch Neurol. 2012 Mar;69(3):368-72. PMID: 22410444 [PubMed - indexed for MEDLINE]view
Ito K, Hutmacher MM, Corrigan BW.2012Modeling of Functional Assessment Questionnaire (FAQ) as continuous bounded data from the ADNI database. J Pharmacokinet Pharmacodyn. 2012 Sep 19. [Epub ahead of print] PMID: 22990808 [PubMed - as supplied by publisher]view
Jack CR Jr, Vemuri P, Wiste HJ, Weigand SD, Lesnick TG, Lowe V, Kantarci K, Bernstein MA, Senjem ML, Gunter JL, Boeve BF, Trojanowski JQ, Shaw LM, Aisen PS, Weiner MW, Petersen RC, Knopman DS; Alzheimer’s Disease Neuroimaging Initiative.2012Shapes of the trajectories of 5 major biomarkers of Alzheimer disease. Arch Neurol. 2012 Jul;69(7):856-67. PMID: 22409939 [PubMed - indexed for MEDLINE]view
Johnson JK, Gross AL, Pa J, McLaren DG, Park LQ, Manly JJ, the Alzheimer's Disease Neuroimaging Initiative2012Longitudinal change in neuropsychological performance using latent growth models: A study of mild cognitive impairment. 2012. Brain Imaging Behav. PMID: 22562439view
Johnstone D, Milward EA, Berretta R, Moscato P; Alzheimer's Disease Neuroimaging Initiative.2012Multivariate protein signatures of pre-clinical Alzheimer's disease in the Alzheimer's disease neuroimaging initiative (ADNI) plasma proteome dataset. PLoS One. 2012;7(4):e34341. Epub 2012 Apr 2. PMID: 22485168 [PubMed - indexed for MEDLINE] view
Kauwe JS, Cruchaga C, Karch CM, Sadler B, Lee M, Mayo K, Latu W, Su'a M, Fagan AM, Holtzman DM, Morris JC; Alzheimer's Disease Neuroimaging Initiative, Goate AM.2012Fine mapping of genetic variants in BIN1, CLU, CR1 and PICALM for association with cerebrospinal fluid biomarkers for Alzheimer's disease. PLoS One. 2011 Feb 9;6(2):e15918. PMID: 21347408 [PubMed - indexed for MEDLINE] Free PMC Article view
Keator DB, Fallon JH, Lakatos A, Fowlkes CC, Potkin SG, Ihler A; for the Alzheimer's Disease Neuroimaging Initiative.2012Feed-forward hierarchical model of the ventral visual stream applied to functional brain image classification. Hum Brain Mapp. 2012 Jul 30. doi: 10.1002/hbm.22149. [Epub ahead of print] PMID: 22847891 [PubMed - as supplied by publisher]view
Kennedy RE, Schneider LS, Cutter GR.2012Biomarker Positive and Negative Subjects in the ADNI Cohort: Clinical Characterization. Curr Alzheimer Res. 2012 Sep 7. [Epub ahead of print] PMID: 22963265 [PubMed - as supplied by publisher]view
Kohannim O, Hibar DP, Jahanshad N, Stein JL, Hua X, Toga AW, Jack CR Jr, Weiner MW, Thompson PM; the Alzheimer’s Disease Neuroimaging Initiative.2012PREDICTING TEMPORAL LOBE VOLUME ON MRI FROM GENOTYPES USING L(1)-L(2) REGULARIZED REGRESSION. Proc IEEE Int Symp Biomed Imaging. 2012:1160-1163. PMID: 22903144 [PubMed]view
Kohannim O, Hibar DP, Stein JL, Jahanshad N, Hua X, Rajagopalan P, Toga AW, Jack CR Jr, Weiner MW, de Zubicaray GI, McMahon KL, Hansell NK, Martin NG, Wright MJ, Thompson PM; The Alzheimer’s Disease Neuroimaging Initiative.2012Discovery and Replication of Gene Influences on Brain Structure Using LASSO Regression. Front Neurosci. 2012;6:115. Epub 2012 Aug 6. PMID: 22888310 [PubMed - as supplied by publisher] Free PMC Article view
Koikkalainen J, Pölönen H, Mattila J, van Gils M, Soininen H, Lötjönen J; Alzheimer's Disease Neuroimaging Initiative.2012Improved classification of Alzheimer's disease data via removal of nuisance variability. PLoS One. 2012;7(2):e31112. Epub 2012 Feb 13. PMID: 22348041 [PubMed - indexed for MEDLINE] Free PMC Article view
Landau SM, Breault C, Joshi AD, Pontecorvo M, Mathis CA, Jagust WJ, Mintun MA; for the Alzheimer’s Disease Neuroimaging Initiative.2012Amyloid-β Imaging with Pittsburgh Compound B and Florbetapir: Comparing Radiotracers and Quantification Methods. J Nucl Med. 2012 Nov 19. [Epub ahead of print] PMID: 23166389 [PubMed - as supplied by publisher]view
Landau SM, Mintun MA, Joshi AD, Koeppe RA, Petersen RC, Aisen PS, Weiner MW, Jagust WJ; Alzheimer's Disease Neuroimaging Initiative.2012Amyloid deposition, hypometabolism, and longitudinal cognitive decline. Ann Neurol. 2012 Oct;72(4):578-86. doi: 10.1002/ana.23650. PMID: 23109153 [PubMed - indexed for MEDLINE]view
Landau SM, Mintun MA, Joshi AD, Koeppe RA, Petersen RC, Aisen PS, Weiner MW, Jagust WJ; for the Alzheimer's Disease Neuroimaging Initiative.2012Amyloid deposition, hypometabolism, and longitudinal cognitive decline. Ann Neurol. 2012 Oct;72(4):578-586. doi: 10.1002/ana.23650. PMID: 23109153 [PubMed - as supplied by publisher] view
Lee GJ, Lu PH, Hua X, Lee S, Wu S, Nguyen K, Teng E, Leow AD, Jack CR Jr, Toga AW, Weiner MW, Bartzokis G, Thompson PM; Alzheimer's Disease Neuroimaging Initiative.2012Depressive symptoms in mild cognitive impairment predict greater atrophy in Alzheimer's disease-related regions. Biol Psychiatry. 2012 May 1;71(9):814-21. Epub 2012 Feb 8. PMID: 22322105 [PubMed - indexed for MEDLINE]view
Llano DA, Devanarayan V, Simon AJ; The Alzheimer’s Disease Neuroimaging Initiative (ADNI).2012Evaluation of Plasma Proteomic Data for Alzheimer Disease State Classification and for the Prediction of Progression From Mild Cognitive Impairment to Alzheimer Disease. Alzheimer Dis Assoc Disord. 2012 Sep 27. [Epub ahead of print] PMID: 23023094 [PubMed - as supplied by publisher]view
Lo RY, Jagust WJ; Alzheimer's Disease Neuroimaging Initiative.2012Predicting missing biomarker data in a longitudinal study of Alzheimer disease. Neurology. 2012 May 1;78(18):1376-82. Epub 2012 Apr 4. PMID: 22491869 [PubMed - indexed for MEDLINE]view
Lo RY, Jagust WJ; Alzheimer's Disease Neuroimaging Initiative.2012Vascular burden and Alzheimer disease pathologic progression. Neurology. 2012 Sep 25;79(13):1349-55. Epub 2012 Sep 12. PMID: 22972646 [PubMed - indexed for MEDLINE]view
Lourdusamy A, Newhouse S, Lunnon K, Proitsi P, Powell J, Hodges A, Nelson SK, Stewart A, Williams S, Kloszewska I, Mecocci P, Soininen H, Tsolaki M, Vellas B, Lovestone S; on behalf of the AddNeuroMed Consortium, Dobson R; the Alzheimer’s Disease Neuroimaging Initiative2012Identification of cis- regulatory variation influencing protein abundance levels in human plasma. 2012.Human molecular genetics. PMID: 22595970view
Mackin RS, Insel P, Aisen PS, Geda YE, Weiner MW; Alzheimer's Disease Neuroimaging Initiative.2012Longitudinal stability of subsyndromal symptoms of depression in individuals with mild cognitive impairment: relationship to conversion to dementia after 3 years. Int J Geriatr Psychiatry. 2012 Apr;27(4):355-63. doi: 10.1002/gps.2713. Epub 2011 Jul 8. PMID: 21744390 [PubMed - indexed for MEDLINE]view
Mackin RS, Insel P, Tosun D, Mueller SG, Schuff N, Truran-Sacrey D, Raptentsetsang ST, Lee JY, Jack CR Jr, Aisen PS, Petersen RC, Weiner MW; the Alzheimerʼs Disease Neuroimaging Initiative.2012The Effect of Subsyndromal Symptoms of Depression and White Matter Lesions on Disability for Individuals With Mild Cognitive Impairment. Am J Geriatr Psychiatry. 2012 Sep 26. [Epub ahead of print] PMID: 23018473 [PubMed - as supplied by publisher]view
Maldjian JA, Whitlow CT2012Whither the Hippocampus? FDG PET Hippocampal Hypometabolism in Alzheimer's Disease Revisited. 2012. American Journal of Neuroradiology. PMID: 22700745view
Mattila J, Koikkalainen J, Virkki A, van Gils M, Lötjönen J; Alzheimer's Disease Neuroimaging Initiative.2012Design and application of a generic clinical decision support system for multiscale data. IEEE Trans Biomed Eng. 2012 Jan;59(1):234-40. Epub 2011 Oct 10. PMID: 21990325 [PubMed - indexed for MEDLINE]view
Meda SA, Narayanan B, Liu J, Perrone-Bizzozero NI, Stevens MC, Calhoun VD, Glahn DC, Shen L, Risacher SL, Saykin AJ, Pearlson GD.2012A large scale multivariate parallel ICA method reveals novel imaging-genetic relationships for Alzheimer's disease in the ADNI cohort. Neuroimage. 2012 Jan 8. [Epub ahead of print] PMID: 22245343 [PubMed - as supplied by publisher]view
Mukherjee S, Kim S, Gibbons LE, Nho K, Risacher SL, Glymour MM, Habeck C, Lee GJ, Mormino E, Ertekin-Taner N, Montine TJ, Decarli C, Saykin AJ, Crane PK; for the Alzheimer’s Disease Neuroimaging Initiative.2012Genetic architecture of resilience of executive functioning. Brain Imaging Behav. 2012 Jun 19. [Epub ahead of print] PMID: 22711244 [PubMed - as supplied by publisher]view
Mukherjee S, Trittschuh E, Gibbons LE, Mackin RS, Saykin A, Crane PK; for the Alzheimer’s Disease Neuroimaging Initiative.2012Dysexecutive and amnesic AD subtypes defined by single indicator and modern psychometric approaches: relationships with SNPs in ADNI. Brain Imaging Behav. 2012 Nov 17. [Epub ahead of print] PMID: 23161456 [PubMed - as supplied by publisher]view
Mungas D, Crane PK, Gibbons LE, Manly JJ, Glymour MM, Jones RN.2012Advanced psychometric analysis and the Alzheimer's Disease Neuroimaging Initiative: reports from the 2011 Friday Harbor conference. Brain Imaging Behav. 2012 Dec 12. [Epub ahead of print] PMID: 23232798 [PubMed - as supplied by publisher] view
Murphy EA, Roddey JC, McEvoy LK, Holland D, Hagler DJ Jr, Dale AM, Brewer JB; Alzheimer’s Disease Neuroimaging Initiative.2012CETP polymorphisms associate with brain structure, atrophy rate, and Alzheimer's disease risk in an APOE-dependent manner. Brain Imaging Behav. 2012 Mar;6(1):16-26. PMID: 21892657 [PubMed - indexed for MEDLINE]view
Ness S, Rafii M, Aisen P, Krams M, Silverman W, Manji H.2012Down's syndrome and Alzheimer's disease: towards secondary prevention. Nat Rev Drug Discov. 2012 Sep;11(9):655-6. doi: 10.1038/nrd3822. Review. PMID: 22935789 [PubMed - indexed for MEDLINE]view
Nestor SM, Gibson E, Gao FQ, Kiss A, Black SE; for the Alzheimer's Disease Neuroimaging Initiative.2012A direct morphometric comparison of five labeling protocols for multi-atlas driven automatic segmentation of the hippocampus in Alzheimer's disease. Neuroimage. 2012 Nov 7. doi:pii: S1053-8119(12)01085-3. 10.1016/j.neuroimage.2012.10.081. [Epub ahead of print] PMID: 23142652 [PubMed - as supplied by publisher]view
Nho K, Risacher SL, Crane PK, Decarli C, Glymour MM, Habeck C, Kim S, Lee GJ, Mormino E, Mukherjee S, Shen L, West JD, Saykin AJ; Alzheimer’s Disease Neuroimaging Initiative (ADNI).2012Voxel and surface-based topography of memory and executive deficits in mild cognitive impairment and Alzheimer's disease. Brain Imaging Behav. 2012 Oct 16. [Epub ahead of print] PMID: 23070747 [PubMed - as supplied by publisher]view
Nir T, Jahanshad N, Jack CR, Weiner MW, Toga AW, Thompson PM; the Alzheimer’s Disease Neuroimaging Initiative (ADNI).2012SMALL WORLD NETWORK MEASURES PREDICT WHITE MATTER DEGENERATION IN PATIENTS WITH EARLY-STAGE MILD COGNITIVE IMPAIRMENT. Proc IEEE Int Symp Biomed Imaging. 2012:1405-1408. PMID: 22903203 [PubMed]view
Park LQ, Gross AL, McLaren DG, Pa J, Johnson JK, Mitchell M, Manly JJ; for the Alzheimer’s Disease Neuroimaging Initiative.2012Confirmatory factor analysis of the ADNI neuropsychological battery. Brain Imaging Behav. 2012 Jul 10. [Epub ahead of print] PMID: 22777078 [PubMed - as supplied by publisher]view
Pillai JA, McEvoy LK, Hagler DJ Jr, Holland D, Dale AM, Salmon DP, Galasko D, Fennema-Notestine C.2012Higher education is not associated with greater cortical thickness in brain areas related to literacy or intelligence in normal aging or mild cognitive impairment. J Clin Exp Neuropsychol. 2012 Aug 21. [Epub ahead of print] PMID: 22905705 [PubMed - as supplied by publisher]view
Rajagopalan P, Refsum H, Hua X, Toga AW, Jack CR Jr, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative.2012Mapping creatinine- and cystatin C-related white matter brain deficits in the elderly. Neurobiol Aging. 2012 Nov 19. doi:pii: S0197-4580(12)00533-7. 10.1016/j.neurobiolaging.2012.10.022. [Epub ahead of print] PMID: 23182131 [PubMed - as supplied by publisher]view
Rajagopalan P, Toga AW, Jack CR, Weiner MW, Thompson PM; for the Alzheimer’s Disease Neuroimaging Initiative.2012Fat-mass-related hormone, plasma leptin, predicts brain volumes in the elderly. Neuroreport. 2012 Dec 12. [Epub ahead of print] PMID: 23238164 [PubMed - as supplied by publisher]view
Ramanan VK, Kim S, Holohan K, Shen L, Nho K, Risacher SL, Foroud TM, Mukherjee S, Crane PK, Aisen PS, Petersen RC, Weiner MW, Saykin AJ; for the Alzheimer’s Disease Neuroimaging Initiative (ADNI).2012Genome-wide pathway analysis of memory impairment in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort implicates gene candidates, canonical pathways, and networks. Brain Imaging Behav. 2012 Aug 3. [Epub ahead of print] PMID: 22865056 [PubMed - as supplied by publisher]view
Rasmussen JM, Lakatos A, van Erp TG, Kruggel F, Keator DB, Fallon JT, Macciardi F, Potkin SG; Alzheimer's Disease Neuroimaging Initiative: 2012Empirical derivation of the reference region for computing diagnostic sensitive ¹⁸fluorodeoxyglucose ratios in Alzheimer's disease based on the ADNI sample. Biochim Biophys Acta. 2012 Mar;1822(3):457-66. Epub 2011 Sep 19. PMID: 21958592 [PubMed - indexed for MEDLINE]view
Reitz C, Tosto G, Mayeux R, Luchsinger JA; the NIA-LOAD/NCRAD Family Study Group and the Alzheimer's Disease Neuroimaging Initiative.2012Genetic Variants in the Fat and Obesity Associated (FTO) Gene and Risk of Alzheimer's Disease. PLoS One. 2012;7(12):e50354. Epub 2012 Dec 12. PMID: 23251365 [PubMed - as supplied by publisher] Free PMC Article view
Rissman RA, Trojanowski JQ, Shaw LM, Aisen PS.2012Longitudinal plasma amyloid beta as a biomarker of Alzheimer's disease. J Neural Transm. 2012 Jul;119(7):843-50. doi: 10.1007/s00702-012-0772-4. Epub 2012 Feb 22. Review. PMID: 22354745 [PubMed - indexed for MEDLINE]view
Samtani MN, Raghavan N, Shi Y, Novak G, Farnum M, Lobanov V, Schultz T, Yang E, Dibernardo A, Narayan VA; & the Alzheimer's Disease Neuroimaging Initiative: 2012Disease Progression Model in MCI Subjects from Alzheimer's Disease Neuroimaging Initiative: CSF Biomarkers Predict Population Subtypes. British Journal of Clinical Pharmacology, epub ahead of print, 2012.view
Sano M, Egelko S, Donohue M, Ferris S, Kaye J, Hayes TL, Mundt JC, Sun CK, Paparello S, Aisen PS; the Alzheimer Disease Cooperative Study Investigators.2012Developing Dementia Prevention Trials: Baseline Report of the Home-Based Assessment Study. Alzheimer Dis Assoc Disord. 2012 Nov 12. [Epub ahead of print] PMID: 23151596 [PubMed - as supplied by publisher]view
Schuff N, Tosun D, Insel PS, Chiang GC, Truran D, Aisen PS, Jack CR Jr, Weiner MW; Alzheimer's Disease Neuroimaging Initiative.2012Nonlinear time course of brain volume loss in cognitively normal and impaired elders. Neurobiol Aging. 2012 May;33(5):845-55. doi: 10.1016/j.neurobiolaging.2010.07.012. Epub 2010 Sep 19. PMID: 20855131 [PubMed - indexed for MEDLINE] view
Shaffer JL, Petrella JR, Sheldon FC, Choudhury KR, Calhoun VD, Coleman RE, Doraiswamy PM; For the Alzheimer’s Disease Neuroimaging Initiative.2012Predicting Cognitive Decline in Subjects at Risk for Alzheimer Disease by Using Combined Cerebrospinal Fluid, MR Imaging, and PET Biomarkers. Radiology. 2012 Dec 11. [Epub ahead of print] PMID: 23232293 [PubMed - as supplied by publisher] view
Shi Y, Lai R, Toga A2012Cortical Surface Reconstruction via Unified Reeb Analysis of Geometric and Topological Outliers in Magnetic Resonance Images. IEEE Trans Med Imaging. 2012 Oct 15. [Epub ahead of print] PMID: 23086519 [PubMed - as supplied by publisher] view
Silver M, Montana G; Alzheimer's Disease Neuroimaging Initiative.2012Fast identification of biological pathways associated with a quantitative trait using group lasso with overlaps. Stat Appl Genet Mol Biol. 2012 Jan 6;11(1):Article 7. doi: 10.2202/1544-6115.1755. PMID: 22499682 [PubMed - indexed for MEDLINE]view
Singh N, Wang AY, Sankaranarayanan P, Fletcher PT, Joshi S; Alzheimer's Disease Neuroimaging Initiative.2012Genetic, structural and functional imaging biomarkers for early detection of conversion from MCI to AD. Med Image Comput Comput Assist Interv. 2012;15(Pt 1):132-40. PMID: 23285544 [PubMed - in process]view
Skinner J, Carvalho JO, Potter GG, Thames A, Zelinski E, Crane PK, Gibbons LE; for the Alzheimer’s Disease Neuroimaging Initiative2012The Alzheimer's Disease Assessment Scale-Cognitive-Plus (ADAS-Cog-Plus): an expansion of the ADAS-Cog to improve responsiveness in MCI. 2012. Brain imaging and behavior. PMID: 22614326view
Smith CD, Andersen AH, Gold BT.2012Structural Brain Alterations before Mild Cognitive Impairment in ADNI: Validation of Volume Loss in a Predefined Antero-Temporal Region. J Alzheimers Dis. 2012 Mar 29. [Epub ahead of print] PMID: 22460332 [PubMed - as supplied by publisher]view
Stein JL, Medland SE, Vasquez AA, Hibar DP, Senstad RE, Winkler AM, Toro R, et.al.2012Identification of common variants associated with human hippocampal and intracranial volumes.Nat Genet. 2012 Apr 15;44(5):552-61. doi: 10.1038/ng.2250. PMID: 22504417 [PubMed - indexed for MEDLINE]view
Stricker NH, Dodge HH, Dowling NM, Han SD, Erosheva EA, Jagust WJ; for the Alzheimer’s Disease Neuroimaging Initiative.2012CSF biomarker associations with change in hippocampal volume and precuneus thickness: implications for the Alzheimer's pathological cascade. Brain Imaging Behav. 2012 May 22. [Epub ahead of print] PMID: 22614327 [PubMed - as supplied by publisher] view
Swaminathan S, Huentelman MJ, Corneveaux JJ, Myers AJ, Faber KM, Foroud T, Mayeux R, Shen L, Kim S, Turk M, Hardy J, Reiman EM, Saykin AJ; the Alzheimer's Disease Neuroimaging Initiative (ADNI) and the NIA-LOAD/NCRAD Family Study Group.2012Analysis of Copy Number Variation in Alzheimer's Disease in a Cohort of Clinically Characterized and Neuropathologically Verified Individuals. PLoS One. 2012;7(12):e50640. Epub 2012 Dec 5. PMID: 23227193 [PubMed - as supplied by publisher] Free PMC Article view
Swaminathan S, Shen L, Risacher SL, Yoder KK, West JD, Kim S, Nho K, Foroud T, Inlow M, Potkin SG, Huentelman MJ, Craig DW, Jagust WJ, Koeppe RA, Mathis CA, Jack CR Jr, Weiner MW, Saykin AJ; Alzheimer’s Disease Neuroimaging Initiative.2012Amyloid pathway-based candidate gene analysis of [(11)C]PiB-PET in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort. Brain Imaging Behav. 2012 Mar;6(1):1-15. PMID: 21901424 [PubMed - indexed for MEDLINE] Free PMC Article view
Teri L, McKenzie G, Logsdon RG, McCurry SM, Bollin S, Mead J, Menne H.2012Translation of two evidence-based programs for training families to improve care of persons with dementia. Gerontologist. 2012 Aug;52(4):452-9. Epub 2012 Jan 12. PMID: 22247431 [PubMed - indexed for MEDLINE]view
Toledo JB, Toledo E, Weiner MW, Jack CR Jr, Jagust W, Lee VM, Shaw LM, Trojanowski JQ; Alzheimer's Disease Neuroimaging Initiative.2012Cardiovascular risk factors, cortisol, and amyloid-β deposition in Alzheimer's Disease Neuroimaging Initiative. Alzheimers Dement. 2012 Nov;8(6):483-9. doi: 10.1016/j.jalz.2011.08.008. PMID: 23102118 [PubMed - in process]view
Toussaint PJ, Perlbarg V, Bellec P, Desarnaud S, Lacomblez L, Doyon J, Habert MO, Benali H; for the Alzheimer's Disease Neuroimaging Initiative.2012Resting state FDG-PET functional connectivity as an early biomarker of Alzheimer's disease using conjoint univariate and independent component analyses. Neuroimage. 2012 Apr 10. [Epub ahead of print] PMID: 22510256 [PubMed - as supplied by publisher]view
Wang H, Nie F, Huang H, Risacher SL, Saykin AJ, Shen L; Alzheimer's Disease Neuroimaging Initiative.2012Identifying disease sensitive and quantitative trait-relevant biomarkers from multidimensional heterogeneous imaging genetics data via sparse multimodal multitask learning. Bioinformatics. 2012 Jun 15;28(12):i127-36. doi: 10.1093/bioinformatics/bts228. PMID: 22689752 [PubMed - indexed for MEDLINE] Free PMC Article view
Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Green RC, Harvey D, Jack CR, Jagust W, Liu E, Morris JC, Petersen RC, Saykin AJ, Schmidt ME, Shaw L, Siuciak JA, Soares H, Toga AW, Trojanowski JQ; Alzheimer’s Disease Neuroimaging Initiative.2012The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimers Dement. 2012 Feb;8(1 Suppl):S1-68. Epub 2011 Nov 2. Review. PMID: 22047634 [PubMed - indexed for MEDLINE]view
Whitwell JL, Wiste HJ, Weigand SD, Rocca WA, Knopman DS, Roberts RO, Boeve BF, Petersen RC, Jack CR Jr; Alzheimer Disease Neuroimaging Initiative.2012Comparison of imaging biomarkers in the Alzheimer Disease Neuroimaging Initiative and the Mayo Clinic Study of Aging. Arch Neurol. 2012 May;69(5):614-22. doi: 10.1001/archneurol.2011.3029.PMID: 22782510 [PubMed - indexed for MEDLINE]view
Wu G, Wang Q, Shen D; Alzheimer's Disease NeuroImaging Initiative.2012Registration of longitudinal brain image sequences with implicit template and spatial-temporal heuristics. Neuroimage. 2012 Jan 2;59(1):404-21. Epub 2011 Jul 23.PMID: 21820065 [PubMed - indexed for MEDLINE]view
Wu L, Rowley J, Mohades S, Leuzy A, Dauar MT, Shin M, Fonov V, Jia J, Gauthier S, Rosa-Neto P; the Alzheimer’s Disease Neuroimaging Initiative.2012Dissociation between Brain Amyloid Deposition and Metabolism in Early Mild Cognitive Impairment. PLoS One. 2012;7(10):e47905. Epub 2012 Oct 24. PMID: 23112868 [PubMed - as supplied by publisher] Free PMC Article view
Wyman BT, Harvey DJ, Crawford K, Bernstein MA, Carmichael O, Cole PE, Crane PK, Decarli C, Fox NC, Gunter JL, Hill D, Killiany RJ, Pachai C, Schwarz AJ, Schuff N, Senjem ML, Suhy J, Thompson PM, Weiner M, Jack CR Jr; Alzheimer’s Disease Neuroimaging Initiative.2012Standardization of analysis sets for reporting results from ADNI MRI data. Alzheimers Dement. 2012 Oct 27. doi:pii: S1552-5260(12)02379-5. 10.1016/j.jalz.2012.06.004. [Epub ahead of print] PMID: 23110865 [PubMed - as supplied by publisher]view
Xie J, Carmichael O.2012Brain shape regression components.Conf Proc IEEE Eng Med Biol Soc. 2012 Aug;2012:2680-3. doi: 10.1109/EMBC.2012.6346516. PMID: 23366477 [PubMed - in process]view
Ye J, Farnum M, Yang E, Verbeeck R, Lobanov V, Raghavan N, Novak G, Dibernardo A, Narayan VA. BMC 2012Sparse learning and stability selection for predicting MCI to AD conversion using baseline ADNI data. Neurol. 2012 Jun 25;12(1):46. [Epub ahead of print] PMID: 22731740 [PubMed - as supplied by publisher] Free Article view
Yuan L, Wang Y, Thompson PM, Narayan VA, Ye J; Alzheimer's Disease Neuroimaging Initiative.2012Multi-source feature learning for joint analysis of incomplete multiple heterogeneous neuroimaging data. Neuroimage. 2012 Jul 2;61(3):622-32. Epub 2012 Mar 29. PMID: 22498655 [PubMed - indexed for MEDLINE]view
Zhang D, Shen D; Alzheimer's Disease Neuroimaging Initiative.2012Predicting Future Clinical Changes of MCI Patients Using Longitudinal and Multimodal Biomarkers. PLoS One. 2012;7(3):e33182. Epub 2012 Mar 22. PMID: 22457741 [PubMed - in process] Free Article view
Zou F, Chai HS, Younkin CS, Allen M, Crook J, Pankratz VS, Carrasquillo MM, Rowley CN, Nair AA, Middha S, Maharjan S, Nguyen T, Ma L, Malphrus KG, Palusak R, Lincoln S, Bisceglio G, Georgescu C, Kouri N, Kolbert CP, Jen J, Haines JL, Mayeux R, Pericak-Vance MA, Farrer LA, Schellenberg GD; Alzheimer's Disease Genetics Consortium, Petersen RC, Graff-Radford NR, Dickson DW, Younkin SG, Ertekin-Taner N.2012Brain expression genome-wide association study (eGWAS) identifies human disease-associated variants. PLoS Genet. 2012;8(6):e1002707. Epub 2012 Jun 7. PMID: 22685416 [PubMed - indexed for MEDLINE] Free PMC Article view
Abdulkadir A, Mortamet B, Vemuri P, Jack CR Jr, Krueger G, Klöppel S; Alzheimer's Disease Neuroimaging Initiative.2011Effects of hardware heterogeneity on the performance of SVM Alzheimer's disease classifier. Neuroimage. 2011 Oct 1;58(3):785-92. Epub 2011 Jun 25. PMID: 21708272 [PubMed - indexed for MEDLINE]view
Aisen PS.2011Clinical trial methodologies for disease-modifying therapeutic approaches. Neurobiol Aging. 2011 Dec;32 Suppl 1:S64-6. Epub 2011 Oct 8. Review. PMID: 21983242 [PubMed - indexed for MEDLINE]view
Aisen PS.2011Q&A: The Alzheimer's Disease Neuroimaging Initiative. BMC Med. 2011 Sep 1;9:101. No abstract available. PMID: 21884605 [PubMed - indexed for MEDLINE] view
Aksu Y, Miller DJ, Kesidis G, Bigler DC, Yang QX.2011An MRI-Derived Definition of MCI-to-AD Conversion for Long-Term, Automatic Prognosis of MCI Patients. PLoS One. 2011;6(10):e25074. Epub 2011 Oct 12. PMID: 22022375 [PubMed - in process]view
Albert Huang, Rafeef Abugharbieh, Roger Tam, and Alzheimer’s Disease Neuroimaging Initiative2011A Hybrid Geometric–Statistical Deformable Model for Automated 3-D Segmentation in Brain MRI IEEE Trans Biomed Eng. Author manuscript; available in PMC 2011 March 31. PMCID: PMC3068615 view
Alexopoulos P, Guo LH, Kratzer M, Westerteicher C, Kurz A, Perneczky R.2011Impact of SORL1 Single Nucleotide Polymorphisms on Alzheimer's Disease Cerebrospinal Fluid Markers. Dement Geriatr Cogn Disord. 2011 Oct 13;32(3):164-170. [Epub ahead of print] PMID: 21997402 [PubMed - as supplied by publisher]view
Antunez C, Boada M, Gonzalez-Perez A, Gayan J, Ramirez-Lorca R, Marin J, Hernandez I, Moreno-Rey C, Moron FJ, Lopez-Arrieta J, Mauleon A, Rosende-Roca M, Noguera-Perea F, Legaz-Garcia A, Vivancos-Moreau L, Velasco J, Carrasco JM, Alegret M, Antequera-Torres M, Manzanares S, Romo A, Blanca I, Ruiz S, Espinosa A, Castano S, Garcia B, Martinez-Herrada B, Vinyes G, Lafuente A, Becker JT, Galan JJ, Serrano-Rios M, Adni AD, Vazquez E, Tarraga L, Saez ME, L O Lopez, Real LM, Ruiz A.2011The membrane-spanning 4-domains, subfamily A (MS4A) gene cluster contains a common variant associated with Alzheimer's Disease. Genome Med. 2011 May 31;3(5):33. PMID: 21627779 [PubMed - as supplied by publisher] view
Ard MC, Edland SD2011Power calculations for clinical trials in Alzheimer's disease. J Alzheimers Dis. 2011;26 Suppl 3:369-77. Review. PMID: 21971476 [PubMed - indexed for MEDLINE]view
Babiloni C, Lizio R, Carducci F, Vecchio F, Redolfi A, Marino S, Tedeschi G, Montella P, Guizzaro A, Esposito F, Bozzao A, Giubilei F, Orzi F, Quattrocchi CC, Soricelli A, Salvatore E, Baglieri A, Bramanti P, Boccardi M, Ferri R, Cosentino F, Ferrara M, Mundi C, Grilli G, Pugliese S, Gerardi G, Parisi L, Vernieri F, Triggiani AI, Pedersen JT, Hårdemark HG, Rossini PM, Frisoni GB.2011Resting State Cortical Electroencephalographic Rhythms and White Matter Vascular Lesions in Subjects with Alzheimer's Disease: An Italian Multicenter Study."J Alzheimers Dis. 2011 Jun 14. [Epub ahead of print] PMID: 21673406 [PubMed - as supplied by publisher]view
Bakken TE, Dale AM, Schork NJ.2011A Geographic Cline of Skull and Brain Morphology among Individuals of European Ancestry. Hum Hered. 2011;72(1):35-44. Epub 2011 Aug 17. PMID: 21849792 [PubMed - in process]view
Bonner-Jackson A, Okonkwo O, Tremont G; and the Alzheimerʼs Disease Neuroimaging Initiative.2011Apolipoprotein E ε2 and Functional Decline in Amnestic Mild Cognitive Impairment and Alzheimer Disease. Am J Geriatr Psychiatry. 2011 Jun 15. [Epub ahead of print] PMID:21685781 [PubMed - as supplied by publisher] view
Bossa M, Zacur E, Olmos S; Alzheimer's Disease Neuroimaging Initiative.2011Statistical analysis of relative pose information of subcortical nuclei: Application on ADNI data. Neuroimage. 2011 Jan 6. [Epub ahead of print] PMID: 21216295 [PubMed - as supplied by publisher].view
Brown PJ, Devanand DP, Liu X, Caccappolo E; Alzheimer's Disease Neuroimaging Initiative.2011Functional impairment in elderly patients with mild cognitive impairment and mild Alzheimer disease.Arch Gen Psychiatry. 2011 Jun;68(6):617-26.view
Carmichael O, Xie J, Fletcher E, Singh B, Decarli C; Alzheimer's Disease Neuroimaging Initiative.2011Localized hippocampus measures are associated with Alzheimer pathology and cognition independent of total hippocampal volume. Neurobiol Aging. 2011 Dec 12. [Epub ahead of print] PMID: 22169204 [PubMed - as supplied by publisher]view
Casanova R, Whitlow CT, Wagner B, Williamson J, Shumaker SA, Maldjian JA, Espeland MA.2011High dimensional classification of structural MRI Alzheimer's disease data based on large scale regularization. Front Neuroinform. 2011;5:22. Epub 2011 Oct 14. PMID: 22016732 [PubMed - in process]view
Chen K, Ayutyanont N, Langbaum JB, Fleisher AS, Reschke C, Lee W, Liu X, Bandy D, Alexander GE, Thompson PM, Shaw L, Trojanowski JQ, Jack CR Jr, Landau SM, Foster NL, Harvey DJ, Weiner MW, Koeppe RA, Jagust WJ, Reiman EM; Alzheimer's Disease Neuroimaging Initiative.2011Characterizing Alzheimer's disease using a hypometabolic convergence index.Neuroimage. 2011 May 1;56(1):52-60. Epub 2011 Jan 27.PMID: 21276856 [PubMed - indexed for MEDLINE]view
Chiang GC, Insel PS, Tosun D, Schuff N, Truran-Sacrey D, Raptentsetsang S, Jack CR Jr, Weiner MW; Alzheimer's Disease Neuroimaging Initiative.2011Identifying cognitively healthy elderly individuals with subsequent memory decline by using automated MR temporoparietal volumes.Radiology. 2011 Jun;259(3):844-51. Epub 2011 Apr 5. PMID: 21467255 [PubMed - indexed for MEDLINE] view
Chiang GC, Insel PS, Tosun D, Schuff N, Truran-Sacrey D, Raptentsetsang ST, Thompson PM, Reiman EM, Jack CR Jr, Fox NC, Jagust WJ, Harvey DJ, Beckett LA, Gamst A, Aisen PS, Petersen RC, Weiner MW; Alzheimer's Disease Neuroimaging Initiative.2011Impact of apolipoprotein ɛ4-cerebrospinal fluid beta-amyloid interaction on hippocampal volume loss over 1 year in mild cognitive impairment. Alzheimers Dement. 2011 Sep;7(5):514-20. PMID: 21889115 [PubMed - in process]view
Chincarini A, Bosco P, Calvini P, Gemme G, Esposito M, Olivieri C, Rei L, Squarcia S, Rodriguez G, Bellotti R, Cerello P, De Mitri I, Retico A, Nobili F; The Alzheimer's Disease Neuroimaging Initiative.2011Local MRI analysis approach in the diagnosis of early and prodromal Alzheimer's disease." Neuroimage. 2011 Jun 16. [Epub ahead of print] PMID: 21718788 [PubMed - as supplied by publisher]view
Cho Y, Seong JK, Jeong Y, Shin SY; for the Alzheimer's Disease Neuroimaging Initiative.2011Individual subject classification for Alzheimer's disease based on incremental learning using a spatial frequency representation of cortical thickness data. Neuroimage. 2011 Oct 8. [Epub ahead of print] PMID: 22008371 [PubMed - as supplied by publisher]view
Chu C, Hsu AL, Chou KH, Bandettini P, Lin CP; for the Alzheimer's Disease Neuroimaging Initiative.2011Does feature selection improve classification accuracy? Impact of sample size and feature selection on classification using anatomical magnetic resonance images. Neuroimage. 2011 Dec 1. [Epub ahead of print] PMID: 22166797 [PubMed - as supplied by publisher]view
Clark DG; for the Alzheimer Disease Neuroimaging Initiative.2011Residual vectors for Alzheimer disease diagnosis and prognostication. Brain Behav. 2011 Nov;1(2):142-152. PMID: 22399094 [PubMed - as supplied by publisher]view
Cover KS, van Schijndel RA, van Dijk BW, Redolfi A, Knol DL, Frisoni GB, Barkhof F, Vrenken H; neuGRID; the Alzheimer's Disease Neuroimaging Initiative.2011Assessing the reproducibility of the SienaX and Siena brain atrophy measures using the ADNI back-to-back MP-RAGE MRI scans. Psychiatry Res. 2011 Jul 14. [Epub ahead of print] PMID: 21764565 [PubMed - as supplied by publisher]view
Cui Y, Liu B, Luo S, Zhen X, Fan M, Liu T, Zhu W, Park M, Jiang T, Jin JS; the Alzheimer's Disease Neuroimaging Initiative.2011Identification of Conversion from Mild Cognitive Impairment to Alzheimer's Disease Using Multivariate Predictors. PLoS One. 2011;6(7):e21896. Epub 2011 Jul 21. PMID: 21814561 [PubMed - as supplied by publisher] Free PMC Article view
Cuingnet R, Rosso C, Chupin M, Lehéricy S, Dormont D, Benali H, Samson Y, Colliot O2011Spatial regularization of SVM for the detection of diffusion alterations associated with stroke outcome.Med Image Anal. 2011 Oct;15(5):729-37. Epub 2011 Jun 6.PMID:21752695[PubMed - in process] view
David R, Friedman L, Mulin E, Noda A, Le Duff F, Kennedy Q, Garcia R, Robert PH, Yesavage JA, Zeitzer JM.2011Lack of Association Between COMT Polymorphisms and Apathy in Alzheimer's Disease.J Alzheimers Dis. 2011 Jul 22. [Epub ahead of print]PMID: 21785189 [PubMed - as supplied by publisher]view
Desikan RS, McEvoy LK, Thompson WK, Holland D, Roddey JC, Blennow K, Aisen PS, Brewer JB, Hyman BT, Dale AM.2011Amyloid-β associated volume loss occurs only in the presence of phospho-tau. Ann Neurol. 2011 Jun 7. doi: 10.1002/ana.22509. [Epub ahead of print] PMID: 22002658 [PubMed - as supplied by publisher]view
Dickerson BC, Wolk DA; the Alzheimer's Disease Neuroimaging Initiative. 2011Dysexecutive versus amnesic phenotypes of very mild Alzheimer's disease are associated with distinct clinical, genetic and cortical thinning characteristics. J Neurol Neurosurg Psychiatry. 82:45-51, 2011.view
Donohue MC, Gamst AC, Aisen PS.2011Requiring an amyloid-β1-42 biomarker for prodromal Alzheimer's disease or mild cognitive impairment does not lead to more efficient clinical trials. Alzheimers Dement. 2011 Mar;7(2):245-6; author reply 247-9. No abstract available.PMID: 21414558 [PubMed - indexed for MEDLINE]view
Donohue MC, Gamst AC, Thomas RG, Xu R, Beckett L, Petersen RC, Weiner MW, Aisen P; for the Alzheimer's Disease Neuroimaging Initiative.2011 The relative efficiency of time-to-threshold and rate of change in longitudinal data. Contemp Clin Trials. Epub ahead of print, 2011.view
Dukart J, Mueller K, Horstmann A, Barthel H, Möller HE, Villringer A, Sabri O, Schroeter ML.2011Combined evaluation of FDG-PET and MRI improves detection and differentiation of dementia.PLoS One. 2011 Mar 23;6(3):e18111.PMID: 21448435 [PubMed - indexed for MEDLINE] view
Erten-Lyons D, Wilmot B, Anur P, McWeeney S, Westaway SK, Silbert L, Kramer P, Kaye J2011Microcephaly genes and risk of late onset Alzheimer Disease. Alzheimer Dis Assoc Disord. Epub ahead of print, 2011. view
Escudero J, Zajicek JP, Ifeachor E.2011Machine Learning classification of MRI features of Alzheimer's disease and mild cognitive impairment subjects to reduce the sample size in clinical trials. Conf Proc IEEE Eng Med Biol Soc. 2011 Aug;2011:7957-60. PMID: 22256186 [PubMed - in process]view
Eskildsen SF, Coupé P, Fonov V, Manjón JV, Leung KK, Guizard N, Wassef SN, Ostergaard LR, Collins DL; The Alzheimer's Disease Neuroimaging Initiative.2011BEaST: Brain extraction based on nonlocal segmentation technique. Neuroimage. 2011 Sep 16. [Epub ahead of print] PMID: 21945694 [PubMed - as supplied by publisher]view
Ewers M, Insel P, Jagust WJ, Shaw L, Trojanowski J JQ, Aisen P, Petersen RC, Schuff N, Weiner MW; for the Alzheimer’s Disease Neuroimaging Initiative (ADNI).2011CSF Biomarker and PIB-PET-Derived Beta-Amyloid Signature Predicts Metabolic, Gray Matter, and Cognitive Changes in Nondemented Subjects. Cereb Cortex. 2011 Oct 29. [Epub ahead of print] PMID: 22038908 [PubMed - as supplied by publisher]view
Ewers M, Schmits S, Hansson O, Walsh C, Fitzpatrick A, Bennett D, Monthon L, Trojanowski JQ, Shaw LM, Faluyi YO, Vellas B, Dubois B, Blennow K, Buerger K, Tiepel SJ, Weiner M, Hampel H, Alzheimer's Disease Neuroimaging Initiative 2011Body mass index is associated with biological CSF markers of core brain pathology of Alzheimer's disease. Neurobiology of Aging, epub ahead of print. PMID: 21684041view
Gomar JJ, Bobes-Bascaran MT, Conejero-Goldberg C, Davies P, Goldberg TE; for the Alzheimer's Disease Neuroimaging Initiative 2011Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's Disease Neuroimaging Initiative. Archives of General Psychiatry, 68: 961-969. PMID: 21893661view
Hampel H, Wilcock G, Andrieu S, Aisen P, Blennow K, Broich K, Carrillo M, Fox NC, Frisoni GB, Isaac M, Lovestone S, Nordberg A, Prvulovic D, Sampaio C, Scheltens P, Weiner M, Winblad B, Coley N, Vellas B; Oxford Task Force Group.2011Biomarkers for Alzheimer's disease therapeutic trials. Prog Neurobiol. 2011 Dec;95(4):579-93. Epub 2010 Dec 2. Review. PMID: 21130138 [PubMed - indexed for MEDLINE]view
Heckemann RA, Keihaninejad S, Aljabar P, Gray KR, Nielsen C, Rueckert D, Hajnal JV, Hammers A; The Alzheimer's Disease Neuroimaging Initiative.2011Automatic morphometry in Alzheimer's disease and mild cognitive impairment. Neuroimage. 2011 Mar 10. [Epub ahead of print] PMID: 21397703 [PubMed - as supplied by publisher]view
Heister D, Brewer JB, Magda S, Blennow K, McEvoy LK; Alzheimer's Disease Neuroimaging Initiative.2011Predicting MCI outcome with clinically available MRI and CSF biomarkers. Neurology. 2011 Oct 25;77(17):1619-28. Epub 2011 Oct 12. PMID: 21998317 [PubMed - indexed for MEDLINE]view
Henley DB, Sundell KL, Sethuraman G, Siemers ER; Alzheimer’s Disease Neuroimaging Initiative2011Safety profile of Alzheimer's disease populations in Alzheimer's Disease Neuroimaging Initiative and other 18-month studies. Alzheimers Dement. 2011 Dec 2. [Epub ahead of print] PMID: 22138370 [PubMed - as supplied by publisher]view
Herholz K, Westwood S, Haense C, Dunn G.2011Evaluation of a Calibrated 18F-FDG PET Score as a Biomarker for Progression in Alzheimer Disease and Mild Cognitive Impairment. J Nucl Med. 2011 Jul 15. [Epub ahead of print] PMID: 21764801 [PubMed - as supplied by publisher]view
Hibar DP, Stein JL, Kohannim O, Jahanshad N, Saykin AJ, Shen L, Kim S, Pankratz N, Foroud T, Huentelman MJ, Potkin SG, Jack CR Jr, Weiner MW, Toga AW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative.2011Voxelwise gene-wide association study (vGeneWAS): multivariate gene-based association testing in 731 elderly subjects. Neuroimage. 2011 Jun 15;56(4):1875-91. Epub 2011 Apr 8. PMID: 21497199 [PubMed - indexed for MEDLINE]view
Hinrichs C, Singh V, Xu G, Johnson SC, The ADNI2011Predicitve markers for AD in a multi-modality framework: An analysis of MCI progression in the ADNI population. Neuroimage. Epub ahead of print, 2011. view
Holland D, Dale AM; the Alzheimer’s Disease Neuroimaging Initiative.2011Nonlinear registration of longitudinal images and measurement of change in regions of interest. Med Image Anal. 2011 Feb 23. [Epub ahead of print] PMID: 21388857 [PubMed - as supplied by publisher]view
Holland D, McEvoy LK, Dale AM; the Alzheimer's Disease Neuroimaging Initiative.2011Unbiased comparison of sample size estimates from longitudinal structural measures in ADNI. Hum Brain Mapp. 2011 Aug 9. doi: 10.1002/hbm.21386. [Epub ahead of print] PMID: 21830259 [PubMed - as supplied by publisher] view
Hollingworth P, Harold D, Sims R, Gerrish A, Lambert JC, Carrasquillo MM, Abraham R, Hamshere ML, Pahwa JS, Moskvina V, et. al.2011Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet. 2011 May;43(5):429-35. Epub 2011 Apr 3. PMID: 21460840 [PubMed - indexed for MEDLINE] Related citationsview
Hu X, Pickering E, Liu YC, Hall S, Fournier H, Katz E, Dechairo B, John S, Van Eerdewegh P, Soares H; the Alzheimer's Disease Neuroimaging Initiative.2011Meta-Analysis for Genome-Wide Association Study Identifies Multiple Variants at the BIN1 Locus Associated with Late-Onset Alzheimer's Disease. PLoS One. 2011 Feb 24;6(2):e16616. PMID: 21390209 [PubMed - as supplied by publisher] Free Article view
Hua X, Gutman B, Boyle CP, Rajagopalan P, Leow AD, Yanovsky I, Kumar AR, Toga AW, Jack CR Jr, Schuff N, Alexander GE, Chen K, Reiman EM, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative.2011Accurate measurement of brain changes in longitudinal MRI scans using tensor-based morphometry. Neuroimage. 2011 Jul 1;57(1):5-14. Epub 2011 Feb 23. PMID: 21320612 [PubMed - indexed for MEDLINE]view
Hurko O, Black SE, Doody R, Doraiswamy PM, Gamst A, Kaye J, Obisesan T, Rusinek H, Scharre D, Sperling R, Weinerk MW, Green RC; for the ADNI Data and Publication Committee.2011The ADNI Publication Policy: Commensurate recognition of critical contributors who are not authors. Neuroimage. 2011 Nov 4. [Epub ahead of print] PMID: 22100665 [PubMed - as supplied by publisher]view
Iglesias JE, Jiang J, Liu CY, Tu Z; Alzheimers Disease Neuroimaging Initiative.2011Classification of Alzheimer's disease using a self-smoothing operator. Med Image Comput Comput Assist Interv. 2011;14(Pt 3):58-65. PMID: 22003684 [PubMed - in process]view
Institute of Medicine (US) Forum on Neuroscience and Nervous System Disorders.2011Future Opportunities to Leverage the Alzheimer’s Disease Neuroimaging Initiative: Workshop Summary.Washington (DC): National Academies Press (US); 2011. PMID: 21796827 [PubMed] Books & Documents view
Jack CR Jr, Vemuri P, Wiste HJ, Weigand SD, Aisen PS, Trojanowski JQ, Shaw LM, Bernstein MA, Petersen RC, Weiner MW, Knopman DS; Alzheimer's Disease Neuroimaging Initiative.2011Evidence for ordering of Alzheimer disease biomarkers. Arch Neurol. 2011 Dec;68(12):1526-35. Epub 2011 Aug 8. PMID: 21825215 [PubMed - indexed for MEDLINE]view
Jack CR Jr, Vemuri P, Wiste HJ, Weigand SD, Aisen PS, Trojanowski JQ, Shaw LM, Bernstein MA, Petersen RC, Weiner MW, Knopman DS; for the Alzheimer's Disease Neuroimaging Initiative.2011Evidence for Ordering of Alzheimer Disease Biomarkers. Arch Neurol. 2011 Aug 8. [Epub ahead of print] PMID: 21825215 [PubMed - as supplied by publisher] view
Jennings JR, Mendelson DN, Muldoon MF, Ryan CM, Gianaros PJ, Raz N, Aisenstein H 2011Regional grey matter shrinks in hypertensive individuals despite successful lowering of blood pressure.Journal of Human Hypertension, epub ahead of print PMCID: PMC3137674view
John SK Kauwe, Carlos Cruchaga, Sarah Bertelsen, Kevin Mayo, Wayne Latu, Petra Nowotny, Anthony L Hinrichs, Anne M Fagan, David M Holtzman, Alzheimer's Disease Neuroimaging Initiative, and Alison M Goate J Alzheimers Dis.2011Validating predicted biological effects of Alzheimer's disease associated SNPs using CSF biomarker levels Author manuscript; available in PMC 2011 February 2. PMCID: PMC3032214 Published in final edited form as: J Alzheimers Dis. 2010; 21(3): 833–842. doi: 10.3233/JAD-2010-091711.view
Kauwe JS, Cruchaga C, Karch CM, Sadler B, Lee M, Mayo K, Latu W, Su'a M, Fagan AM, Holtzman DM, Morris JC; Alzheimer's Disease Neuroimaging Initiative, Goate AM.2011Fine mapping of genetic variants in BIN1, CLU, CR1 and PICALM for association with cerebrospinal fluid biomarkers for Alzheimer's disease. PLoS One. 2011 Feb 9;6(2):e15918. PMID: 21347408 [PubMed - in process] Free PMC Article view
Khachaturian ZS, Petersen RC, Snyder PJ, Khachaturian AS, Aisen P, de Leon M, Greenberg BD, Kukull W, Maruff P, Sperling RA, Stern Y, Touchon J, Vellas B, Andrieu S, Weiner MW, Carrillo MC, Bain LJ.2011Developing a global strategy to prevent Alzheimer's disease: Leon Thal Symposium 2010." Alzheimers Dement. 2011 Mar;7(2):127-32. PMID: 21414553 [PubMed - indexed for MEDLINE]view
Kloszewska I, Wahlund LO, Soininen H, Lovestone S, Evans A, Spenger C, for the AddNeuroMed Consortium, Simmons A, Westman E, Muehlboeck S, Mecocci P, Vellas B, Tsolaki M, :2011The AddNeuroMed framework for multi-centre MRI assessment of Alzheimer's disease: experience from the first 24 months. Geriatric Psychiatry. 26: 75-82, 2011. view
Koikkalainen J, Läotjäonen J, Thurfjell L, Rueckert D, Waldemar G, Soininen H; the Alzheimer's Disease Neuroimaging Initiative.2011Multi-Template Tensor-Based Morphometry: Application to Analysis of Alzheimer's Disease. Neuroimage. 2011 Mar 15. [Epub ahead of print] PMID: 21419228 [PubMed - as supplied by publisher] view
Leslie M. Shaw, Hugo Vanderstichele, Malgorzata Knapik-Czajka, Michal Figurski, Els Coart, Kaj Blennow, Holly Soares, Adam J. Simon, Piotr Lewczuk, Robert A. Dean, Eric Siemers, William Potter, Virginia M.-Y. Lee, John Q. Trojanowski, Alzheimer’s Disease Neuroimaging Initiative2011Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI Acta Neuropathol. Author manuscript; available in PMC 2011 September 17. Published in final edited form as: Acta Neuropathol. 2011 May; 121(5): 597–609. Published online 2011 February 11. doi: 10.1007/s00401-011-0808-0 PMCID: PMC3175107view
Li X, Long X, Laurienti P, Wyatt C.2011Registration of Images With Varying Topology Using Embedded Maps. IEEE Trans Med Imaging. 2011 Dec 20. [Epub ahead of print] PMID: 22194239 [PubMed - as supplied by publisher]view
Li Y, Wang Y, Wu G, Shi F, Zhou L, Lin W, Shen D; The Alzheimer's Disease Neuroimaging Initiative.2011Discriminant analysis of longitudinal cortical thickness changes in Alzheimer's disease using dynamic and network features. Neurobiol Aging. 2011 Jan 25. [Epub ahead of print] PMID: 21272960 [PubMed - as supplied by publisher].view
Liao S, Jia H, Wu G, Shen D, The Alzheimer's Disease Neuroimaging Initiative.2011A pilot study of quantitative MRI measurements of ventricular volume and cortical atrophy for the differential diagnosis of normal pressure hydrocephalus.Neurol Res Int. 2012;2012:718150. Epub 2011 Aug 7.PMID: 21860791 [PubMed - in process]view
Llano DA, Laforet G, Devanarayan V, ADNI 2011Derivation of a new ADAS-cog Composite Using Tree-based Multivariate Analysis: Prediction of Conversion From Mild Cognitive Impairment to Alzheimer Diseaes. Alz. Dis. Assoc. Disord., 25:73-84, 2011. PMID: 20847637view
Lo RY, Hubbard AE, Shaw LM, Trojanowski JQ, Petersen RC, Aisen PS, Weiner MW, Jagust WJ; Alzheimer's Disease Neuroimaging Initiative.2011Longitudinal change of biomarkers in cognitive decline. Arch Neurol. 2011 Oct;68(10):1257-66. Epub 2011 Jun 13. PMID: 21670386 [PubMed - indexed for MEDLINE]view
Lötjönen J, Wolz R, Koikkalainen J, Julkunen V, Thurfjell L, Lundqvist R, Waldemar G, Soininen H, Rueckert D; The Alzheimer's Disease Neuroimaging Initiative.2011Fast and robust extraction of hippocampus from MR images for diagnostics of Alzheimer's disease. Neuroimage. 2011 Jan 28. [Epub ahead of print] PMID: 21281717 [PubMed - as supplied by publisher].view
Mackin RS, Insel P, Aisen PS, Geda YE, Weiner MW.2011Longitudinal stability of subsyndromal symptoms of depression in individuals with mild cognitive impairment: relationship to conversion to dementia after 3 years. Int J Geriatr Psychiatry. 2011 Jul 8. doi: 10.1002/gps.2713. [Epub ahead of print] PMID: 21744390 [PubMed - as supplied by publisher]view
Markiewicz PJ, Matthews JC, Declerck J, Herholz K, for the Alzheimer's Disease Neuroimaging Initiative 2011Verification of predicted robustness and accuracy of multivariate analysis. Neuroimage, Epub ahead of print, 2011 PMID: 21338696view
Marshal GA, Rentz DM, Frey MT, Locascio JJ, Johnson KA, Sperling RA, Alzheimer's Diease Neuroimaing Initiative2011Executive function and instrumental activities of daily living in mild cognitive impairment and Alzheimer's disease. Alzheimer's & Dementia, 7:300-308, 2011. view
Marshall GA, Olson LE, Frey MT, Maye J, Becker JA, Rentz DM, Sperling RA, Johnson KA.2011Instrumental activities of daily living impairment is associated with increased amyloid burden.Dement Geriatr Cogn Disord. 2011;31(6):443-50. Epub 2011 Jul 20.PMID:21778725 [PubMed - in process] view
Mattila J, Koikkalainen J, Virkki A, Simonsen A, van Gils M, Waldemar G, Soininen H, Lötjönen J.2011A Disease State Fingerprint for Evaluation of Alzheimer's Disease.J Alzheimers Dis. 2011 Jul 28. [Epub ahead of print] PMID: 21799247 [PubMed - as supplied by publisher]view
McEvoy LK, Holland D, Hagler DJ Jr, Fennema-Notestine C, Brewer JB, Dale AM; Alzheimer's Disease Neuroimaging Initiative.2011Mild cognitive impairment: baseline and longitudinal structural MR imaging measures improve predictive prognosis. Radiology. 2011 Jun;259(3):834-43. Epub 2011 Apr 6. PMID: 21471273 [PubMed - indexed for MEDLINE] view
Moore DW, Kovanlikaya I, Heier LA, Raj A, Huang C, Chu KW, Relkin NR.2011A pilot study of quantitative MRI measurements of ventricular volume and cortical atrophy for the differential diagnosis of normal pressure hydrocephalus.Neurol Res Int. 2012;2012:718150. Epub 2011 Aug 7.PMID: 21860791 [PubMed - in process]view
Murphy EA, Roddey JC, McEvoy LK, Holland D, Hagler DJ Jr, Dale AM, Brewer JB 2011CETP polymorphisms associate with brain structure, atrophy rate, and Alzheimer's disease risk in an APOE-dependent manner. Alzheimer's Disease Neuroimaging Initiative Brain Imaging Behavior, epub ahead of print PMID: 21892657view
Naj AC, Jun G, Beecham GW, Wang LS, Vardarajan BN, Buros J, Gallins PJ, Buxbaum JD, Jarvik GP, Crane PK, Larson EB, et al.2011Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.Nat Genet. 2011 May;43(5):436-41. Epub 2011 Apr 3. PMID: 21460841 [PubMed - indexed for MEDLINE]view
Nho K, Shen L, Kim S, Swaminathan S, Risacher SL, Saykin AJ; the Alzheimer’s Disease Neuroimaging Initiative (ADNI).2011The Effect of Reference Panels and Software Tools on Genotype Imputation. AMIA Annu Symp Proc. 2011;2011:1013-1018. Epub 2011 Oct 22. PMID: 22195161 [PubMed - as supplied by publisher]view
O'Bryant SE, Xiao G, Barber R, Huebinger R, Wilhelmsen K, Edwards M, Graff-Radford N, Doody R, Diaz-Arrastia R; for the Texas Alzheimer's Research & Care Consortium; for the Alzheimer's Disease Neuroimaging Initiative.2011A Blood-Based Screening Tool for Alzheimer's Disease That Spans Serum and Plasma: Findings from TARC and ADNI. PLoS One. 2011;6(12):e28092. Epub 2011 Dec 7. PMID: 22163278 [PubMed - as supplied by publisher] Free PMC Article view
Oscar Acosta, Pierrick Bourgeat, Maria A. Zuluaga, Jurgen Fripp, Olivier Salvado, Sébastien Ourselin, and Alzheimer’s Disease Neuroimaging Initiative2011Automated voxel-based 3D cortical thickness measurement in a combined Lagrangian–Eulerian PDE approach using partial volume maps Med Image Anal. Author manuscript; available in PMC 2011 March 31. PMCID: PMC3068613 view
Pachauri D, Hinrichs C, Chung M, Johnson S, Singh V.2011Topology based Kernels with application to inference problems in Alzheimer's disease. IEEE Trans Med Imaging, 29 April 2011 view
Padilla P, Gorriz J, Ramirez J, Salas-Gonzalez D, Illan I.2011NMF-SVM Based CAD Tool Applied to Functional Brain Images for the Diagnosis of Alzheimer's Disease. IEEE Trans Med Imaging. 2011 Sep 12. [Epub ahead of print] PMID:21914569 [PubMed - as supplied by publisher] view
Pontecorvo MJ, Mintun MA.2011PET amyloid imaging as a tool for early diagnosis and identifying patients at risk for progression to Alzheimer's disease. Alzheimers Res Ther. 2011 Mar 29;3(2):11. [Epub ahead of print] PMID: 21457498 [PubMed - as supplied by publisher] view
Poulin SP, Dautoff R, Morris JC, Barrett LF, Dickerson BC, Alzheimer's Disease Neuroimaging Initiative 2011Amygdala atrophy is prominent in early Alzheimer's disease and relates to symptom severity.Psychiatry Res. 194:7-13 PMID: 21920712 PMCID: PMC3185127view
Rafii M, Taylor C, Coutinho A, Kim K, Galasko D.2011Comparison of the memory performance index with standard neuropsychological measures of cognition. Am J Alzheimers Dis Other Demen. 2011 May;26(3):235-9. Epub 2011 Mar 15. PMID: 21406427 [PubMed - indexed for MEDLINE]view
Rafii MS, Walsh S, Little JT, Behan K, Reynolds B, Ward C, Jin S, Thomas R, Aisen PS; Alzheimer's Disease Cooperative Study.2011A phase II trial of huperzine A in mild to moderate Alzheimer disease. Neurology. 2011 Apr 19;76(16):1389-94. PMID:21502597 view
Rajagopalan P, Hua X, Toga AW, Jack CR Jr, Weiner MW, Thompson PM.2011Homocysteine effects on brain volumes mapped in 732 elderly individuals. Neuroreport. 2011 Jun 11;22(8):391-5. PMID: 21512418 [PubMed - indexed for MEDLINE] view
Rammouz G, Lecanu L, Aisen P, Papadopoulos V.2011A Lead Study on Oxidative Stress-Mediated Dehydroepiandrosterone Formation in Serum: The Biochemical Basis for a diagnosis of Alzheimer’s Disease Journal of Alzheimer's Disease 24 (2011) 5-16 DOI 10.3233/JAD-2011-101941 IOS Press PMID: 21335661 [PubMed - in process] view
Rasmussen J, Lakatos A, van Erp TG, Kruggel F, Keator DB, Fallon J, Macciardi F, Potkin SG; Alzheimer's Disease Neuroimaging Initiative.2011Empirical derivation of the reference region for computing diagnostic sensitive (18)fluorodeoxyglucose ratios in Alzheimer's disease based on the ADNI sample. Biochim Biophys Acta. 2011 Sep 19. [Epub ahead of print] PMID: 21958592 [PubMed - as supplied by publisher]view
Reiman EM, Langbaum JB, Fleisher AS, Caselli RJ, Chen K, Ayutyanont N, Quiroz YT, Kosik KS, Lopera F, Tariot PN.2011Alzheimer's Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments. J Alzheimers Dis. 2011;26 Suppl 3:321-9. Review. PMID: 21971471 [PubMed - indexed for MEDLINE] view
Samtani MN, Farnum M, Lobanov V, Yang E, Raghavan N, Dibernardo A, Narayan V, Initiative AD.2011An Improved Model for Disease Progression in Patients From the Alzheimer's Disease Neuroimaging Initiative.J Clin Pharmacol. 2011 Jun 9. PMID: 21659625 [PubMed - as supplied by publisher] view
Sano M, Bell KL, Galasko D, Galvin JE, Thomas RG, van Dyck CH, Aisen PS.2011A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease. Neurology. 2011 Aug 9;77(6):556-63. Epub 2011 Jul 27. PMID:21795660view
Sano M, Raman R, Emond J, Thomas RG, Petersen R, Schneider LS, Aisen PS.2011Adding delayed recall to the Alzheimer Disease Assessment Scale is useful in studies of mild cognitive impairment but not Alzheimer disease. Alzheimer Dis Assoc Disord. 2011 Apr-Jun;25(2):122-7. PMID: 20921876 [PubMed - indexed for MEDLINE]view
Schmand B, Eikelenboom P, van Gool WA, the Alzheimer's Disease Neuroimaging Initiative 2011Value of neuropsychological tests, neuroimaging, and biomarkers for diagnosing Alzheimer's disease in younger and older age cohorts. Journal of the American Geriatric Society, epub ahead of print, 2011. PMID: 21883100view
Schneider LS, Insel PS, Weiner MW; for the Alzheimer's Disease Neuroimaging Initiative.2011Treatment With Cholinesterase Inhibitors and Memantine of Patients in the Alzheimer's Disease Neuroimaging Initiative. Arch Neurol. 2011 Jan;68(1):58-66. PMID: 21220675 [PubMed - as supplied by publisher] Related citations.view
Schott JM; ADNI Investigators.2011Using CSF biomarkers to replicate genetic associations in Alzheimer's disease. Neurobiol Aging. 2011 Apr 1. [Epub ahead of print] PMID: 21459483 [PubMed - as supplied by publisher]view
Shen L, Kim S, Qi Y, Inlow M, Swaminathan S, Nho K, Wan J, Risacher SL, Shaw LM, Trojanowski JQ, Weiner MW, Saykin AJ; ADNI.2011Identifying Neuroimaging and Proteomic Biomarkers for MCI and AD via the Elastic Net. Lect Notes Comput Sci. 2011;7012:27-34. PMID: 22039314 [PubMed]view
Shi Y, Lai R, Toga AW.2011CoRPORATE: cortical reconstruction by pruning outliers with Reeb analysis and topology-preserving evolution. Inf Process Med Imaging. 2011;22:233-44. PMID: 21761660 [PubMed - in process] view
Spaminato MV, Rumbolt Z, Hosker RJ, Mintzer JE, Alzheimer's Disease Neuroimaging Initiative2011Apolipoportein E and gray matter volume loss in patients with mild cognitive impairment and Alzheimer disease. Radiology. Epub ahead of print, 2011 view
Spiegel R, Berres M, Miserez AR, Monsch AU.2011For debate: substituting placebo controls in long-term Alzheimer's prevention trials. Alzheimers Res Ther. 2011 Mar 21;3(2):9. [Epub ahead of print] PMID: 21418632 [PubMed - as supplied by publisher] view
Stein JL, Hibar DP, Madsen SK, Khamis M, McMahon KL, de Zubicaray GI, Hansell NK, Montgomery GW, Martin NG, Wright MJ, Saykin AJ, Jack CR Jr, Weiner MW, Toga AW, Thompson PM.2011Discovery and replication of dopamine-related gene effects on caudate volume in young and elderly populations (N=1198) using genome-wide search. Mol Psychiatry. 2011 Apr 19. [Epub ahead of print] PMID: 21502949 [PubMed - as supplied by publisher]view
Stricker NH, Chang YL, Fennema-Notestine C, Delano-Wood L, Salmon DP, Bondi MW, Dale AM, for the Alzheimer's Disease Neuroimaging Initiative 2011Distinct profiles of brain and cognitive changes in the very old with Alzheimer disease. Neurology, 77:713-721. PMCID: PMC3164395view
Swaminathan S, Kim S, Shen L, Risacher SL, Foroud T, Pankratz N, Potkin SG, Huentelman MJ, Craig DW, Weiner MW, Saykin AJ, The Alzheimer's Disease Neuroimaging Initiative Adni.2011Genomic Copy Number Analysis in Alzheimer's Disease and Mild Cognitive Impairment: An ADNI Study. 2011;2011:729478. Epub 2011 Jun 2. PMID: 21660214 [PubMed - in process] view
Swaminathan S, Shen L, Risacher SL, Yoder KK, West JD, Kim S, Nho K, Foroud T, Inlow M, Potkin SG, Huentelman MJ, Craig DW, Jagust WJ, Koeppe RA, Mathis CA, Jack CR Jr, Weiner MW, Saykin AJ; the Alzheimer’s Disease Neuroimaging Initiative (ADNI).2011Amyloid pathway-based candidate gene analysis of [(11)C]PiB-PET in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort.Brain Imaging Behav. 2011 Sep 8. [Epub ahead of print]PMID: 21901424 [PubMed - as supplied by publisher]view
Tariot PN, Schneider LS, Cummings J, Thomas RG, Raman R, Jakimovich LJ, Loy R, Bartocci B, Fleisher A, Ismail MS, Porsteinsson A, Weiner M, Jack CR Jr, Thal L, Aisen PS; for the Alzheimer's Disease Cooperative Study Group.2011"Chronic Divalproex Sodium to Attenuate Agitation and Clinical Progression of Alzheimer Disease. Arch Gen Psychiatry. 2011 Aug;68(8):853-861. PMID: 21810649 [PubMed - as supplied by publisher] " view
Thompson WK, Hallmayer J, O'Hara R, Alzheimer's Disease Neuroimaging Initiative 2011Design considerations fro characterizing psychiatric trajectories across the lifespan: Application to effects of APOE e4 on cerebral cortical thickness in Alzheimer's disease. American Journal of Psychiatry, 168:894-903. PMID: 21724665view
Thompson WK, Holland D; Alzheimer's Disease Neuroimaging Initiative.2011Bias in tensor based morphometry Stat-ROI measures may result in unrealistic power estimates. Neuroimage. 2011 Jul 1;57(1):1-4; discussion 5-14. Epub 2011 Feb 22. PMID:21349340 [PubMed - indexed for MEDLINE] view
Toledo JB, Vanderstichele H, Figurski M, Aisen PS, Petersen RC, Weiner MW, Jack CR Jr, Jagust W, Decarli C, Toga AW, Toledo E, Xie SX, Lee VM, Trojanowski JQ, Shaw LM.2011Factors affecting Aβ plasma levels and their utility as biomarkers in ADNI. Acta Neuropathol. 2011 Oct;122(4):401-13. Epub 2011 Jul 30. PMID: 21805181 [PubMed - in process]view
Tosun D, Schuff N, Mathis CA, Jagust W, Weiner MW; Alzheimer's Disease NeuroImaging Initiative.2011Spatial patterns of brain amyloid-beta burden and atrophy rate associations in mild cognitive impairment." Brain. 2011 Apr;134(Pt 4):1077-88. Epub 2011 Mar 22. PMID: 21429865 [PubMed - indexed for MEDLINE]view
Tractenberg RE, Pietrzak RH.2011Intra-individual variability in Alzheimer's disease and cognitive aging: definitions, context, and effect sizes. PLoS One. 2011 Apr 19;6(4):e16973. PMID: 21526188 [PubMed - in process] Free Article view
Vemuri P, Weigand SD, Przybelski SA, Knopman DS, Smith GE, Trojanowski JQ, Shaw LM, Decarli CS, Carmichael O, Bernstein MA, Aisen PS, Weiner M, Petersen RC, Jack CR Jr; Alzheimer's Disease Neuroimaging Initiative.2011Cognitive reserve and Alzheimer's disease biomarkers are independent determinants of cognition. Brain. 2011 May;134(Pt 5):1479-92. Epub 2011 Apr 7. PMID: 21478184 [PubMed - indexed for MEDLINE] view
Vidoni ED, Townley RA, Honea RA, Burns JM; For the Alzheimer's Disease Neuroimaging Initiative.2011Alzheimer disease biomarkers are associated with body mass index. Neurology. 2011 Nov 22;77(21):1913-1920. PMID: 22105948 [PubMed - as supplied by publisher]view
Wang H, Nie F, Huang H, Kim S, Nho K, Risacher SL, Saykin AJ, Shen L; For the Alzheimer’s Disease Neuroimaging Initiative.2011Identifying Quantitative Trait Loci via Group-Sparse Multi-Task Regression and Feature Selection: An Imaging Genetics Study of the ADNI Cohort. Bioinformatics. 2011 Dec 6. [Epub ahead of print] PMID: 22155867 [PubMed - as supplied by publisher]view
Wang H, Nie F, Huang H, Risacher S, Saykin AJ, Shen L; ADNI.2011Identifying AD-sensitive and cognition-relevant imaging biomarkers via joint classification and regression. Med Image Comput Comput Assist Interv. 2011;14(Pt 3):115-23. PMID: 22003691 [PubMed - indexed for MEDLINE]view
Wang Y, Song Y, Rajagopalan P, An T, Liu K, Chou YY, Gutman B, Toga AW, Thompson PM; The Alzheimer's Disease Neuroimaging Initiative.2011Surface-based TBM boosts power to detect disease effects on the brain: An N=804 ADNI study. Neuroimage. 2011 Mar 23. [Epub ahead of print] PMID: 21440071 [PubMed - as supplied by publisher] view
Weigand SD, Vemuri P, Wiste HJ, Senjem ML, Pankratz VS, Aisen PS, Weiner MW, Petersen RC, Shaw LM, Trojanowski JQ, Knopman DS, Jack CR Jr; Alzheimer's Disease Neuroimaging Initiative.2011Transforming cerebrospinal fluid Aβ42 measures into calculated Pittsburgh Compound B units of brain Aβ amyloid."Alzheimers Dement. 2011 Mar;7(2):133-41. Epub 2011 Feb 1. PMID: 21282074 [PubMed - indexed for MEDLINE]view
Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Green RC, Harvey D, Jack CR, Jagust W, Liu E, Morris JC, Petersen RC, Saykin AJ, Schmidt ME, Shaw L, Siuciak JA, Soares H, Toga AW, Trojanowski JQ; Alzheimer’s Disease Neuroimaging Initiative.2011The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception. Alzheimers Dement. 2011 Oct 31. [Epub ahead of print] PMID: 22047634 [PubMed - as supplied by publisher]view
Westman E, Simmons A, Muehlboeck JS, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Weiner MW, Lovestone S, Spenger C, Wahlund LO; for the AddNeuroMed consortium and the Alzheimer's Disease Neuroimaging Initiative.2011AddNeuroMed and ADNI: Similar patterns of Alzheimer's atrophy and automated MRI classification accuracy in Europe and North America.Neuroimage. 2011 Jul 1. [Epub ahead of print]PMID: 21763442 [PubMed - as supplied by publisher]view
Wolz R, Aljabar P, Hajnal JV, Lötjönen J, Rueckert D; The Alzheimer’s Disease Neuroimaging Initiative.2011Nonlinear dimensionality reduction combining MR imaging with non-imaging information. Med Image Anal. 2011 Dec 22. [Epub ahead of print] PMID: 22244037 [PubMed - as supplied by publisher]view
Wolz R, Julkunen V, Koikkalainen J, Niskanen E, Zhang DP, Rueckert D, Soininen H, Lötjönen J; Alzheimer's Disease Neuroimaging Initiative.2011Multi-method analysis of MRI images in early diagnostics of Alzheimer's disease. PLoS One. 2011;6(10):e25446. Epub 2011 Oct 13. PMID: 22022397 [PubMed - indexed for MEDLINE] Free PMC Article view
Wolz R, Julkunen V, Koikkalainen J, Niskanen E, Zhang DP, Rueckert D, Soininen H, Lötjönen J; the Alzheimer's Disease Neuroimaging Initiative.2011Multi-Method Analysis of MRI Images in Early Diagnostics of Alzheimer's Disease. PLoS One. 2011;6(10):e25446. Epub 2011 Oct 13. PMID: 22022397 [PubMed - as supplied by publisher] view
Yang W, Lui RL, Gao JH, Chan TF, Yau ST, Sperling RA, Huang X.2011Independent component analysis-based classification of Alzheimer's disease MRI data.J Alzheimers Dis. 2011 Jan;24(4):775-83.PMID:21321398 [PubMed - in process] view
Yesavage JA, Noda A, Hernandez B, Friedman L, Cheng JJ, Tinklenberg JR, Hallmayer J, O'hara R, David R, Robert P, Landsverk E, Zeitzer JM; Alzheimer's Disease Neuroimaging Initiative2011Circadian clock gene polymorphisms and sleep--wake disturbance in Alzheimer disease.Am J Geriatr Psychiatry. 2011 Jul;19(7):635-43.PMID:21709609[PubMed - in process] view
Zhang D, Shen D; The Alzheimer's Disease Neuroimaging Initiative.2011Multi-modal multi-task learning for joint prediction of multiple regression and classification variables in Alzheimer's disease. Neuroimage. 2011 Oct 4. [Epub ahead of print] PMID: 21992749 [PubMed - as supplied by publisher]view
Zhang D, Wang Y, Zhou L, Yuan H, Shen D; the Alzheimer's Disease Neuroimaging Initiative.2011Multimodal Classification of Alzheimer's Disease and Mild Cognitive Impairment. Neuroimage. 2011 Jan 11. [Epub ahead of print] PMID: 21236349 [PubMed - as supplied by publisher].view
Zhang T, Davatzikos C2011ODVBA: Optimally-discriminiative voxel-based analysis. IEEE Trans Med Imaging, Epub ahead of print, 2011 view
Zhang T, Guo L, Li K, Zhu D, Cui G, Liu T.2011Predicting functional brain ROIs via fiber shape models. Med Image Comput Comput Assist Interv. 2011;14(Pt 2):42-9. PMID: 21995011 [PubMed - in process]view
Zhou L, Wang Y, Li Y, Yap PT, Shen D; and the Alzheimer's Disease Neuroimaging Initiative (ADNI).2011Hierarchical Anatomical Brain Networks for MCI Prediction: Revisiting Volumetric Measures. PLoS One. 2011;6(7):e21935. Epub 2011 Jul 19.PMID: 21818280 [PubMed - in process] Free Article view
Aisen PS, Petersen RC, Donohue MC, Gamst A, Raman R, Thomas RG, Walter S, Trojanowski JQ, Shaw LM, Beckett LA, Jack CR Jr, Jagust W, Toga AW, Saykin AJ, Morris JC, Green RC, Weiner MW; Alzheimer's Disease Neuroimaging Initiative.2010Clinical Core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans. Alzheimers Dement. 2010 May;6(3):239-46. Review. PMID: 20451872 [PubMed - indexed for MEDLINE]view
Andrawis JP, Hwang KS, Green AE, Kotlerman J, Elashoff D, Morra JH, Cummings JL, Toga AW, Thompson PM, Apostolova LG.2010Effects of ApoE4 and maternal history of dementia on hippocampal atrophy. Neurobiol Aging. 2010 Sep 10. [Epub ahead of print] PMID: 20833446 [PubMed - as supplied by publisher]view
Apostolova LG, Hwang KS, Andrawis JP, Green AE, Babakchanian S, Morra JH, Cummings JL, Toga AW, Trojanowski JQ, Shaw LM, Jack CR Jr, Petersen RC, Aisen PS, Jagust WJ, Koeppe RA, Mathis CA, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative.20103D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects. Neurobiol Aging. 2010 Aug;31(8):1284-303. Epub 2010 Jun 11. PMID: 20538372 [PubMed - indexed for MEDLINE] Free PMC Articleview
Apostolova LG, Morra JH, Green AE, Hwang KS, Avedissian C, Woo E, Cummings JL, Toga AW, Jack CR Jr, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative.2010Automated 3D mapping of baseline and 12-month associations between three verbal memory measures and hippocampal atrophy in 490 ADNI subjects. Neuroimage. 2010 Jan 15. [Epub ahead of print] PMID: 20083211 [PubMed - as supplied by publisher]view
Apostolova LG, Thompson PM, Green AE, Hwang KS, Zoumalan C, Jack CR Jr, Harvey DJ, Petersen RC, Thal LJ, Aisen PS, Toga AW, Cummings JL, Decarli CS.20103D comparison of low, intermediate, and advanced hippocampal atrophy in MCI. Hum Brain Mapp. 2010 Feb 8. [Epub ahead of print] PMID: 20143386 [PubMed - as supplied by publisher]view
Bateman RJ, Aisen PS, De Strooper B, Fox NC, Lemere CA, Ringman JM, Salloway S, Sperling RA, Windisch M, Xiong C.2010Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease. Alzheimers Res Ther. 2011 Jan 6;2(6):35. [Epub ahead of print] PMID: 21211070 [PubMed - as supplied by publisher].view
Bauer CM, Jara H, Killiany R; Alzheimer's Disease Neuroimaging Initiative.2010Whole brain quantitative T2 MRI across multiple scanners with dual echo FSE: Applications to AD, MCI, and normal aging. Neuroimage. 2010 May 1. [Epub ahead of print] PMID: 20441797 [PubMed - as supplied by publisher]view
Beckett LA, Harvey DJ, Gamst A, Donohue M, Kornak J, Zhang H, Kuo JH; Alzheimer's Disease Neuroimaging Initiative.2010The Alzheimer's Disease Neuroimaging Initiative: Annual change in biomarkers and clinical outcomes. Alzheimers Dement. May; 6(3):257-64, 2010. view
Biffi A, Anderson CD, Desikan RS, Sabuncu M, Cortellini L, Schmansky N, Salat D, Rosan J, 2010 For the ADNI : Genetic Variation and Neuroimaging Measures in Alzheimer disease. Archives in Neurology. 67: 677-685, 2010. view
Biffi A, Anderson CD, Desikan RS, Sabuncu M, Cortellini L, Schmansky N, Salat D, Rosand J; for the Alzheimer's Disease Neuroimaging Initiative (ADNI).2010Genetic Variation and Neuroimaging Measures in Alzheimer Disease. Arch Neurol. 2010 Jun;67(6):677-685. PMID: 20558387 [PubMed - as supplied by publisher]view
Bossa M, Zacur E, Olmos S, Alzheimer's Disease Neuroimaging Initiative.2010Tensor-based morphometry with stationary velocity field diffeomorphic registration: Application to ADNI. Neuroimage. 2010 Mar 5. PMID: 20211269 PMCID: PMC3068621view
Cairns NJ, Taylor-Reinwald L, Morris JC; Alzheimer's Disease Neuroimaging Initiative.2010Autopsy consent, brain collection, and standardized neuropathologic assessment of ADNI participants: the essential role of the neuropathology core. Alzheimers Dement. 2010 May; 6(3):274-9. view
Carmichael O, Schwarz C, Drucker D, Fletcher E, Harvey D, Beckett L, Jack CR Jr, Weiner M, Decarli C; for the Alzheimer's Disease Neuroimaging Initiative.2010Longitudinal Changes in White Matter Disease and Cognition in the First Year of the Alzheimer Disease Neuroimaging Initiative. Arch Neurol. 2010 Nov;67(11):1370-1378.PMID: 21060014 [PubMed - as supplied by publisher].view
Caroli A, Frisoni GB; The Alzheimer's Disease Neuroimaging Initiative.2010The dynamics of Alzheimer's disease biomarkers in the Alzheimer's Disease Neuroimaging Initiative cohort. Neurobiol Aging. 2010 Jun 8. [Epub ahead of print] PMID: 20538373 [PubMed - as supplied by publisher]view
Chen K, Langbaum JB, Fleisher AS, Ayutyanont N, Reschke C, Lee W, Liu X, Bandy D, Alexander GE, Thompson PM, Foster NL, Harvey DJ, de Leon MJ, Koeppe RA, Jagust WJ, Weiner MW, Reiman EM; The Alzheimer's Disease Neuroimaging Initiative.2010Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: Findings from the Alzheimer's disease neuroimaging initiative. Neuroimage. 2010 Mar 1. [Epub ahead of print] PMID: 20202480 [PubMed - as supplied by publisher]view
Chen W, Song X, Zhang Y, Darvesh S, Ningnannan Z, D'Arcy R, Black S, Rockwood K 2010An MRI-Based Semiquantitative Index for the Evaluation of Brain Atrophy and Lesions in Alzheimer’s Disease, Mild Cognitive Impairment and Normal Aging.Dement. And Geri Cog Disord, 30: 121-130, 2010 view
Chiang GC, Insel PS, Tosun D, Schuff N, Truran-Sacrey D, Raptensetang ST, Jack CR, Aisen PS, Petersen RC, Weiner MD, and the ADNI 2010Hippocampal atrophy rates and CSF biomarkers in elderly APOE2 normals.Neurology, 75: 1976-1981, 2010 view
Chou YY, Leporé N, Saharan P, Madsen SK, Hua X, Jack CR, Shaw LM, Trojanowski JQ, Weiner MW, Toga AW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative.2010Ventricular maps in 804 ADNI subjects: correlations with CSF biomarkers and clinical decline. Neurobiol Aging. 2010 Aug;31(8):1386-400. PMID: 20620663 [PubMed - in process]view
Cronk BB, Johnson DK, Burns JM; Alzheimer's Disease Neuroimaging Initiative.2010Body Mass Index and Cognitive Decline in Mild Cognitive Impairment Alzheimer Disease Assoc Disorder. 2010. PMID: 19571736.view
Cruchaga C, Kauwe JS, Mayo K, Spiegel N, Bertelsen S, Nowotny P, Shah AR, Abraham R, Hollingworth P, Harold D, Owen MM, Williams J, Lovestone S, . 2010SNPs associated with cerebrospinal fluid phospho-tau levels influence rate of decline in Alzheimer's disease. PLoS Genet. 2010 Sep 16;6(9).view
Cuingnet R, Chupin M, Benali H, Colliot O 2010Verification of predicted robustness and accuracy of multivariate analysis. Neuroimage, Epub ahead of print, 2011 view
Cuingnet R, Gérardin E, Tessieras J, Auzias G, Lehéricy S, Habert MO, Chupin M, Benali H, Colliot O; the Alzheimer's Disease Neuroimaging Initiative.2010Automatic classification of patients with Alzheimer's disease from structural MRI: A comparison of ten methods using the ADNI database. Neuroimage. 2010 Jun 10. [Epub ahead of print] PMID: 20542124 [PubMed - as supplied by publisher]view
Cummings JL.2010Integrating ADNI results into Alzheimer's disease drug development programs. Neurobiol Aging. 2010 May 4. [Epub ahead of print] PMID: 20447734 [PubMed - as supplied by publisher]view
Davatzikos C, Bhatt P, Shaw LM, Batmanghelich KN, Trojanowski JQ.2010Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification. Neurobiol Aging. 2010 Jun 29. [Epub ahead of print] PMID: 20594615 [PubMed - as supplied by publisher]view
Desikan RS, Cabral HJ, Settecase F, Hess CP, Dillon WP, Glastonbury CM, Weiner MW, Schmansky NJ, Salat DH, Fiscl B, the ADNI:2010Automated MRI measures predict progression to Alzheimer's disease. Neurobiology of Aging. 31: 1364-1374, 2010. view
DW, Gerber JD, Allen AN, Corneveaux JJ, Dechairo BM, Potkin SG, Weiner MW, Thompson P; Alzheimer's Disease Neuroimaging Initiative.Stein JL, Hua X, Lee S, Ho AJ, Leow AD, Toga AW, Saykin AJ, Shen L, Foroud T, Pankratz N, Huentelman MJ, Craig.2010Voxelwise genome-wide association study (vGWAS). Neuroimage.2010 Nov 15;53(3):1160-74. Epub 2010 Feb 17. PMID: 20171287 [PubMed - indexed for MEDLINE].view
Edland SD, Emond JA, Aisen PS, Petersen RC.2010NIA-funded Alzheimer centers are more efficient than commercial clinical recruitment sites for conducting secondary prevention trials of dementia. Alzheimer Dis Assoc Disord. 2010 Apr-Jun;24(2):159-64. PMID: 20505433 [PubMed - indexed for MEDLINE]view
Epstein NU, Saykin AJ, Risacher SL, Gao S, Farlow MR; and the Alzheimer's Disease Neuroimaging Initiative (ADNI).2010Differences in medication use in the Alzheimer's disease neuroimaging initiative: analysis of baseline characteristics. Drugs Aging. 2010 Aug 1;27(8):677-86. doi: 10.2165/11538260-000000000-00000. PMID: 20658795 [PubMed - in process]view
Erten-Lyons D, Wilmot B, Anur P, McWeeney S, Westaway SK, Silbert L, Kramer P, Kaye J. Alzheimer Dis Assoc Disord, 2011 2010Microcephaly genes and risk of late onset Alzheimer Disease view
Evans MC, Barnes J, Nielsen C, Kim LG, Clegg SL, Blair M, Leung KK, Douiri A, Boyes RG, Ourselin S, Fox NC; Alzheimer's Disease Neuroimaging Initiative.2010Volume changes in Alzheimer's disease and mild cognitive impairment: cognitive associations. (2010) Eur Radiol.20(3):674-82 PMID:19760240.view
Fan M, Liu B, Zhou Y, Zhen X, Xu C, Jiang T, and the ADNI 2010Cortical thickness is associated with different apolipoprotein E genotypes in healthy elderly adults. Neuroscience Letters, 479: 332-336, 2010 view
Filipovych R, Davatzikos C; For the Alzheimer’s Disease Neuroimaging Initiative.2010Semi-supervised Pattern Classification of Medical Images: Application to Mild Cognitive Impairment (MCI). Neuroimage. 2010 Dec 30. [Epub ahead of print] PMID: 21195776 [PubMed - as supplied by publisher].view
Fjell AM, Amlien IK, Westlye LT, Stenset V, Fladby T, Skinningsrud A, Eilsertsen DE, Bjørnerud A, Walhovd KB.2010CSF biomarker pathology correlates with a medial temporo-parietal network affected by very mild to moderate Alzheimer's disease but not a fronto-striatal network affected by healthy aging.(2010) Neuroimage. 49(2):1820-30. PMID:19800012.view
Fjell AM, Walhovd KB, Fennema-Notestine C, McEvoy LK, Hagler DJ, Holland D, Blennow K, Brewer JB, Dale AM; Alzheimer's Disease Neuroimaging Initiative.2010Brain Atrophy in Healthy Aging Is Related to CSF Levels of A{beta}1-42 Cerebral Cortex. 2010. PMID: 20051356.view
Fjell AM, Walhovd KB, Fennema-Notestine C, McEvoy LK, Hagler DJ, Holland D, Brewer JB, Dale AM; Alzheimer's Disease Neuroimaging Initiative.2010CSF biomarkers in prediction of cerebral and clinical change in mild cognitive impairment and Alzheimer's disease Journal of Neuroscience. 2010. PMID: 20147537 PMCID: PMC2828879.view
Fjell AM, Westlye LT, Espeseth T, Reinvang I, Dale AM, Holland D, Walhovd KB; Alzheimer's Disease Neuroimaging Initiative.2010Cortical gray matter atrophy in healthy aging cannot be explained by undetected incipient cognitive disorders: a comment on Burgmans et al. (2009) Neuropsychology. 2010. PMID: 20230119.view
Franke K, Ziegler G, Klöppel S, Gaser C; Alzheimer's Disease Neuroimaging Initiative.2010Estimating the age of healthy subjects from T1-weighted MRI scans using kernel methods: Exploring the influence of various parameters NeuroImage. 2010. PMID: 20070949.view
Frisoni G, Weiner M 2010Alzheimer’s Disease Neuroimaging Initiative special issue. Neurobiol Aging, 31(8):1259-62, 2010 view
Furney SJ, Simmons A, Breen G, Pedroso I, Lunnon K, Proitsi P, Hodges A, Powell J, Wahlund LO, Loszewska I, Mecocci P, Soinnen H, Tsolaki M, Vellas B, Spenger C, Lathrop M, Shen L, Kim S, Saykin AJ, Weiner MW, Lovestone S2010Genome wide association with MRI atrophy measures as a quantitative trait locus for Alzheimer’s disease. Molecular Psychiatryview
Geert De Meyer, PhD; Fred Shapiro, MLS; Hugo Vanderstichele, PhD; Eugeen Vanmechelen, PhD; Sebastiaan Engelborghs, MD, PhD; Peter Paul De Deyn, MD, PhD; Els Coart, PhD; Oskar Hansson, MD; Lennart Minthon, MD; Henrik Zetterberg, MD, PhD; Kaj Blennow, MD, PhD; Leslie Shaw, PhD; John Q. Trojanowski, MD, PhD; for the Alzheimer's Disease Neuroimaging Initiative2010Diagnosis-Independent Alzheimer Disease Biomarker Signature in Cognitively Normal Elderly People Arch Neurol. 2010;67(8):949-956. doi:10.1001/archneurol.2010.179view
Gerber S, Tasdizen T, Thomas Fletcher P, Joshi S, Whitaker R.2010Manifold modeling for brain population analysis. Med Image Anal. 2010 Jun 4. [Epub ahead of print] PMID: 20579930 [PubMed - as supplied by publisher]view
Greene SJ, Killiany RJ; The Alzheimer's Disease Neuroimaging Initiative.2010Subregions of the inferior parietal lobule are affected in the progression to Alzheimer's disease. Neurobiol Aging. 2010 Jun 4. [Epub ahead of print] PMID: 20570398 [PubMed - as supplied by publisher]view
Habeck C, Stern Y; Alzheimer's Disease Neuroimaging Initiative.2010Multivariate data analysis for neuroimaging data: overview and application to Alzheimer's disease. Cell Biochem Biophys. 2010 Nov;58(2):53-67. Review. PMID: 20658269 [PubMed - indexed for MEDLINE].view
Hampel H, Wilcock G, Andrieu S, Aisen P, Blennow K, Broich K, Carrillo M, Fox NC, Frisoni GB, Isaac M, Lovestone S, Nordberg A, Prvulovic D, Sampaio C, Scheltens P, Weiner M, Winblad B, Coley N, Vellas B; for the Oxford Task Force Group.2010Biomarkers for Alzheimer's disease therapeutic trials. Prog Neurobiol. 2010 Dec 3. [Epub ahead of print] PMID: 21130138 [PubMed - as supplied by publisher].view
Han MR, Schellenberg GD, Wang LS, Neuroimaging Initiative AD.2010Genome-wide association reveals genetic effects on human Abeta42 and tau protein levels in cerebrospinal fluids: a case control study. BMC Neurol. 2010 Oct 8;10(1):90. [Epub ahead of print] PMID: 20932310 [PubMed - as supplied by publisher].view
Heaton RK, Clifford DB, Franklin DR Jr, Woods SP, Ake C, Vaida F, Ellis RJ, Letendre SL, Marcotte TD, Atkinson JH, Rivera-Mindt M, Vigil OR, Taylor MJ, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I; CHARTER Group.2010HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study.Neurology. 2010 Dec 7;75(23):2087-96. PMID:21135382view
Heckemann RA, Keihaninejad S, Aljabar P, Rueckert D, Hajnal JV, Hammers A; The Alzheimer's Disease Neuroimaging Initiative.2010Improving intersubject image registration using tissue-class information benefits robustness and accuracy of multi-atlas based anatomical segmentation. Neuroimage. 2010 Jan 26. [Epub ahead of print] PMID: 20114079 [PubMed - as supplied by publisher]view
Ho AJ, Hua X, Lee S, Leow AD, Yanovsky I, Gutman B, Dinov ID, Leporé N, Stein JL, Toga AW, Jack CR Jr, Bernstein MA, Reiman EM, Harvey DJ, Kornak J, Schuff N, Alexander GE, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative.2010Comparing 3 T and 1.5 T MRI for tracking Alzheimer's disease progression with tensor-based morphometry. Hum Brain Mapp. 2010 Apr;31(4):499-514. PMID: 19780044 [PubMed - indexed for MEDLINE]view
Ho AJ, Raji CA, Becker JT, Lopez OL, Kuller LH, Hua X, Lee S, Hibar D, Dinov ID, Stein JL, Jack CR Jr, Weiner MW, Toga AW, Thompson PM; Cardiovascular Health Study; ADNI.2010Obesity is linked with lower brain volume in 700 AD and MCI patients. Neurobiol Aging. 2010 Jun 4. [Epub ahead of print] PMID: 20570405 [PubMed - as supplied by publisher]view
Ho AJ, Stein JL, Hua X, Lee S, Hibar DP, Leow AD, Dinov ID, Toga AW, Saykin AJ, Shen L, Foroud T, Pankratz N, Huentelman MJ, Craig DW, Gerber JD, Allen AN, Corneveaux JJ, Stephan DA, DeCarli CS, DeChairo BM, Potkin SG, Jack CR Jr, Weiner MW, Raji CA, Lopez OL, Becker JT, Carmichael OT, Thompson PM; Alzheimer's Disease Neuroimaging Initiative.2010A commonly carried allele of the obesity-related FTO gene is associated with reduced brain volume in the healthy elderly. Proc Natl Acad Sci U S A. 2010 May 4;107(18):8404-9. Epub 2010 Apr 19. PMID: 20404173 [PubMed - indexed for MEDLINE] Free Article view
Holland D, Brewer JB, Hagler DJ, Fenema-Notestine C, Dale AM; Alzheimer's Disease Neuroimaging Initiative.2010Subregional neuroanatomical change as a biomarker for Alzheimer's disease. Proc Natl Acad Sci U S A. 2009 Dec 8;106(49):20954-9. PMID: 19996185 [PubMed - indexed for MEDLINE] Free PMC Article Free textview
Hua X, Hibar DP, Lee S, Toga AW, Jack CR Jr, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative.2010Sex and age differences in atrophic rates: an ADNI study with n=1368 MRI scans. Neurobiol Aging. 2010 Aug;31(8):1463-80. PMID: 20620666 [PubMed - in process]view
Hua X, Lee S, Hibar DP, Yanovsky I, Leow AD, Toga AW, Jack CR Jr, Bernstein MA, Reiman EM, Harvey DJ, Kornak J, Schuff N, Alexander GE, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative.2010Mapping Alzheimer's disease progression in 1309 MRI scans: power estimates for different inter-scan intervals. Neuroimage. 2010 May 15;51(1):63-75. Epub 2010 Feb 6. PMID: 20139010 [PubMed - indexed for MEDLINE] view
Huang S, Li J, Sun L, Ye J, Fleisher A, Wu T, Chen K, Reiman E; Alzheimer's Disease NeuroImaging Initiative.2010Learning brain connectivity of Alzheimer's disease by sparse inverse covariance estimation. Neuroimage. 2010 Apr 15;50(3):935-49. Epub 2010 Jan 14. PMID: 20079441 [PubMed - indexed for MEDLINE]view
Illan IA, Gorriz JM, Ramirez J, Salas-Gonzalez D, Lopez MM, Segovia F, Chaves R, Gomez-Rio M, Puntonet CG, the ADNI 201018F-FDG PET Imaging analysis for computer aided Alzheimer’s diagnosis. Information Sciences, 181: 903-916, 2011 view
Ito K, Ahadieh S, Corrigan B, French J, Fullerton T, Tensfeldt T; Alzheimer's Disease Working Group.2010Disease progression meta-analysis model in Alzheimer's disease (2010) Disease progression meta-analysis model in Alzheimer's disease. Alzheimers Dement, 6(1):39-53. PMID:19592311.view
Jack CR Jr, Bernstein MA, Borowski BJ, Gunter JL, Fox NC, Thompson PM, Schuff N, Krueger G, Killiany RJ, Decarli CS, Dale AM, Carmichael OW, Tosun D, Weiner MW; Alzheimer's Disease Neuroimaging Initiative.2010Update on the magnetic resonance imaging core of the Alzheimer's disease neuroimaging initiative. Alzheimers Dement. 2010 May;6(3):212-20. Review. PMID: 20451869 [PubMed - indexed for MEDLINE]view
Jack CR Jr, Wiste HJ, Vemuri P, Weigand SD, Senjem ML, Zeng G, Bernstein MA, Gunter JL, Pankratz VS, Aisen PS, Weiner MW, Petersen RC, Shaw LM, Trojanowski JQ, Knopman DS; the Alzheimer’s Disease Neuroimaging Initiative.2010Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease. Brain. 2010 Oct 8. [Epub ahead of print] PMID: 20935035 [PubMed - as supplied by publisher].view
Jagust WJ, Bandy D, Chen K, Foster NL, Landau SM, Mathis CA, Price JC, Reiman EM, Skovronsky D, Koeppe RA, and the ADNI2010The Alzhimer's Disease Neuroimaging Initiative positron emission tomography core. Alzheimer's & Dementia. 6: 221-229, 2010.view
Jun G, Naj AC, Beecham GW, Wang LS, Buros J, Gallins PJ, Buxbaum JD, Ertekin-Taner N, Fallin MD, Friedland R, Inzelberg R, Kramer P, Rogaeva E, St George-Hyslop P; Alzheimer's Disease Genetics Consortium, Cantwell LB, Dombroski BA, Saykin AJ, Reiman EM, Bennett DA, Morris JC, Lunetta KL, Martin ER, Montine TJ, Goate AM, Blacker D, Tsuang DW, Beekly D, Cupples LA, Hakonarson H, Kukull W, Foroud TM, Haines J, Mayeux R, Farrer LA, Pericak-Vance MA, Schellenberg GD.2010Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes. Arch Neurol. 2010 Dec;67(12):1473-84. Epub 2010 Aug 9. PMID: 20697030 [PubMed - indexed for MEDLINE].view
Karow DS, McEvoy L, Fennema-Notestine C, Hagler DJ, Jennings RG, Brewer JB, Hoh CK, Dale AM and the ADNI:2010Relative capability of MR imaging and FDG PET to depict changes associated with prodromal and early Alzheimer disease. Radiology. 256:932-942, 2010view
Keihaninejad S, Heckemann RA, Fagiolo G, Symms MR, Hajnal JV, Hammers A; Alzheimer's Disease Neuroimaging Initiative.2010A robust method to estimate the intracranial volume across MRI field strengths (1.5T and 3T). Neuroimage. 2010 May 1;50(4):1427-37. Epub 2010 Jan 28. PMID: 20114082 [PubMed - indexed for MEDLINE]view
Kim S, Swaminathan S, Shen L, Risacher SL, Nho K, Foroud T, Shaw LM, Trojanowski JQ, Potkin SG, Huentelman MJ, Craig DW, Dechairo BM, Aisen PS, Petersen RC, Weiner MW, Saykin AJ; For the Alzheimer's Disease Neuroimaging Initiative.2010Genome-wide association study of CSF biomarkers A{beta}1-42, t-tau, and p-tau181p in the ADNI cohort. Neurology. 2010 Dec 1. [Epub ahead of print] PMID: 21123754 [PubMed - as supplied by publisher].view
Kohannim O, Hua X, Hibar DP, Lee S, Chou YY, Toga AW, Jack CR Jr, Weiner MW, Thompson PM; The Alzheimer's Disease Neuroimaging Initiative.2010Boosting power for clinical trials using classifiers based on multiple biomarkers. Neurobiol Aging. 2010 Jun 9. [Epub ahead of print] PMID: 20541286 [PubMed - as supplied by publisher]view
Kruggel F, Turner J, Muftuler LT; The Alzheimer's Disease Neuroimaging Initiative.2010Impact of scanner hardware and imaging protocol on image quality and compartment volume precision in the ADNI cohort. (2010) Neuroimage. 49(3):2123-2133. PMID: 19913626.view
Lakatos A, Derbeneva O, Younes D, Keator D, Bakken T, Lvova M, Brandon M, Guffanti G, Reglodi D, Saykin A, Weiner M, Macciardi F, Schork N, Wallace DC, Potkin SG; Alzheimer's Disease Neuroimaging Initiative.2010Association between mitochondrial DNA variations and Alzheimer's disease in the ADNI cohort. Neurobiol Aging. 2010 Jun 8. [Epub ahead of print] PMID: 20538375 [PubMed - as supplied by publisher]view
Landau SM, Harvey D, Madison CM, Reiman EM, Foster NL, Aisen PS, Petersen RC, Shaw LM, Trojanowski JQ, Jack CR Jr, Weiner MW, Jagust WJ; Alzheimer's Disease Neuroimaging Initiative.2010Comparing predictors of conversion and decline in mild cognitive impairment. Neurology. 2010 Jul 20;75(3):230-8. Epub 2010 Jun 30.view
Lemoine B, Rayburn S, Benton R 2010Data fusion and feature selection for Alzheimer's disease. Comp Sci, 6334: 320-327, 2010 view
Leung KK, Barnes J, Modat M, Ridgway GR, Bartlett JW, Fox NC, Ourselin S, the ADNI:2010 Brain MAPS: An automated, accurate and robust brain extraction technique using a template library. Neuroimage. Epub ahead of print, 2010. view
Leung KK, Barnes J, Ridgway GR, Bartlett JW, Clarkson MJ, Macdonald K, Schuff N, Fox NC, Ourselin S; the Alzheimer's Disease Neuroimaging Initiative.2010Automated cross-sectional and longitudinal hippocampal volume measurement in mild cognitive impairment and Alzheimer's disease. Neuroimage. 2010 Mar 12. [Epub ahead of print] PMID: 20230901 [PubMed - as supplied by publisher]view
Li Y, Wang Y, Xue Z, Shi F, Lin W, Shen D; Alzheimer's Disease Neuroimaging Initiative.2010Consistent 4D cortical thickness measurement for longitudinal neuroimaging study. Med Image Comput Comput Assist Interv. 2010;13(Pt 2):133-42. PMID: 20879308 [PubMed - in process]view
Llano DA, Laforet G, Devanarayan V; The Alzheimer's Disease Neuroimaging Initiative.2010Derivation of a new ADAS-cog Composite Using Tree-based Multivariate Analysis: Prediction of Conversion From Mild Cognitive Impairment to Alzheimer Disease. Alzheimer Dis Assoc Disord. 2010 Sep 16. [Epub ahead of print] PMID: 20847637 [PubMed - as supplied by publisher]view
Lopez M, Ramirez J, Gorriz JM, Alvarez I, Salas-Gonzalez D, Segovia F, Chaves R, Padilla P, Gomez-Rio M, and the ADNI 2010Principal component analysis-based techniques and supervised classification schemes for the early detection of Alzheimer’s disease. Neurocomputing, 74: 1260-1271, 2011 view
Lorenzi M, Donohue M, Paternicò D, Scarpazza C, Ostrowitzki S, Blin O, Irving E, Frisoni GB; The Alzheimer's Disease Neuroimaging Initiative.2010Enrichment through biomarkers in clinical trials of Alzheimer's drugs in patients with mild cognitive impairment. Neurobiol Aging. 2010 Jun 9. [Epub ahead of print] PMID: 20541287 [PubMed - as supplied by publisher]view
Madsen SK, Ho AJ, Saharan PS, Toga AW, Jack CR, Weiner MW, Thompson PM, ADNI20103D maps localize caudate nucleus atrophy in 400 Alzheimer's disease, mild cognitive impairment, and healthy elderly subjects. Neurobiology of Aging. 31: 1312-1325, 2010.view
Markiewicz PJ, Matthews JC, Declerck J, Herholz K, for the Alzheimer's Disease Neuroimaging Initiative 2010Verification of predicted robustness and accuracy of multivariate analysis. Neuroimage, Epub ahead of print, 2011 view
McEvoy LK, Edland SD, Holland D, Hagler DJ Jr, Roddey JC, Fennema-Notestine C, Salmon DP, Koyama AK, Aisen PS, Brewer JB, Dale AM; Alzheimer's Disease Neuroimaging Initiative.2010Neuroimaging enrichment strategy for secondary prevention trials in Alzheimer disease. Alzheimer Dis Assoc Disord. 2010 Jul-Sep;24(3):269-77. PMID: 20683184 [PubMed - indexed for MEDLINE].view
McLaughlin T, Feldman H, Fillit H, Sano M, Schmitt F, Aisen P, Leibman C, Mucha L, Ryan JM, Sullivan SD, Spackman DE, Neumann PJ, Cohen J, Stern Y.2010Dependence as a unifying construct in defining Alzheimer's disease severity. Alzheimers Dement. 2010 Nov;6(6):482-93.PMID: 21044778 [PubMed - in process].view
Murphy EA, Holland D, Donohue M, McEvoy LK, Hagler DJ Jr, Dale AM, Brewer JB; Alzheimer's Disease Neuroimaging Initiative.2010Six-month atrophy in MTL structures is associated with subsequent memory decline in elderly controls. Neuroimage. 2010 Jul 12. [Epub ahead of print] PMID: 20633660 [PubMed - as supplied by publisher]view
Nettiksimmons J, Harvey D, Brewer J, Carmichael O, Decarli C, Jack CR Jr, Petersen R, Shaw LM, Trojanowski JQ, Weiner MW, Beckett L; The Alzheimer's Disease Neuroimaging Initiative.2010Subtypes based on cerebrospinal fluid and magnetic resonance imaging markers in normal elderly predict cognitive decline. Neurobiol Aging. 2010 Jun 7. [Epub ahead of print] PMID: 20542598 [PubMed - as supplied by publisher]view
Park H, Seo J; ADNI.2010Application of multidimensional scaling to quantify shape in Alzheimer's disease and its correlation with Mini Mental State Examination: a feasibility study. J Neurosci Methods. 2011 Jan 15;194(2):380-5. Epub 2010 Nov 11. PMID: 21074558 [PubMed - indexed for MEDLINE] view
Pelaez-Coca M, Bossa M, Olmos S; the Alzheimer's Disease Neuroimaging Initiative (ADNI).2010Discrimination of AD and normal subjects from MRI: anatomical versus statistical regions. Neurosci Lett. 2010 Oct 8. [Epub ahead of print] PMID: 20937359 [PubMed - as supplied by publisher].view
Petersen RC, Aisen PS, Beckett LA, Donahue MJ, Gamst AC, Harvey DJ, Jack Jr CR, Jagust WJ, Shaw LM, Toga AW, Trojanowski JQ, Weiner MW, and the Alzheimer’s Disease Neuroimaging Initiative.2010Alzheimer’s Disease Neuroimaging Initiative (ADNI): Clinical characterization(2010) Neurol., 74(3): 201-9.view
Petersen RC.2010Alzheimer's disease: progress in prediction. Lancet Neurol. 2010 Jan;9(1):4-5. No abstract available. PMID: 20083022 [PubMed - in process]view
Quinn JF, Raman R, Thomas RG, Yurko-Mauro K, Nelson EB, Van Dyck C, Galvin JE, Emond J, Jack CR Jr, Weiner M, Shinto L, Aisen PS.2010Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. JAMA. 2010 Nov 3;304(17):1903-11.PMID: 21045096 [PubMed - indexed for MEDLINE].view
Rafii MS.2010The pulse of drug development for Alzheimer's disease. Rev Recent Clin Trials. 2010 Jan 1;5(1):57-62. Review. PMID: 20205688 [PubMed - indexed for MEDLINE]view
Rimol LM, Agartz I, Djurovic S, Brown AA, Roddey JC, Kähler AK, Mattingsdal M, Athanasiu L, Joyner AH, Schork NJ, Halgren E, Sundet K, Melle I, Dale AM, Andreassen OA; Alzheimer's Disease Neuroimaging Initiative.2010Sex-dependent association of common variants of microcephaly genes with brain structure. (2010) S Proc Natl Acad Sci U S A. 107(1):384-8. PMID:20080800.view
Risacher SL, Shen L, West JD, Kim S, McDonald BC, Beckett LA, Harvey DJ, Jack CR Jr, Weiner MW, Saykin AJ; Alzheimer's Disease Neuroimaging Initiative (ADNI).2010Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort. Neurobiol Aging. 2010 Aug;31(8):1401-18. PMID: 20620664 [PubMed - in process]view
Risser L, Vialard FX, Wolz R, Holm DD, Rueckert D 2010Simultaneous fine and coarse diffeomorphic registration: application to atrophy measurement in Alzheimer's disease .Med Image Comput Comput Assist Interv., 13(2):610-7 view
Rousseau F; The Alzheimer's Disease Neuroimaging Initiative.2010A non-local approach for image super-resolution using intermodality priors. Med Image Anal. 2010 May 6. [Epub ahead of print] PMID: 20580893 [PubMed - as supplied by publisher]view
Rowe CC, Ellis KA, Rimajova M, Bourgeat P, Pike KE, Jones G, Fripp J, Tochon-Danguy H, Morandeau L, O'Keefe G, Price R, Raniga P, Robins P, Acosta O, Lenzo N, Szoeke C, Salvado O, Head R, Martins R, Masters CL, Ames D, Villemagne VL 2010Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging. Neurobiol Aging, 31(8):1275-83, 2010view
Sabbagh MN, Agro A, Bell J, Aisen PS, Schweizer E, Galasko D.2010PF-04494700, an Oral Inhibitor of Receptor for Advanced Glycation End Products (RAGE), in Alzheimer Disease. Alzheimer Dis Assoc Disord. 2010 Dec 28. [Epub ahead of print] PMID: 21192237 [PubMed - as supplied by publisher].view
Sano M, Raman R, Emond J, Thomas RG, Petersen R, Schneider LS, Aisen PS.2010Adding Delayed Recall to the Alzheimer Disease Assessment Scale is Useful in Studies of Mild Cognitive Impairment But Not Alzheimer Disease. Alzheimer Dis Assoc Disord. 2010 Oct 1. [Epub ahead of print] PMID: 20921876 [PubMed - as supplied by publisher].view
Saykin AJ, Shen L, Foroud TM, Potkin SG, Swaminathan S, Kim S, Risacher SL, Nho K, Huentelman MJ, Craig DW, Thompson PM, Stein JL, Moore JH, Farrer LA, Green RC, Bertram L, Jack CR Jr, Weiner MW; Alzheimer's Disease Neuroimaging Initiative.2010Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans.Alzheimers Dement. 2010 May;6(3):265-73. PMID: 20451875 [PubMed - indexed for MEDLINE]view
Schmidt ME, Siemers E, Snyder PJ, Potter WZ, Cole P, Soares H.2010The Alzheimer's disease neuroimaging initiative: perspectives of the Industry Scientific Advisory Board. Alzheimers Dement. 2010 May;6(3):286-90. PMID: 20451878 [PubMed - in process]view
Schneider LS, Kennedy RE, Cutter GR; Alzheimer's Disease Neuroimaging Initiative.2010Requiring an amyloid-beta1-42 biomarker for prodromal Alzheimer's disease or mild cognitive impairment does not lead to more efficient clinical trials. Alzheimers Dement. 2010 Sep;6(5):367-77. PMID: 20813339 [PubMed - indexed for MEDLINE].view
Schott JM, Bartlett JW, Barnes J, Leung KK, Ourselin S, Fox NC; Alzheimer's Disease Neuroimaging Initiative investigators.2010Reduced sample sizes for atrophy outcomes in Alzheimer's disease trials: baseline adjustment. Neurobiol Aging. 2010 Aug;31(8):1452-62, 1462.e1-2. PMID: 20620665 [PubMed - in process]view
Schott JM, Bartlett JW, Fox NC, Barnes J and the ADNI 2010Increased brain atrophy rates in cognitively normal older adults with low cerebrospinal fluid A?1-42. Annals of Neurology, 68: 825-834, 201view
Schuff N, Tosun D, Insel PS, Chiang GC, Truran D, Aisen PS, Jack CR Jr, Weiner MW; Alzheimer's Disease Neuroimaging Initiative.2010Nonlinear time course of brain volume loss in cognitively normal and impaired elders. Neurobiol Aging. 2010 Sep 18. [Epub ahead of print] PMID: 20855131 [PubMed - as supplied by publisher]view
Shen L, Kim S, Risacher SL, Nho K, Swaminathan S, West JD, Foroud T, Pankratz N, Moore JH, Sloan CD, Huentelman MJ, Craig DW, Dechairo BM, Potkin SG, Jack CR Jr, Weiner MW, Saykin AJ; Alzheimer's Disease Neuroimaging Initiative.2010Whole genome association study of brain-wide imaging phenotypes for identifying quantitative trait loci in MCI and AD: A study of the ADNI cohort. Neuroimage. 2010 Nov 15;53(3):1051-63. Epub 2010 Jan 25. PMID: 20100581 [PubMed - indexed for MEDLINE].view
Shen L, Qi Y, Kim S, Nho K, Wan J, Risacher SL, Saykin AJ; ADNI.2010Sparse bayesian learning for identifying imaging biomarkers in AD prediction. Med Image Comput Comput Assist Interv. 2010;13(Pt 3):611-8.PMID: 20879451 [PubMed - indexed for MEDLINE].view
Silver M, Montana G, Nichols TE; the Alzheimer's Disease Neuroimaging Initiative.2010False positives in neuroimaging genetics using voxel-based morphometry data. Neuroimage. 2010 Sep 17. [Epub ahead of print] PMID: 20849959 [PubMed - as supplied by publisher]view
Singh N, Fletcher PT, Preston JS, Ha L, King R, Marron JS, Wiener M, Joshi S.2010Multivariate statistical analysis of deformation momenta relating anatomical shape to neuropsychological measures. Med Image Comput Comput Assist Interv. 2010;13(Pt 3):529-37. PMID: 20879441 [PubMed - in process]view
Stein JL, Hua X, Lee S, Ho AJ, Leow AD, Toga AW, Saykin AJ, Shen L, Foroud T, Pankratz N, Huentelman MJ, Craig DW, Gerber JD, Allen AN, Corneveaux JJ, Dechairo BM, Potkin SG, Weiner MW, Thompson PM; the Alzheimer's Disease Neuroimaging Initiative.2010Voxelwise Genome-Wide Association Study (vGWAS). Neuroimage. 2010 Feb 17. [Epub ahead of print] PMID: 20171287 [PubMed - as supplied by publisher]view
Stein JL, Hua X, Morra JH, Lee S, Hibar DP, Ho AJ, Leow AD, Toga AW, Sul JH, Kang HM, Eskin E, Saykin AJ, Shen L, Foroud T, Pankratz N, Huentelman MJ, Craig DW, Gerber JD, Allen AN, Corneveaux JJ, Stephan DA, Webster J, Dechairo BM, Potkin SG, Jack CR Jr, Weiner MW, Thompson PM; the Alzheimer's Disease Neuroimaging Initiative.2010Genome-wide analysis reveals novel genes influencing temporal lobe structure with relevance to neurodegeneration in Alzheimer's disease. Neuroimage. 2010 Feb 27. [Epub ahead of print] PMID: 20197096 [PubMed - as supplied by publisher]view
Stonnington CM, Chu C, Klöppel S, Jack CR Jr, Ashburner J, Frackowiak RS; Alzheimer Disease Neuroimaging Initiative.2010Predicting clinical scores from magnetic resonance scans in Alzheimer's disease. Neuroimage. 2010 Jul 15;51(4):1405-13. Epub 2010 Mar 25.PMID: 20347044 [PubMed - indexed for MEDLINE]view
Thompson WK, Holland D, the Alzheimer's Disease Neuroimaging Initiative 2010Bias in tensor based morphometry Stat-ROI measures may result in unrealistic power estimates Neuroimage, epub ahead of print, 2011 view
Tosun D, Schuff N, Truran-Sacrey D, Shaw LM, Trojanowski JQ, Aisen P, Peterson R, Weiner MW; Alzheimer's Disease Neuroimaging Initiative.2010Relations between brain tissue loss, CSF biomarkers, and the ApoE genetic profile: a longitudinal MRI study. Neurobiol Aging. 2010 Aug;31(8):1340-54. Epub 2010 Jun 8. PMID: 20570401 [PubMed - indexed for MEDLINE]view
Tractenberg RE, Yumoto F, Jin S, Morris JC.2010Sample size requirements for training to a kappa agreement criterion on clinical dementia ratings. Alzheimer Dis Assoc Disord. 2010 Jul-Sep;24(3):264-8. PMID:20473138 [PubMed - indexed for MEDLINE] view
Trojanowski JQ, Vandeerstichele H, Korecka M, Clark CM, Aisen PS, Petersen RC, Blennow K, Soares H, Simon A, Lewczuk P, Dean R, Siemers E, Potter WZ, Weiner MW, Jack CR Jr, Jagust W, Toga AW, Lee VM, Shaw LM; Alzheimer's Disease Neuroimaging Initiative.2010Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects. Alzheimers Dement. 2010 May;6(3):230-8. Review. PMID: 20451871 [PubMed - indexed for MEDLINE]view
Vellas B, Aisen PS.2010Editorial: early Alzheimer's trials: new developments. J Nutr Health Aging. 2010;14(4):293. PMID: 20305997 [PubMed - in process]view
Vemuri P, Wiste HJ, Weigand SD, Knopman DS, Shaw LM, Trojanowski JQ, Aisen PS, Weiner M, Petersen RC, Jack CR Jr; Alzheimer's Disease Neuroimaging Initiative2010Effect of apolipoprotein E on biomarkers of amyloid load and neuronal pathology in Alzheimer disease. Ann Neurol. 2010 Mar;67(3):308-16. PMID: 20373342 [PubMed - indexed for MEDLINE]view
Vemuri P, Wiste HJ, Weigand SD, Knopman DS, Trojanowski JQ, Shaw LM, Bernstein MA, Aisen PS, Weiner M, Petersen RC, Jack CR Jr; Alzheimer's Disease Neuroimaging Initiative.2010Serial MRI and CSF biomarkers in normal aging, MCI, and AD. Neurology. 2010 Jul 13;75(2):143-51. PMID:20625167 [PubMed - indexed for MEDLINE] view
Vounou M, Nichols TE, Montana G; Alzheimer's Disease Neuroimaging Initiative.2010Discovering genetic associations with high-dimensional neuroimaging phenotypes: A sparse reduced-rank regression approach. Neuroimage. 2010 Nov 15;53(3):1147-59. Epub 2010 Jul 17. PMID: 20624472 [PubMed - indexed for MEDLINE] Related citations.view
Walhovd KB, Fjell AM, Brewer J, McEvoy LK, Fennema-Notestine C, Hagler DJ Jr, Jennings RG, Karow D, Dale AM; the Alzheimer's Disease Neuroimaging Initiative.2010Combining MR imaging, positron-emission tomography, and CSF biomarkers in the diagnosis and prognosis of Alzheimer disease AJNR American Journal of Neuroradiology. 2010. PMID: 20075088 PMCID: PMC2821467.view
Wang H, Das S,Pluta J, Craige C, Altinay M, Avants B, Weiner M, Mueller S, Yushkevich P: Standing on the shoulders of giants2010Improving medical image segmentation via learning based bias correction. Med Image Comput Assist Interv, 13: 105-112, 2010 view
Weiner MW, Aisen PS, Jack CR Jr, Jagust WJ, Trojanowski JQ, Shaw L, Saykin AJ, Morris JC, Cairns N, Beckett LA, Toga A, Green R, Walter S, Soares H, Snyder P, Siemers E, Potter W, Cole PE, Schmidt M; Alzheimer's Disease Neuroimaging Initiative.2010The Alzheimer's disease neuroimaging initiative: progress report and future plans. Alzheimers Dement. 2010 May;6(3):202-11.e7. Review. PMID: 20451868 [PubMed - indexed for MEDLINE]view
Whitehair DC, Sherzai A, Emond J, Raman R, Aisen PS, Petersen RC, Fleisher AS; Alzheimer's Disease Cooperative Study.2010Influence of apolipoprotein E varepsilon4 on rates of cognitive and functional decline in mild cognitive impairment. Alzheimers Dement. 2010 Sep;6(5):412-9. PMID: 20813342 [PubMed - indexed for MEDLINE].view
Wolk DA, Dickerson BC; Alzheimer's Disease Neuroimaging Initiative, Weiner M, Aiello M, Aisen P, Albert MS, Alexander G, Anderson HS, Anderson K, Apostolova L, Arnold S, Ashford W; et al. 2010Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease. Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):10256-61. Epub 2010 May 17. PMID: 20479234 [PubMed - indexed for MEDLINE]view
Wolz R, Heckemann RA, Aljabar P, Hajnal JV, Hammers A, Lotjonen J, Rueckert D; the Alzheimer's Disease Neuroimaging Initiative.2010Measurement of hippocampal atrophy using 4D graph-cut segmentation: Application to ADNI. Neuroimage. 2010 Apr 8. [Epub ahead of print] PMID: 20382238 [PubMed - as supplied by publisher]view
Wu X, Chen K, Yao L, Ayutyanont N, Langbaum JB, Fleisher A, Reschke C, Lee W, Liu X, Alexander GE, Bandy D, Foster NL, Thompson PM, Harvey DJ, Weiner MW, Koeppe RA, Jagust WJ, Reiman EM; Alzheimer's Disease Neuroimaging Initiative.2010Assessing the reliability to detect cerebral hypometabolism in probable Alzheimer's disease and amnestic mild cognitive impairment. J Neurosci Methods. 2010 Oct 15;192(2):277-85. Epub 2010 Aug 1. PMID: 20678521 [PubMed - indexed for MEDLINE].view
Xu C, Wang Z, Fan M, Liu B, Song M, Zhen X, Jiang T 2010ADNI: Effects of BDNF val66met polymorphism on brain metabolism. Molecular Neuroscience., 21: 802-807, 2010. view
Yang W, Chen X, Hong X, and Huang X 2010ICA-Based automatic classification of magnetic resonance images from ADNI data. Computer Science, 6330: 340-347, 2010 view
Acosta O, Bourgeat P, Zuluaga MA, Fripp J, Salvado O, Ourselin S.2009Automated voxel-based 3D cortical thickness measurement in a combined Lagrangian-Eulerian PDE approach using partial volume maps Medical Image Analysis. 2009. PMID: 19648050.view
Aisen PS.2009Alzheimer's disease therapeutic research: the path forward. Alzheimers Res Ther. 2009 Jul 9;1(1):2. [Epub ahead of print] PMID: 19674435 [PubMed - as supplied by publisher]view
Aisen PS.2009Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Facilitating Alzheimer's disease drug development in the United States. Alzheimer's Dement. 2009 Mar;5(2):125-7. No abstract available. PMID: 19328440 [PubMed - indexed for MEDLINE]view
Apostolova LG, Green AE, Hwang K, Morra JH, Cummings JL, Toga AW, Jack CR, Weiner MW, Thompson PM.2009 Mapping correlations between serum Abeta and tau and hippocampal atrophy measures in 282 ADNI subjects. AAN 61st Annual Meeting, Seattle, WA, April 25-May 2, 2009.view
Arai H.2009[Pre-symptomatic detection of Alzheimer's disease and mild cognitive impairment] Rinsho Shinkeigaku. 2009 Nov;49(11):838-40. Japanese. PMID: 20030225 [PubMed - in process]view
Brewer JB.2009Fully-automated volumetric MRI with normative ranges: translation to clinical practice. (2009) Behav Neurol. 21(1):21-8 PMID: 19847042.view
Calvini P, Chincarini A, Gemme G, Penco MA, Squarcia S, Nobili F, Rodriguez G, Bellotti R, Catanzariti E, Cerello P, De Mitri I, Fantacci ME; Alzheimer's Disease Neuroimaging Initiative.2009Automatic analysis of medial temporal lobe atrophy from structural MRIs for the early assessment of Alzheimer disease Medical Physics. 2009. PMID: 19746807 PMCID: PMC2724178.view
Chang YL, Bondi MW, Fennema-Notestine C, McEvoy LK, Hagler DJ Jr, Jacobson MW, Dale AM; Alzheimer's Disease Neuroimaging Initiative.2009Brain substrates of learning and retention in mild cognitive impairment diagnosis and progression to Alzheimer's diseaseNeuropsychology. 2009. PMID: 20034503 PMCID: PMC2851550.view
Chang YL, Jacobson MW, Fennema-Notestine C, Hagler DJ Jr, Jennings RG, Dale AM, McEvoy LK; Alzheimer's Disease Neuroimaging Initiative.2009Level of Executive Function Influences Verbal Memory in Amnestic Mild Cognitive Impairment and Predicts Prefrontal and Posterior Cingulate Thickness Cerebral Cortex. 2009. PMID: 19776343 PMCID: PMC2912652.view
Chou YY, Lepore N, Avedissia C, Madsen SK, Parikshak N, Hua X, Shaw LM, Trojanowski JQ, Weiner MW, Toga AW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative.2009Mapping Correlations Between Ventricular Expansion and CSF Amyloid and Tau Biomarkers, in 240 Subjects with Alzheimer's Disease, Mild Cognitive Impairment and Elderly Controls NueroImage. 2009. PMID: 2696357.view
Chupin M, Gérardin E, Cuingnet R, Boutet C, Lemieux L, Lehéricy S, Benali H, Garnero L, Colliot O; Alzheimer's Disease Neuroimaging Initiative.2009Fully automatic hippocampus segmentation and classification in Alzheimer's disease and mild cognitive impairment applied on data from ADNI. Hippocampus. 2009 Jun;19(6):579-87.PMID: 19437497 [PubMed - indexed for MEDLINE]view
Clark, C.M., Davatzikos, C., Borthakur, A., Newberg, A., Leight, S., Lee, V.M.-Y., Trojanowski, J.Q.2009Biomarkers for early detection of Alzheimer pathology. NeuroSignals, 16:11-18, 2008view
Clarkson MJ, Ourselin S, Nielsen C, Leung KK, Barnes J, Whitwell JL, Gunter JL, Hill DL, Weiner MW, Jack CR Jr, Fox NC; Alzheimer's Disease Neuroimaging 2009Comparison of phantom and registration scaling corrections using the ADNI cohort.view
Cruchaga C, Kauwe JS, Bertelsen S, Nowotny P, Shah AR, et. al.2009SNPs in the regulatory subunit of calcineurin are associated with CSF tau protein levels, brain mRNA levels. Alzheimer's and Dementia, 5(4 Suppl1):P471-P472, 2009.view
Davatzikos C, Xu F, An Y, Fan Y, Resnick SM.2009Longitudinal progression of Alzheimer's-like patterns of atrophy in normal older adults: the SPARE-AD index. (2009) Brain. 132(Pt 8):2026-35. PMID:19416949.view
De Meyer, G., Shapiro, F., Vanderstichele, H., Vanmechelen, E., Engleborghs, B., De Deyn, P.-P., Hanson, O., Minthon, L., Zetterberg, H., Blennow, K., Shaw, L.M., Trojanowski, J.Q., and Altheimer's Disease Neuroimaging Initiative.2009A mixture modeling approach to biomarker assessment reveals an Alzheimer's disease signature in more than a third of cognitively normal elderly people. Arch. Neurol., Submitted, 2009.view
Ewers, M., Walsh, C., Trojanowski, J.Q., Shaw, L.M., Petersen, R.C., Jack, C.R., Jr., Bokde, A.W.L., Feldman, H., Alexander, G., Sheltens, P., Vellas, B., Dubois, B., Hampel, H., and the Alzheimer’s Disease Neuroimaging Initiative (ADNI)2009Multi-modal biological marker based signature and diagnosis of early Alzheimer's disease. Submitted, 2009.view
Fennema-Notestine C, Hagler DJ Jr, McEvoy LK, Fleisher AS, Wu EH, Karow DS, Dale AM; Alzheimer's Disease Neuroimaging Initiative.2009Structural MRI biomarkers for prec linical and mild Alzheimer's disease. Hum Brain Mapp. 2009 Oct;30(10):3238-53. PMID: 19277975 [PubMed - indexed for MEDLINE]view
Fennema-Notestine C, McEvoy LK, Hagler DJ Jr, Jacobson MW, Dale AM; Alzheimer's Disease Neuroimaging Initiative.2009Structural neuroimaging in the detection and prognosis of pre-clinical and early AD Behavioral Neurology. 2009. PMID: 19847040.view
Fjell AM, Walhovd KB, Fennema-Notestine C, McEvoy LK, Hagler DJ, Holland D, Brewer JB, Dale AM; Alzheimer's Disease Neuroimaging Initiative.2009One-year brain atrophy evident in healthy aging Journal of Neuroscience. 2009. PMID: 19955375 PMCID: PMC2827793.view
Fleisher AS, Donohue M, Chen K, Brewer JB, Aisen PS; Alzheimer's Disease Neuroimaging Initiative.2009Applications of neuroimaging to disease-modification trials in Alzheimer's disease. Behav Neurol. 2009;21(1):129-36. Review. PMID: 19847051 [PubMed - indexed for MEDLINE]view
Gunter JL, Bernstein MA, Borowski BJ, Ward CP, Britson PJ, Felmlee JP, Schuff N, Weiner M, Jack CR.2009Measurement of MRI scanner performance with the ADNI phantom. Med Phys. 2009 Jun;36(6):2193-205. PMID: 19610308 [PubMed - indexed for MEDLINE]view
Haense C, Herholz K, Jagust WJ, Heiss WD; Alzheimer's Disease Neuroimaging Initiative.2009Performance of FDG PET for Detection of Alzheimer's Disease in Two Independent Multicenter Samples (NEST-DD and ADNI) Dementia and Geriatric Cognitive Disorders. 2009. PMID: 19786778.view
Hampel H, Shen Y, Walsh DM, Aisen P, Shaw LM, Zetterberg H, Trojanowski JQ, and Blennow K.2009Biological markers of ß-amyloid related mechanisms in Alzheimer's disease. Exper. Neurol., In press, 2009. PMID: 19815015 [PubMed - as supplied by publisher]view
Hill D.2009Neuroimaging to assess safety and efficacy of AD therapies. Expert Opin Investig Drugs. 2009 Nov 30. [Epub ahead of print] PMID: 19947893 [PubMed - as supplied by publisher]view
Hinrichs C, Singh V, Mukherjee L, Xu G, Chung MK, Johnson SC; Alzheimer's Disease Neuroimaging Initiative.2009Spatially augmented LPboosting for AD classification with evaluations on the ADNI dataset. (2009) Neuroimage. 48(1):138-49. PMID: 19481161.view
Hirata-Fukae C, Li HF, Ma L, Hoe HS, Rebeck GW, Aisen PS, Matsuoka Y.2009Levels of soluble and insoluble tau reflect overall status of tau phosphorylation in vivo. Neurosci Lett. 2009 Jan 23;450(1):51-5. Epub 2008 Nov 13. PMID: 19022346 [PubMed - indexed for MEDLINE]view
Holland D, Brewer JB, Hagler DJ, Fenema-Notestine C, Dale AM; the Alzheimer's Disease Neuroimaging Initiative, Weiner M, Thal L, Petersen R, Jack CR Jr, Jagust W, Trojanowki J, Toga AW, Beckett L, Green RC, Gamst A, Potter WZ, Montine T, Anders D, Bernstein M, Felmlee J, Fox N, Thompson P, Schuff N, Alexander G, Bandy D, Koeppe RA, Foster N, Reiman EM, Chen K, Shaw L, Lee VM, Korecka M, Crawford K, Neu S, Harvey D, Kornak J, Kachaturian Z, Frank R, Snyder PJ, Molchan S, Kaye J, Vorobik R, Quinn J, Schneider L, Pawluczyk S, Spann B, Fleisher AS, Vanderswag H, Heidebrink JL, Lord JL, Johnson K, Doody RS, Villanueva-Meyer J, Chowdhury M, Stern Y, Honig LS, Bell KL, Morris JC, Mintun MA, Schneider S, Marson D, Griffith R, Badger B, Grossman H, Tang C, Stern J, Detoledo-Morrell L, Shah RC, Bach J, Duara R, Isaacson R, Strauman S, Albert MS, Pedroso J, Toroney J, Rusinek H, de Leon MJ, De Santi SM, Doraiswamy PM, Petrella JR, Aiello M, Clark CM, Pham C, Nunez J, Smith CD, Given CA 2nd, Hardy P, Dekosky ST, Oakley M, Simpson DM, Ismail MS, Porsteinsson A, McCallum C, Cramer SC, Mulnard RA, McAdams-Ortiz C, Diaz-Arrastia R, Martin-Cook K, Devous M, Levey AI, Lah JJ, Cellar JS, Burns JM, Anderson HS, Laubinger MM, Bartzokis G, Silverman DH, Lu PH, Fletcher R, Parfitt F, Johnson H, Farlow M, Herring S, Hake AM, van Dyck CH, Macavoy MG, Bifano LA, Chertkow H, Bergman H, Hosein C, Black S, Graham S, Caldwell C, Feldman H, Assaly M, Hsiung GY, Kertesz A, Rogers J, Trost D, Bernick C, Gitelman D, Johnson N, Mesulam M, Sadowsky C, Villena T, Mesner S, Aisen PS, Johnson KB, Behan KE, Sperling RA, Rentz DM, Johnson KA, Rosen A, Tinklenberg J, Ashford W, Sabbagh M, Connor D, Obradov S, Killiany R, Norbash A, Obisesan TO, Jayam-Trouth A, Wang P, Auchus AP, Huang J, Friedland RP, Decarli C, Fletcher E, Carmichael O, Kittur S, Mirje S, Johnson SC, Borrie M, Lee TY, Asthana S, Carlsson CM, Potkin SG, Highum D, Preda A, Nguyen D, Tariot PN, Hendin BA, Scharre DW, Kataki M, Beversdorf DQ, Zimmerman EA, Celmins D, Brown AD, Gandy S, Marenberg ME, Rovner BW, Pearlson G, Blank K, Anderson K, Saykin AJ, Santulli RB, Pare N, Williamson JD, Sink KM, Potter H, Ashok Raj B, Giordano A, Ott BR, Wu CK, Cohen R, Wilks KL, Safirstein BE.2009Subregional neuroanatomical change as a biomarker for Alzheimer's disease. Proc Natl Acad Sci U S A. 2009 Dec 8;106(49):20954-20959. PMID: 19996185 [PubMed - as supplied by publisher]view
Hu, W.T., Chen-Plotkin, A., Arnold, S., Grossman, M., Clark, C.M., Shaw,L.M., Leight, S.,b McCluskey, L., Elman, L., Karlawish, J., Hurting, H.I., Siderowf, S., Soares, S., Lee, V.M.-Y., and Trojanowski, J.Q. CSF 2009biomarkers for Alzheimer's disease and frontotemporal lobar degeneration, Submitted, 2009.view
Hua X, Lee S, Yanovsky I, Leow AD, Chou YY, Ho AJ, Gutman B, Toga AW, Jack CR Jr, Bernstein MA, Reiman EM, Harvey DJ, Kornak J, Schuff N, Alexander GE, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative.2009Optimizing power to track brain degeneration in Alzheimer's disease and mild cognitive impairment with tensor-based morphometry: an ADNI study of 515 subjects. Neuroimage. 2009 Dec;48(4):668-81. Epub 2009 Jul 14.view
Huang A, Abugharbieh R, Tam R; Alzheimer's Disease Neuroimaging Initiative.2009A Hybrid Geometric-Statistical Deformable Model for Automated 3D Segmentation in Brain MRI IEEE Trans Biomed Engineering. 2009. PMID: 19336280.view
Irizarry MC, Raman R, Schwarzschild MA, Becerra LM, Thomas RG, Peterson RC, Ascherio A, Aisen PS.2009Plasma urate and progression of mild cognitive impairment. Neurodegener Dis. 2009;6(1-2):23-8. Epub 2008 Nov 5. PMID: 19066433 [PubMed - indexed for MEDLINE]view
Jack CR Jr, Lowe VJ, Weigand SD, Wiste HJ, Senjem ML, Knopman DS, Shiung MM, Gunter JL, Boeve BF, Kemp BJ, Weiner M, Petersen RC; Alzheimer's Disease Neuroimaging Initiative.2009Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease. Brain. 2009 May;132(Pt 5):1355-65. Epub 2009 Mar 31. PMID: 19339253 [PubMed - indexed for MEDLINE]view
Jack, C.R., Knopman, D.S., Jagust, W.J., Shaw, L.M., Aisen, P.S., Petersen, R.C., Trojanowski, J.Q.2009 Modeling dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurology, Submitted, 2009.view
Jacobson MW, McEvoy LK, Dale A, Fennema-Notestine C; Alzheimer's Disease Neuroimaging Initiative.2009Cognitive phenotypes, brain morphometry and the detection of cognitive decline in preclinical AD Behavioral Neurology. 2009. PMID: 19847043 PMCID: PMC2864725.view
Jagust, W.J., Landau, S.M., Shaw, L.M., Trojanowski, J.Q., Koeppe, R.A., Reiman, E.M., Foster, N.L., Petersen, R.C., Weiner M.W., Price, J.C., Mathis, C.A., and the Alzheimer's Disease Neuroimaging Initiative.2009Relationships between biomarkers in aging and dementia. Neurology, In press, 2009view
Joshi A, Koeppe RA, Fessler JA.2009Reducing between scanner differences in multi-center PET studies. (2009) Neuroimage. 15;46(1):154-9. PMID:19457369.view
Joyner AH, Roddy CJ, Bloss CS, Bakken TE, Rimol LM, Melle I, Agartz I, Djurovic S, Topol EJ, Schork NJ, Andreassen OA, Dale AM.2009A common MECP2 haplotype associates with reduced cortical surface area in humans in two independent populations. (2009) Proc Natl Acad Sci U S A, 106(36):15483-8 PMID:19717458.view
Kauwe JS, Bertelsen S, Mayo K, Cruchaga C, Abraham R, Hollingworth P, Harold D, Owen MJ, Williams J, Lovestone S, Morris JC, Goate AM; the Alzheimer's Disease Neuroimaging InitiativeSome of the data used in the preparation of this article were obtained from the Alzheimer's disease neuroimaging initiative (ADNI) database (www.loni.ucla.edu\ADNI). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. ADNI investigators include (complete listing available at http://www.loni.ucla.edu/ADNI/About/About_Investigators.shtml)..2009Suggestive synergy between genetic variants in TF and HFE as risk factors for Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet. 2009 Dec 22. [Epub ahead of print] PMID: 20029940 [PubMed - as supplied by publisher]view
Kewei C, Lee W, Liu X, Alexander G, Bandy D, Reschke C, Foster N, Weiner M, Jagust W, Reiman E; Alzheimer's Disease Neuroimaging Initiative.2009The Consistency of Hypometabolic Brain Voxels in Probable Alzheimer's Disease and Anmesic Mild Cognitive Impairment Patients from the Alzheimer's Disease Neuroimaging Initiative Alzheimer's and Dementia. 2008. DOI: 10.1016/j.jalz.2008.05.919.view
Khachaturian ZS, Camí J, Andrieu S, Avila J, Boada Rovira M, Breteler M, Froelich L, Gauthier S, Gómez-Isla T, Khachaturian AS, Kuller LH, Larson EB, Lopez OL, Martinez-Lage JM, Petersen RC, Schellenberg GD, Sunyer J, Vellas B, Bain LJ.2009Creating a transatlantic research enterprise for preventing Alzheimer's disease. Alzheimers Dement. 2009 Jul;5(4):361-6. PMID: 19560106 [PubMed - indexed for MEDLINE]view
Khachaturian ZS, Snyder PJ, Doody R, Aisen P, Comer M, Dwyer J, Frank RA, Holzapfel A, Khachaturian AS, Korczyn AD, Roses A, Simpkins JW, Schneider LS, Albert MS, Egge R, Deves A, Ferris S, Greenberg BD, Johnson C, Kukull WA, Poirier J, Schenk D, Thies W, Gauthier S, Gilman S, Bernick C, Cummings JL, Fillit H, Grundman M, Kaye J, Mucke L, Reisberg B, Sano M, Pickeral O, Petersen RC, Mohs RC, Carrillo M, Corey-Bloom JP, Foster NL, Jacobsen S, Lee V, Potter WZ, Sabbagh MN, Salmon D, Trojanowski JQ, Wexler N, Bain LJ.2009A roadmap for the prevention of dementia II: Leon Thal Symposium 2008. Alzheimers Dement. 2009 Mar;5(2):85-92. PMID: 19328434 [PubMed - indexed for MEDLINE]view
King RD, George AT, Jeon T, Hynan LS, Youn TS, Kennedy DN, Dickerson B and the Alzheime's Disease Neuroimaging Initiative.2009Characterization of atrophic changes in the cerebral cortex using fractal dimensional analysis. (2009) Brain Imaging and Behavior, 3:154-66. PMID:20740072.view
Korecka, M., Clark, C.M., Lee, V.M.-Y., Trojanowski, J.Q., Shaw, L.M.2009 Quantification of 8-iso-PGF2a and 8,12-iso-iPF2a-VI in CSF and brain tissue from patients with Alzheimer's disease by HPLC with tandem mass spectrometry. J. Neurochemistry, Submitted, 2009.view
Kovacevic S, Rafii MS, Brewer JB; Alzheimer's Disease Neuroimaging Initiative.2009High-throughput, fully automated volumetry for prediction of MMSE and CDR decline in mild cognitive impairment. Alzheimer Dis Assoc Disord. 2009 Apr-Jun;23(2):139-45. PMID: 19474571 [PubMed - indexed for MEDLINE]view
Landau SM, Harvey D, Madison CM, Koeppe RA, Reiman EM, Foster NL, Weiner MW, Jagust WJ, the Alzheimer's Disease Neuroimaging Initiative. 2009Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiology of Aging, In Press, 2009.view
Leow AD, Yanovsky I, Parikshak N, Hua X, Lee S, Toga AW, Jack CR Jr, Bernstein MA, Britson PJ, Gunter JL, Ward CP, Borowski B, Shaw LM, Trojanowski JQ, Fleisher AS, Harvey D, Kornak J, Schuff N, Alexander GE, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative.2009Alzheimer's disease neuroimaging initiative: a one-year follow up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition. Neuroimage. 2009 Apr 15;45(3):645-55. PMID: 19280686 [PubMed - indexed for MEDLINE]view
Leung KK, Clarkson MJ, Bartlett JW, Clegg S, Jack CR Jr, Weiner MW, Fox NC, Ourselin S; the Alzheimer's Disease Neuroimaging Initiative.2009Robust atrophy rate measurement in Alzheimer's disease using multi-site serial MRI: tissue-specific intensity normalisation and parameter selection. Neuroimage. 2009 Dec 21. [Epub ahead of print] PMID: 20034579 [PubMed - as supplied by publisher] Related articles view
Lötjönen JM, Wolz R, Koikkalainen JR, Thurfjell L, Waldemar G, Soininen H, Rueckert D; Alzheimer's Disease Neuroimaging Initiative.2009Fast and robust multi-atlas segmentation of brain magnetic resonance images NeuroImage. 2009. PMID: 19857578.view
Lu PH, Edland SD, Teng E, Tingus K, Petersen RC, Cummings JL; Alzheimer's Disease Cooperative Study Group.2009Donepezil delays progression to AD in MCI subjects with depressive symptoms. Neurology. 2009 Jun 16;72(24):2115-21. PMID:19528519view
Matsuoka Y, Andrews HF, Becker AG, Gray AJ, Mehta PD, Sano MC, Dalton AJ, Aisen PS.2009The relationship of plasma Abeta levels to dementia in aging individuals with Down syndrome. Alzheimer Dis Assoc Disord. 2009 Oct-Dec;23(4):315-8. PMID: 19571732 [PubMed - indexed for MEDLINE]view
McDonald CR, McEvoy LK, Gharapetian L, Fennema-Notestine C, Hagler DJ Jr, Holland D, Koyama A, Brewer JB, Dale AM; Alzheimer's Disease Neuroimaging Initiative.2009Regional rates of neocortical atrophy from normal aging to early Alzheimer disease Neurology. 2009. PMID: 19667321 PMCID: PMC2727145.view
McEvoy L.K., Fennema-Notestine C., Cooper, J.C., Hagler, D. Jr., Holland, D., Karow D.S., Pung, C.J. Brewer J.B., Dale A.M. for the Alzheimer's Disease Neuroimaging Initiative.2009 Alzheimer's Disease: Quantitative structural neuroimaging for detection and prediction clinical and structural changes in mild cognitive impairment. Radiology, 1(1):195-205, 2009 .view
Misra C, Fan Y, Davatzikos C. 2009 Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: Results from ADNI. NeuroImage, 44(4):1415-22, 2009 .view
Mormino EC, Kluth JT, Madison CM, Rabinovici GD, Baker SL, Miller BL, Koeppe RA, Mathis CA, Weiner MW, Jagust WJ; Alzheimer's Disease Neuroimaging Initiative.2009Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. Brain. 2009 May;132(Pt 5):1310-23. Epub 2008 Nov 28. PMID: 19042931 [PubMed - indexed for MEDLINE]view
Morra JH, Tu Z, Apostolova LG, Green AE, Avedissian C, Madsen SK, Parikshak N, Hua X, Toga AW, Jack CR Jr, Schuff N, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative.2009Automated 3D mapping of hippocampal atrophy and its clinical correlates in 400 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. Hum Brain Mapp. 2009 Sep;30(9):2766-88. PMID: 19172649 [PubMed - in process]view
Morra JH, Tu Z, Apostolova LG, Green AE, Avedissian C, Madsen SK, Parikshak N, Toga AW, Jack CR Jr, Schuff N, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative.2009Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. Neuroimage. 2009 Mar;45(1 Suppl):S3-15. Epub 2008 Nov 8. PMID: 19041724 [PubMed - indexed for MEDLINE]view
Mortamet B, Bernstein MA, Jack CR Jr, Gunter JL, Ward C, Britson PJ, Meuli R, Thiran JP, Krueger G; Alzheimer's Disease Neuroimaging Initiative.2009Automatic quality assessment in structural brain magnetic resonance imaging. Magn Reson Med. 2009 Aug;62(2):365-72. PMID: 19526493 [PubMed - in process]view
Okonkwo, O.C., Alosco, M.L., Griffith, H.R., Mielke, M.M., Shaw, L.M., Trojanowski, J.Q., Tremont, G., and the Alzheimer's Disease Neuroimaging Initiative.2009 CSF abnormalities and rate of decline in everyday function. Arch. Neurol., Submitted, 2009.view
Petersen RC, and Trojanowski JQ.2009Use of Alzheimer’s Disease biomarkers: Potentially yes for clinical trials, but not yet for clinical practice. (2009) JAMA, 302(4):436-7. PMID:19622825.view
Petersen RC, Jack Jr, CR.2009Imaging and Biomarkers in Early Alzheimer's Disease and Mild Cognitive Impairment. Clinical Pharmacology and Therapeutics, In Press, 2009. PMID: 19710641 [PubMed - indexed for MEDLINE]view
Petersen RC, Roberts RO, Knopman DS, Boeve BF, Geda YE, Ivnik RJ, Smith GE, Jack CR Jr.2009Mild cognitive impairment: ten years later. Arch Neurol. 2009 Dec;66(12):1447-55. PMID: 20008648 [PubMed - in process]view
Petersen RC.2009Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." A national registry on aging. Alzheimers Dement. 2009 Mar;5(2):105-7. No abstract available. PMID: 19328436 [PubMed - indexed for MEDLINE]view
Petersen RC.2009Early Diagnosis of Alzheimer’s Disease: Is MCI too late? (2009) Curr Alzheimer Res, 6(4):324-30. PMID:19689230.view
Petersen, R.C., Aisen, P.S., Beckett, L.A., Donahue, M.J., Gamst, A.C., Harvey, D.J., Jack Jr., C.R., Jagust, W,J., Shaw, L.M., Toga, A.W., Trojanowski, J.Q., Weiner, M.W., and the Alzheimer's Disease Neuroimaging Initiative.2009Alzheimer's Disease Neuroimaging Initiative (ADNI): Clinical characterization, Neurol., In press, 2009.view
Petersen, R.C., and Trojanowski, J.Q.2009 Time for Alzheimer's Disease biomarkers? Potentially yes for clinical trials, but not yet for clinical practice. JAMA, 302(4):436-7, 2009.view
Posner H, Cano S, Aisen P, Selnes O, Stern Y, Thomas R, Weiner M, Zajicek J, Zeger S, Hobart J.2009 The ADAS-cog's Performance as a Measure - Lessons from the ADNI Study: Part 1 – Evaluation Using Traditional Psychometric Methods. AAN 61st Annual Meeting, Seattle, WA, April 25-May 2, 2009.view
Potkin SG, Guffanti G, Lakatos A, Turner JA, Kruggel F, Fallon JH, Saykin AJ, Orro A, Lupoli S, Salvi E, Weiner M, Macciardi F.2009 Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's disease. PLoS ONE, 4(8):e6501-15, 2009.view
Qiu A, Fennema-Notestine C, Dale AM, Miller MI; Alzheimer's Disease Neuroimaging Initiative.2009Regional shape abnormalities in mild cognitive impairment and Alzheimer's diseaseNeuroImage. 2009. PMID: 19280688 PMCID: PMC2847795.view
Querbes, O., Aubry F., Pariente J., Lotterie J.A., Demonet J.F., Duret V., Puel M., Berry I., Fort J.C., Celsis P.; the Alzheimer's Disease Neuroimaging Initiative.2009 Early Diagnosis of Alzheimer's Disease Using Cortical Thickness: Impact of Cognitive Reserve. Brain, 2009 . (In press)view
Rafii MS, Aisen PS.2009Recent developments in Alzheimer's disease therapeutics. BMC Med. 2009 Feb 19;7:7. Review. PMID: 19228370 [PubMed - indexed for MEDLINE]view
Raman R, Thomas RG, Weiner MW, Jack CR, Ernstrom K, Aisen PS, Tariot PN, Quinn JF.2009MRI substudy participation in Alzheimer disease (AD) clinical trials: baseline comparability of a substudy sample to entire study population. Alzheimer Dis Assoc Disord. 2009 Oct-Dec;23(4):333-6. PMID: 19571733 [PubMed - indexed for MEDLINE] Free PMC Article Free textview
Reiman, E et. al.2009Categorical and Correlational Analyses of Baseline Fluorodeoxyglucose Positron Emission Tomography Images From the Alzheimer's Disease Neuroimaging Initiative (ADNI). NeuroImage, 2009 . in pressview
Risacher SL, Saykin AJ, West JD, Shen L, Firpi HA, McDonald BC, and the Alzheimer's Disease Neuroimaging Initiative (ADNI)2009Baseline MRI Predictors of Conversion from MCI to Probable AD in the ADNI Cohort. Current Alzheimer Research, 6:347-361, 2009. PMID 19689234view
Sabbagh MN, Tariot PN.2009Commentary on ""a roadmap for the prevention of dementia II. Leon Thal Symposium 2008. A national registry to identify a cohort for Alzheimer's disease prevention studies. Alzheimers Dement. 2009 Mar;5(2):128-9. No abstract available. PMID:19328441 [PubMed - indexed for MEDLINE] view
Schneider LS, Raman R, Schmitt FA, Doody RS, Insel P, Clark CM, Morris JC, Reisberg B, Petersen RC, Ferris SH. Alzheimer Dis Assoc Disord.2009Characteristics and performance of a modified version of the ADCS-CGIC CIBIC+ for mild cognitive impairment clinical trials. 2009 Jul-Sep;23(3):260-7. PMID: 19812469 [PubMed - indexed for MEDLINE]view
Schuff N, Woerner N, Boreta L, Kornfield T, Shaw LM, Trojanowski JQ, Thompson PM, Jack CR Jr, Weiner MW, and the Alzheimer's Disease Neuroimaging Initiative.2009MRI of Hippocampal Volume Loss in Early Alzheimer's Disease in Relation to ApoE Genotype and Biomarkers. Brain. 132(Pt 4):1067-77, 2009.view
Shaw LM, Vanderstichele H, Knapik-Czajka M, Clark CM, Aisen PS, Petersen RC, Blennow K, Soares H, Simon A, Lewczuk P, Dean R, Siemers E, Potter W, Lee VM, Trojanowski JQ; Alzheimer's Disease Neuroimaging Initiative.2009Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. Ann Neurol. 2009 Apr;65(4):403-13.PMID: 19296504 [PubMed - indexed for MEDLINE]view
Simmons A, Westman E, Muehlboeck S, Mecocci P, Vellas B, Tsolaki M, Kloszewska I, Wahlund LO, Soininen H, Lovestone S, Evans A, Spenger C; AddNeuroMed Consortium.2009MRI measures of Alzheimer's disease and the AddNeuroMed study. (2009) Ann N Y Acad Sci.1180:47-55 PMID:19906260.view
Tosun D, Schuff N, Raptentsetsang S, Truran-Sacrey D, Shaw L, Trojanowski J, Weiner M.2009Associations Between Baseline Concentration of Alzheimer's Disease Biochemical Markers and MRI Regional Rates of Brain Tissue Loss in ADNI Data. Alzheimer's Association 2009 International Conference on Alzheimer's Disease (ICAD), July 11-16, 2009.view
Tractenberg RE, Aisen PS, Hancock GR, Rebeck GW.2009No cross-sectional influence of APOE epsilon4 dose on clinical tests in Alzheimer's disease. Neurobiol Aging. 2009 Aug;30(8):1327-8. Epub 2008 Feb 20. PMID: 18083276 [PubMed - indexed for MEDLINE]view
Tractenberg RE, Aisen PS.2009Agreement in cognitive and clinical assessments in Alzheimer's disease. Dement Geriatr Cogn Disord. 2009;27(4):344-52. Epub 2009 Mar 17. PMID: 19293567 [PubMed - indexed for MEDLINE]view
Tractenberg RE; Alzheimer's Disease Neuroimaging Initiative.2009Analytic methods for factors, dimensions and endpoints in clinical trials for Alzheimer's disease Journal of Nutritional Health Aging. 2009. PMID: 19262962.view
Vemuri, P., Wiste, H.J., Weigand, S.D., Shaw, L.M., Trojanowski, J.Q., Weiner, M., Knopman, D.S., Petersen, R.C., Jack Jr, C.R., and the Alzheimer’s Disease Neuroimaging Initiative 2009MRI and CSF biomarkers in normal, MCI, AD: Predicting future clinical change. Neurol., 73:287-293, 2009a. PMID: 19636048 [PubMed - indexed for MEDLINE] view
Vemuri, P., Wiste, H.J., Weigand, S.D., Shaw, L.M., Trojanowski, J.Q., Weiner, M., Knopman, D.S., Petersen, R.C., Jack Jr, C.R., and the Alzheimer's Disease Neuroimaging Initiative.2009MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change Neurology.73:294-301, 2009b. PMID: 19636049 PMCID: PMC2715214. view
Vozdolska R, Sano M, Aisen P, Edland SD.2009The net effect of alternative allocation ratios on recruitment time and trial cost. Clin Trials. 2009 Apr;6(2):126-32. PMID: 19342464 [PubMed - indexed for MEDLINE]view
Weiner, MW. 2009Editorial: Imaging and Biomarkers Will be Used for Detection and Monitoring Progression of Early Alzheimer's Disease. J Nutr Health Aging, 13(4):332, 2009 . view
Wolz R, Aljabar P, Hajnal JV, Hammers A, Rueckert D; Alzheimer's Disease Neuroimaging Initiative.2009LEAP: Learning Embeddings for Atlas Propagation NeuroImage. 2009. PMID: 19815080.view
Yushkevich PA, Avants BB, Das SR, Pluta J, Altinay M, Craige C; Alzheimer's Disease Neuroimaging Initiative.2009Bias in Estimation of Hippocampal Atrophy using Deformation-Based Morphometry Arises from Asymmetric Global Normalization: An Illustration in ADNI 3 Tesla MRI Data. Neuroimage. . [Epub ahead of print] PMID: 20005963 [PubMed - as supplied by publisher]view
Aisen PS, Schneider LS, Sano M, Diaz-Arrastia R, van Dyck CH, Weiner MF, Bottiglieri T, Jin S, Stokes KT, Thomas RG, and Thal LJ for the Alzheimer’s Disease Cooperative Study.2008High Dose B Vitamin Supplementation and Cognitive Decline in Alzheimer's Disease: A Randomized Controlled Trial. JAMA, in pressView
Aisen PS. 2008Leon Thal and the therapeutic age of Alzheimer’s disease. Alzheimer’s & Dementia, 4: S4-6
Aisen PS. 2008Treatment for MCI: is the evidence sufficient? Neurology, 70: 2020-1
Aisen PS. 2008Inflammatory Hypothesis of Alzheimer’s Disease: Dead or Alive? Alzheimer’s Disease and Associated Disorders, 22: 4-5View
Aisen PS. 2008An aspirin a day for Alzheimer's disease? Lancet Neurology, 7:20-21View
Aisen PS. 2008Tarenflurbil: a shot on goal. Lancet Neurology, 7: 468-9
Alexander GE, Hanson KD, Chen K, Reiman EM, Bernstein MA, Kornak J, Schuff NW, Fox NC, Thompson PM, Weiner MW, Jack CR; Alzheimer's Disease Neuroimaging Initiative.2008Six-Month MRI Gray Matter Declines in Alzheimer Dementia Evaluated by Voxel-Based Morphometry with Multivariate Network Analysis: Preliminary Findings from the Alzheimer's Disease Neuroimaging Initiative (ADNI) Alzheimer's and Dementia. 2008. DOI: 10.1016/j.jalz.2008.05.011.view
Becker RE, Greig NH.2008 Alzheimer's disease drug development: old problems require new priorities. CNS Neurol Disord Drug Targets, 7(6):499-511, 2008 .view
Bourgeat P, Acosta O, Fripp J, ourselin S, Masters C, Hudson P, Rowe C, Villemagne V, Salvado O; Alzheimer's Disease Neuroimaging Initiative.2008New cortical thickness estimation method for atrophy characterization of Alzheimer's disease patients Alzheimer's and Dementia. 2008. DOI: 10.1016/j.jalz.2008.05.072.view
Boyes RG, Gunter JL, Frost C, Janke AL, Yeatman T, Hill DL, Bernstein MA, Thompson PM, Weiner MW, Schuff N, Alexander GE, Killiany RJ, DeCarli C, Jack CR, Fox NC; ADNI Study.2008Intensity non-uniformity correction using N3 on 3-T scanners with multichannel phased array coils. Neuroimage. 2008 Feb 15;39(4):1752-62. Epub 2007 Oct 30. PMID: 18063391 [PubMed - indexed for MEDLINE]view
Doody RS, Gavrilova SI, Sano M, Thomas RG, Aisen PS, Bachurin SO, Seely L, Hung D; dimebon investigators.2008Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study. Lancet. 2008 Jul 19;372(9634):207-15. PMID: 18640457 [PubMed - indexed for MEDLINE]view
Fan Y, Batmanghelich N, Clark CM, Davatzikos C, the Alzheimer's Disease Neuroimaging Initiative.2008Spatial Patterns of Brain Atrophy in MCI Patients, Identified via High-Dimensional Pattern Classification, Predict Subsequent Cognitive Decline. NeurImage, 39(4): 1731-1743, 2008 .view
Fleisher AS, Raman R, Siemers ER, Becerra L, Clark CM, Dean RA, Farlow MR, Galvin JE, Peskind ER, Quinn JF, Sherzai A, Sowell BB, Aisen PS, Thal LJ.2008Phase 2 safety trial targeting amyloid beta production with a gamma-secretase inhibitor in Alzheimer disease. Arch Neurol. 65:1031-8, 2008.View
Fleisher AS, Sun S, Taylor C, Ward CP, Gamst AC, Petersen RC, Jack Jr CR, Aisen PS, Thal LJ for the Alzheimer’s Disease Cooperative Study.2008Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment.Neurology. 2008 Jan 15;70(3):191-9. PMID:18195264view
Frisoni GB, Henneman WJP, Weiner MW, Scheltens P, Vellas B, Reynish E, Hudecova J, Hampel H, Burger K, Blennow K, Waldemar G, Johannsen P, Wahlund L-O, Zito G, Rossini PM, Winblad B, Barkhof F, Alzheimer's Disease Neuroimaging Initiative.2008The pilot European Alzheimer's Disease Neuroimaging Initiative of the European Alzheimer's Disease Consortium. Alzheimer's & Dementia, 4(4): 255-64, 2008 .view
Gunter JL, Borowski B, Bernstein M, Ward C, Brsiton P, Felmlee J, Schuff N, Winer M, Jack C; Alzheimer's Disease Neuroimaging Initiative.2008Systematics of the Alzheimer's Disease Neuroimaging Initiative (ADNI) Phantom Alzheimer's and Dementia. 2008. DOI: 10.1016/j.jalz.2008.05.1091.view
Gunter JL, Borowski B, Briston P, Berstein M, Ward C, Felmlee J, Schuff N, Weiner M, Jack CR; Alzheimer's Disease Neuroimaging Initiative.2008Phantom & Scanner Longitudinal Performance Alzheimer's and Dementia. 2008. DOI: 10.1016/j.jalz.2008.05.125.view
Hampel H, Burger K, Teipel SJ, Bokde ALW, Zetterberg H, Blennow K.2008Core Candidate Neurochemical and Imaging Biomarkers of Alzheimer's Disease. (2008) Alzheimer’s & Dementia, 4(1):38-48 PMID: 18631949.view
Hirata-Fukae C, Li HF, Hoe HS, Gray AJ, Minami SS, Hamada K, Niikura T, Hua F, Tsukagoshi-Nagai H, Horikoshi-Sakuraba Y, Mughal M, Rebeck GW, LaFerla FM, Mattson MP, Iwata N, Saido TC, Klein WL, Duff KE, Aisen PS, Matsuoka Y.2008Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model. Brain Res. 2008 Jun 24;1216:92-103. Epub 2008 Apr 10. PMID: 18486110 [PubMed - indexed for MEDLINE]view
Hirata-Fukae C, Sidahmed EH, Gooskens TP, Aisen PS, Dewachter I, Devijver H, Van Leuven F, Matsuoka Y.2008Beta-site amyloid precursor protein-cleaving enzyme-1 (BACE1)-mediated changes of endogenous amyloid beta in wild-type and transgenic mice in vivo. Neurosci Lett. 2008 Apr 25;435(3):186-9. Epub 2008 Mar 10. PMID: 18343582 [PubMed - indexed for MEDLINE]view
Hodes RJ, Buckholtz N, Cahan V, Morrison-Bogorad M.2008Eyes on the prize: Federal Alzheimer's research effort aims to facilitate interventions. Alzheimers Dement. 2008 Jan;4(1 Suppl 1):S37-47. Epub 2007 Dec 21.View
Holland D, Hagler DJ, Fennema-Notestine C, Dale, AM; Alzheimer's Disease Neuroimaging Initiative.2008Longitudinal Nonlinear-Registration and Quantative Analysis of Change in Whole Brain and Regions of Interest Alzheimer's and Dementia. 2008. DOI: 10.1016/j.jalz.2008.05.838.view
Hua X, Leow AD, Lee S, Klunder AD, Toga AW, Lepore N, Chou YY, Brun C, Chiang MC, Barysheva M, Jack CR Jr, Bernstein MA, Britson PJ, Ward CP, Whitwell JL, Borowski B, Fleisher AS, Fox NC, Boyes RG, Barnes J, Harvey D, Kornak J, Schuff N, Boreta L, Alexander GE, Weiner MW, Thompson PM; the Alzheimer's Disease Neuroimaging Initiative.20083D Characterization of Brain Atrophy in Alzheimer's disease and Mild Cognitive Impairment Using Tensor-based Morphometry NeuroImage. 2008. PMID: 18378167 PMCID: PMC2556222.view
Hua X, Leow AD, Parikshak N, Lee S, Chiang MC, Toga AW, Jack CR Jr, Weiner MW, Thompson PM; the Alzheimer's Disease Neuroimaging Initiative.2008Tensor-based Morphometry as a Neuroimaging Biomarker for Alzheimer's Disease: an Mri Study of 676 Alzheimer's, Mild Cognitive Impairment and Normal Subjects NeuroImage. 2008. PMID: 18691658.view
Jack CR Jr, Bernstein MA, Fox NC, Thompson P, Alexander G, Harvey D, Borowski B, Britson PJ, L Whitwell J, Ward C, Dale AM, Felmlee JP, Gunter JL, Hill DL, Killiany R, Schuff N, Fox-Bosetti S, Lin C, Studholme C, DeCarli CS, Krueger G, Ward HA, Metzger GJ, Scott KT, Mallozzi R, Blezek D, Levy J, Debbins JP, Fleisher AS, Albert M, Green R, Bartzokis G, Glover G, Mugler J, Weiner MW.2008The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods. J Magn Reson Imaging. 2008 Apr;27(4):685-91. PMID: 18302232 [PubMed - indexed for MEDLINE]view
Jack CR Jr, Petersen RC, Grundman M, Jin S, Gamst A, Ward CP, Sencakova D, Doody RS, Thal LJ; Members of the Alzheimer's Disease Cooperative Study (ADCS).2008Longitudinal MRI findings from the vitamin E and donepezil treatment study for MCI. Neurobiol Aging.(9):1285-95. Epub 2007 Apr 23.View
Karlawish J, Kim SY, Knopman D, van Dyck CH, James BD, Marson D.2008The views of Alzheimer disease patients and their study partners on proxy consent for clinical trial enrollment. Am J Geriatr Psychiatry. 2008 Mar;16(3):240-7. PMID:18310554 view
Karlawish J, Kim SY, Knopman D, van Dyck CH, James BD, Marson D.2008Interpreting the clinical significance of capacity scores for informed consent in Alzheimer disease clinical trials. Am J Geriatr Psychiatry. 2008 Jul;16(7):568-74. Epub 2008 Jun 12. PMID:18556397view
Kaye J.2008Home-based technologies: a new paradigm for conducting dementia prevention trials. Alzheimers Dement. 2008 Jan;4(1 Suppl 1):S60-6. Epub 2007 Dec 21. Review. PMID:18632003 view
Kemppainen NM, Aalto S, Karrasch M, Någren K, Savisto N, Oikonen V, Viitanen M, Parkkola R, Rinne JO; Alzheimer's Disease Neuroimaging Initiative.2008Automated Quantitative Analysis Methods for the Diagnosis of Alzheimer's Disease with 11C-PIB and 18F-FDG PET Annals of Neurology. 2008. PMID: 18023012.view
Khachaturian ZS, Petersen RC, Gauthier S, Buckholtz N, Corey-Bloom JP, Evans B, Fillit H, Foster N, Greenberg B, Grundman M, Sano M, Simpkins J, Schneider LS, Weiner MW, Galasko D, Hyman B, Kuller L, Schenk D, Snyder S, Thomas RG, Tuszynski MH, Vellas B, 2008A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium. Alzheimers Dement, 4:156-63
Landau SM, Madison C, Wu D, Cheung C, Foster N, Reiman E, Koeppe R, Weiner M, Jagust WJ; Alzheimer's Disease Neuroimaging Initiative.2008Pinpointing Change in Alzheimer's Disease: Longitudinal FDG-PET Analysis From the Alzheimer's Disease Neuroimaging Initiative (ADNI) Alzheimer's and Dementia. 2008. DOI: 10.1016/j.jalz.2008.05.848.view
Little J, Walsh S, Aisen PS.2008Huperzine A for Alzheimer’s Disease. Expert Opinion on Investigational Drugs, 17: 209-215
Matsuoka Y, Jouroukhin Y, Gray AJ, Ma L, Hirata-Fukae C, Li HF, Feng L, Lecanu L, Walker BR, Planel E, Arancio O, Gozes I, Aisen PS.2008A neuronal microtubule-interacting agent, NAPVSIPQ, reduces tau pathology and enhances cognitive function in a mouse model of Alzheimer's disease. J Pharmacol Exp Ther. 325(1):146-53. Epub. 2008 Jan 16
Mhyre TR, Loy R, Tariot PN, Profenno LA, Maguire-Zeiss KA, Zhang D, Coleman PD, Federoff HJ.2008Proteomic analysis of peripheral leukocytes in Alzheimer's disease patients treated with divalproex sodium. Neurobiol Aging. 2008 Nov;29(11):1631-43. Epub 2007 May 22. PMID:17521776 view
Mormino EC, Kluth JT, Madison CM, Rabinovici GD, Baker SL, Miller BL, Koeppe RA, Mathis CA, Weiner MW, Jagust WJ, and the Alzheimer’s Disease Neuroimaging Initiative.2008Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. Brain Nov 28 [Epub ahead of print], 2008 .view
Morra JH, Tu Z, Apostolova LG, Green AE, Avedissian C, Madsen SK, Parikshak N, Hua X, Toga AW, Jack CR Jr, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative.2008Validation of a fully automated 3D hippocampal segmentation method using subjects with Alzheimer's disease mild cognitive impairment, and elderly controls. Neuroimage. 2008 Oct 15;43(1):59-68. Epub 2008 Jul 16. Erratum in: Neuroimage. 2009 Feb 15;44(4):1439. PMID: 18675918 [PubMed - indexed for MEDLINE]view
Nestor SM, Rupsingh R, Borrie M, Smith M, Accomazzi V, Wells JL, Fogarty J, Bartha R, and the Alzheimer's Disease Neuroimaging Initiative. 2008 Ventricular Enlargement as a Possible Measure of Alzheimer's Disease Progression Validated Using the Alzheimer's Disease Neuroimaging Initiative Database. Brain 131(Pt 9):2443-54, 2008 .view
Neu SC, Toga AW; Alzheimer's Disease Neuroimaging Initiative.2008Automatic Localization of Anatomical Point Landmarks for Brain Image Processing Algorithms Neuroinformatics. 2008. PMID: 18512163.view
Paul S. Aisen, Lon S. Schneider, Mary Sano, Ramon Diaz-Arrastia, Christopher H. van Dyck, Myron F. Weiner, Teodoro Bottiglieri, Shelia Jin, Karen T. Stokes, Ronald G. Thomas, Leon J. Thal for the members of the Alzheimer’s Disease Cooperative Study2008High-Dose B Vitamin Supplementation and Cognitive Decline in Alzheimer Disease: A Randomized Controlled Trial. JAMA, 300(15):1774-1783
Petersen RC, Negash S.2008Mild cognitive impairment: an overview. CNS Spectr. 2008 Jan;13(1):45-53. Review. PMID: 18204414 [PubMed - indexed for MEDLINE]view
Petersen RC.2008Challenges in clinical research on Alzheimer's disease: Leon Thal's legacy. Alzheimers Dement. 2008 Jan;4(1 Suppl 1):S88-90. Epub 2007 Dec 21. Review. No abstract available. PMID: 18632008 [PubMed - indexed for MEDLINE]view
Peterson RC, Aisen P, Beckett L, Donohue M, Weng Q, Salmon D, Weiner M; Alzheimer's Disease Neuroimaging Initiative.2008Baseline Characteristics Alzheimer's and Dementia. 2008. DOI: 10.1016/j.jalz.2008.05.1603.view
Reiman EM, Kewwi C, Ayutyanont N, Lee W, Bandy D, Reschke C, Alexander GE, Weiner MW, Koeppe RA, Foster NL, Jagust WJ; Alzheimer's Disease Neuroimaging Initiative.2008Twelve-Month Cerebral Metabolic Declines in Probable Alzheimer's Disease and Amnestic Mild Cognitive Impairment: Preliminary Findings from the Alzheimer's Disease Neuroimaging Initiative Alzheimer's and Dementia. 2008. DOI: 10.1016/j.jalz.2008.05.225.view
Rousseau F; Alzheimer's Disease Neuroimaging Initiative.2008Brain Hallucination: a Non-local Approach for Image Magnification Lecture Notes in Computer science. 2008. DOI: 10.1007/978-3-540-88682-2_38.view
Sano M, Grossman H, Van Dyk K.2008Preventing Alzheimer's disease : separating fact from fiction. CNS Drugs. 2008;22(11):887-902. Review.PMID: 18840031view
Schuff N, Woerner N, Boreta L, Kornfield T, Jack CR Jr, Weiner MW; Alzheimer's Disease Neuroimaging Initiative.2008Rate of Hippocampal Atrophy in the Alzheimer's Disease Neuroimaging Initiative (ADNI): Effects of APOE4 and Value of Additional MRI Scans Alzheimer's and Dementia. 2008. DOI: 10.1016/j.jalz.2008.05.428.view
Shaw LM.2008 PENN biomarker core of the Alzheimer's Disease Neuroimaging Initiative. Neurosignals, 16(1):19-23, 2008 .view
Tractenberg RE, Aisen PS, Hancock GR, William Rebeck G.2008No cross-sectional influence of APOE varepsilon4 dose on clinical tests in Alzheimer's disease. Neurobiol Aging, in press
van Straaten EC, Harvey D, Scheltens P, Barkhof F, Petersen RC, Thal LJ, Jack CR Jr, DeCarli C; Alzheimer's Disease Cooperative Study Group.2008Periventricular white matter hyperintensities increase the likelihood of progression from amnestic mild cognitive impairment to dementia. J Neurol. 2008 Sep;255(9):1302-8. Epub 2008 Sep 25. PMID: 18825439 [PubMed - indexed for MEDLINE]view
Vanderstichele, H., De Meyer, G., Shapiro, F., Engelborghs, B., DeDeyn, P.P., Shaw, L.M., and Trojanowski, J.Q.2008 Alzheimer's disease biomarkers: From concept to clinical utility. In: Biomarkers For Early Diagnosis Of Alzheimer's Disease, D. Galimberti, E. Scarpini (Eds.), Nova Science Publishers, Inc., Hauppauge, NY, pp. 81-122, 2008.view
Visser PJ, Verhey FRJ, Boada M, Bullock R, De Deyn PP, Frisoni GB, Frolich L, Hampel H, Jolles J, Jones R, Minthon L, Nobili F, Olde Rikkert M, Ousset P-J, Rigaurd A-S, Scheltens P, Soininen H, Spiru L, Touchon J, Tsolaki M, Vellas B, Wahlund LO, Wilcock G, Winblad B, DESCRIPA study group.2008 Development of Screening Guidelines and Clinical Criteria for Predementia Alzheimer’s Disease. Neuroepidemiology, 30:254-265, 2008 .view
Walhovd KB, Fjell AM, Dale AM, McEvoy LK, Brewer J, Karow DS, Salmon DP, Fennema-Notestine C; the Alzheimer's Disease Neuroimaging Initiative. 2008Multi-modal imaging predicts memory performance in normal aging and cognitive decline. Neurobiol Aging, Oct 5 [Epub ahead of print], 2008.view
Weiner MW; Alzheimer's Disease Neuroimaging Initiative.2008Progress Report Alzheimer's and Dementia. 2008. DOI: 10.1016/j.jalz.2008.05.183.view
Zhu CW, Leibman C, McLaughlin T, Scarmeas N, Albert M, Brandt J, Blacker D, Sano M, Stern Y.2008The Effects of Patient Function and Dependence on Costs of Care in Alzheimer's Disease. J Am Geriatr Soc. View
Arai H.2007Alzheimer's Disease Neuroimaging Initiative and mild cognitive impairment. (2007) RinshoShinkeigaku, 47(11):905-7. PMID:18210831.view
Batmanghelich N, Taskar B, Davatzikos C.2007A general and unifying framework for feature construction, in image-based pattern classification. (2009) Inf Process Med Imaging. 21:423-34. PMID:19694282.view
Bossa M, Hernandez M, Olmos S.2007Tensor-based morphometry with mappings parameterized by stationary velocity fields in Alzheimer's disease neuroimaging initiative MICCAI. 2007. PMID: 18051116.view
Chen K, Reiman EM, Alexander GE, Lee W, Reschke C, Smilovici O, Bandy D, Weiner MW, Keoppe RA, Jagust WJ.2007Six-month cerebral metabolic declines in Alzheimer's Disease, amnestic mild cognitive impairment and elderly normal control groups: Preliminary findings from the Alzheimer's Disease Neuroimaging Initiative Alzheimer's and Dementia. 2007. DOI: 10.1016/j.jalz.2007.04.081.view
Chen K, Reiman EM, Alexander GE, Smilovici O, Lee W, Reschke C, Bandy D, Foster NL, Weiner MW, Koeppe RA, Jagust WJ.2007The pattern and severity of FDG PET abnormalities in Alzheimer's Disease and amnestic mild cognitive impairment: Preliminary findings from the Alzheimer's Disease Neuroimaging Initiative Alzheimer's and Dementia. 2007. DOI: 10.1016/j.jalz.2007.04.240.view
DeCarli C, Frisoni GB, Clark CM, Harvey D, Grundman M, Petersen RC, Thal LJ, Jin S, Jack CR Jr, Scheltens P; Alzheimer's Disease Cooperative Study Group.2007Qualitative estimates of medial temporal atrophy as a predictor of progression from mild cognitive impairment to dementia. Arch Neurol. 2007 Jan;64(1):108-15. Erratum in: Arch Neurol; 2007 March; 64(3): 459View
Fennema-Notestine C, Haglera DJ, Wua EH, Podrazaa K, Fleishera AS, Karowa DS, McEvoya LK, Dalea AM; the Alzheimer's Disease Neuroimaging Initiative.2007Preliminary cross-sectional and longitudinal cortical thickness analyses of MRI data from the Alzheimer's Disease Neuroimaging Initiative (ADNI) using Morphometry BIRN methods Alzheimer's and Dementia. 2007. DOI: 10.1016/j.jalz.2007.04.027.view
Fisher A, Hanin I, Poewe W, Windisch M.2007MRI of Alzheimer's and Parkinson's: The Alzheimer's Disease Neuroimaging Initiative (ADNI-Info.Org) Neurodegenerative Diseases. 2007. DOI: 10.1159/000102531.view
Fleisher AS, Sowell BB, Taylor C, Gamst AC, Petersen RC, Thal LJ.2007Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment. Neurology;PMID: 17287448 [PubMed - as supplied by publisher
Fletcher PT, Powell S, Foster NL, Joshi SC.2007Quantifying metabolic asymmetry modulo structure in Alzheimer’s disease. (2007) Inf Process Med Imaging, 20:446-57. PMID: 17633720.view
Gray AJ, Sakaguchi G, Shiratori C, Becker AG, LaFrancois J, Aisen PS, Duff K, Matsuoka Y.2007Antibody against C-terminal Abeta selectively elevates plasma Abeta. Neuroreport;18(3):293-6.
Gunter JL, Bernstein MA, Briston PJ, Felmlee JP, Schuff N, Weiner M, Jack CR.2007MRI System Tracking and Correction using the ADNI Phantom Alzheimer's and Dementia. 2007. DOI: 10.1016/j.jalz.2007.04.254.view
Karow DS, Hagler DJ, Fennema-Notestine C, McEvoy LK, Wu EH, Brewer JB, Fleisher AS, Hoh CK, Dale AM; the Alzheimer's Disease Neuroimaging Initiative.2007Preliminary cross-sectional analysis of PET data from the Alzheimer's Disease Neuroimaging Initiative Alzheimer's and Dementia. 2007. DOI: 10.1016/j.jalz.2007.04.258.view
Kurlan R, Cummings J, Raman R, Thal L; Alzheimer’s Disease Cooperative Study.2007Quetiapine for agitation or psychosis in patients with dementia and parkinsonism. Neurology. 2007 Apr 24;68(17):1356:63.View
Mhyre TR, Loy R, Tariot PN, Profenno LA, Maguire-Zeiss KA, Zhang D, Coleman PD, Federoff HJ.2007Proteomic analysis of peripheral leukocytes in Alzheimer's disease patients treated with divalproex sodium. Neurobiol Aging.View
Petersen RC.2007The current status of mild cognitive impairment--what do we tell our patients? Nat Clin Pract Neurol; 3(2):60-1.
Petersen RC.2007Mild cognitive impairment: current research and clinical implications. Semin Neurol; 27(1):22-31.
Shaw LM.2007PENN Biomarker Core of the Alzheimer's Disease NeuroImaging Intiative Neurosignals. 2007. PMID: 18097156 PMCID: PMC2696349.view
Tractenberg RE, Aisen PS, Hancock GR, William Rebeck G.2007No cross-sectional influence of APOE varepsilon4 dose on clinical tests in Alzheimer's disease. Neurobiol Aging.View
Tractenberg RE, Aisen PS, Weiner MF, Fuh JL.2007A simple method to rule out dementia in community-based cohorts. Alzheimer's & Dementia, 3:28-32
Clark, Christopher2006Frontotemporal Lobar Degeneration With Motor Neuron Disease: A Clinical and Pathological Spectrum. Arch Neurol, vol. 63, pp 489-490
Cummings J. L.2006Alzheimer’s Disease Clinical Trials: Where are we now? The Canadian Journal of Neurological Sciences, volume 33, number, page 5
Cummings J. L.2006Effects of Donepezil on Neuropsychiatric Symptoms in Patients With Dementia and Severe Behavioral Disorders. Am J Geriatr Psychiatry 14:605-612.
Cummings J. L.2006Behavioral effects of memantine in Alzheimer disease patients receiving donepezil treatment. NEUROLOGY;67:57-63
Cummings JL, Raman R, Ernstrom K, Salmon D, Ferris SH; Alzheimer's Disease Cooperative Study Group.2006ADCS Prevention Instrument Project: behavioral measures in primary prevention trials. Alzheimer Dis Assoc Disord. 20(4 Suppl 3):S147-51
Ferris SH, Aisen PS, Cummings J, Galasko D, Salmon DP, Schneider L, Sano M, Whitehouse PJ, Edland S, Thal LJ; Alzheimer's Disease Cooperative Study Group.2006ADCS Prevention Instrument Project: overview and initial results. Alzheimer Dis Assoc Disord;20(4 Suppl 3):S109-23. View
Galasko D, Bennett DA, Sano M, Marson D, Kaye J, Edland SD; Alzheimer's Disease Cooperative Study.2006ADCS Prevention Instrument Project: assessment of instrumental activities of daily living for community-dwelling elderly individuals in dementia prevention clinical trials. Alzheimer Dis Assoc Disord. 20(4 Suppl 3):S152-69
Knopman, DS2006Incidence and Causes of Nondegenerative Nonvascular Dementia. Arch Neurol ;63:218-221
Knopman, DS2006Dementia and Cerebrovascular Disease. Mayo Clin Proc; vol. 81, no. 11
Knopman, DS2006Current treatment of mild cognitive impairment and Alzheimer's disease. Curr Neurol Neurosci Rep;6(5):365-71.
Leow AD, Klunder AD, Jack CR Jr, Toga AW, Dale AM, Bernstein MA, Britson PJ, Gunter JL, Ward CP, Whitwell JL, Borowski BJ, Fleisher AS, Fox NC, Harvey D, Kornak J, Schuff N, Studholme C, Alexander GE, Weiner MW, Thompson PM; ADNI Preparatory Phase Study.2006Longitudinal Stability of MRI for Mapping Brain Change using Tensor-Based Morphometry NeuroImage. 2006. PMID: 16480900 PMCID: PMC1941663.view
Marson, Daniel2006Financial capacity in persons with schizophrenia and serious mental illness: clinical and research ethics aspects. Schizophr Bull: 32(1):81-91
Mintzer, Jacobo E2006Risperidone in the Treatment of Psychosis of Alzheimer Disease: Results From a Prospective Clinical Trial. Am J Geriatr Psychiatry 14:280-291.
Patterson MB, Whitehouse PJ, Edland SD, Sami SA, Sano M, Smyth K, Weiner MF; Alzheimer's Disease Cooperative Study Group.2006ADCS Prevention Instrument Project: quality of life assessment (QOL). Alzheimer Dis Assoc Disord; 20(4 Suppl 3):S179-90.
Petersen RC.2006Neuropathologic Features of Amnestic Mild Cognitive Impairment. Arch Neuro.;63:665-672
Petersen RC.2006Mild Cognitive Impairment Should Be Considered for DSM-V. Journal of Geriatric Psychiatry and Neurology, Vol. 19, No. 3, 147-154.
Raskind, Murray A.2006Olanzapine-Induced Weight Gain and Increased Visceral Adiposity is Blocked by Melatonin Replacement Therapy in Rats. Neuropsychopharmacology.
Risacher SL, Saykin AJ, West JD, Shen L, Firpi HA, McDonald BC ;Alzheimer's Disease Neuroimaging Initiative.2006Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort Current Alzheimer Research. 2006. PMID: 19689234 PMCID: PMC2764863.view
Salmon DP, Cummings JL, Jin S, Sano M, Sperling RA, Zamrini E, Petersen RC, Edland SD, Thal LJ, Ferris SH; Alzheimer's Disease Cooperative Study.2006ADCS Prevention Instrument Project: development of a brief verbal memory test for primary prevention clinical trials. Alzheimer Dis Assoc Disord; 20(4 Suppl 3):S139-46.
Sano M, Egelko S, Jin S, Cummings J, Clark CM, Pawluczyk S, Thomas RJ, Schittini M, Thal LJ; Alzheimer's Disease Cooperative Study Group.2006Spanish instrument protocol: new treatment efficacy instruments for Spanish-speaking patients in Alzheimer disease clinical trials. Alzheimer Dis Assoc Disord; 20(4):232-41.
Sano M, Zhu CW, Whitehouse PJ, Edland S, Jin S, Ernstrom K, Thomas RG, Thal LJ, Ferris SH; Alzheimer Disease Cooperative Study Group.2006ADCS Prevention Instrument Project: pharmacoeconomics: assessing health-related resource use among healthy elderly. Alzheimer Dis Assoc Disord; 20(4 Suppl 3):S191-202.
Sano M.2006Neurological Testing in the Diagnosis of Dementia. Journal of Geriatric Psychiatry and Neurology, Vol. 19, No. 3, 155-159
Sano M.2006A guide to diagnosis of Alzheimer’s disease. CNS Spectr; 97(7 Suppl 5):16-9
Schimitt, Frederick A.2006A Systematic Review of Assessment and Treatment of Moderate to Severe Alzheimer’s Disease. Prim Care Companion J Clin Psychiatry. 2006; 8(3): 158–159
Schneider LS, Clark CM, Doody R, Ferris SH, Morris JC, Raman R, Reisberg B, Schmitt FA.2006ADCS Prevention Instrument Project: ADCS-clinicians' global impression of change scales (ADCS-CGIC), self-rated and study partner-rated versions. Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4 Suppl 3):S124-38.PMID:17135806view
Tariot, P. N.2006Quetiapine Treatment of Psychosis Associated With Dementia: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial. Am J Geriatr Psychiatry 14:767-776.
Thal, L. J.2006Prevention of Alzheimer Disease. Alzheimer Disease & Associated Disorders. 20 Supplement 2:S97-99.
Thal, L. J.2006The Role of Biomarkers in Clinical Trials for Alzheimer Disease. Alzheimer Disease & Associated Disorders. 20(1): 6-15.
Tractenberg RE, Aisen PS, Weiner MF, Cummings JL.2006Independent contributions of neural and 'higher order' deficits to symptoms in Alzheimer’s disease: a latent variable modeling approach. Alzheimer’s & Dementia, 2: 303-313
Tractenberg, R. E.2006Characterizing sleep problems in persons with Alzheimer’s disease and normal elderly. Journal of Sleep Research, vol. 15, issue 1, pg. 97.
Walsh SP, Raman R, Jones KB, Aisen PS; Alzheimer's Disease Cooperative Study Group2006ADCS Prevention Instrument Project: the Mail-In Cognitive Function Screening Instrument (MCFSI). Alzheimer Dis Assoc Disord;20(4 Suppl 3):S170-8.
Weiner, Myron F.2006Psychiatry for Neurologists. Arch Neur vol. 63, pp 623-624
Weiner, Myron F.2006Measuring QOL in dementia. International Psychogeriatrics, 18: 357-358
Weiner, Myron F.2006Comparison of the Test of Everyday Functional Abilities with a Direct Measure of Daily Function. Dement Geriatr Cogn Disord ;22:83-86
Weiner, Myron F.2006Standards in Dementia Care. Arch Neur vol. 63, pp. 466
Whitehouse PJ, Rajcan JL, Sami SA, Patterson MB, Smyth KA, Edland SD, George DR.2006ADCS Prevention Instrument Project: pilot testing of a book club as a psychosocial intervention and recruitment and retention strategy. Alzheimer Dis Assoc Disord. 20(4 Suppl 3):S203-8
Yesavage, Jerome A.2006Spatial Test for Agricultural Pesticide “Blow-In” Effect on Prevalence of Parkinson’s Disease. Journal of Geriatric Psychiatry and Neurology, vol. 19, no. 1, 32-35
Aisen P.S.2005Can rofecoxib delay a diagnosis of Alzheimer's disease in patients with mild cognitive impairment? Nat Clin Pract Neurol;1(1):20-1.
Aisen P.S.2005The development of anti-amyloid therapy for Alzheimer's disease : from secretase modulators to polymerisation inhibitors. CNS Drugs;19(12):989-96.
Aisen P.S.2005Pharmacologic treatment options in Alzheimer's disease: optimizing disease management. J Am Acad Nurse Pract;Suppl:5-7.
Aisen P.S.2005The Development of Anti-Amyloid Therapy for Alzheimer’s Disease: From Secretase Modulators to Polymerization Inhibitors. CNS Drugs, Vol. 19, No. 12: pages 989-996(8).
Bennet, David2005The Rush Memory and Aging Project: Study Design and Baseline Characteristics of the Study Cohort. Neuroepidemology;25:163-175.
Bennet, David2005Immunization therapy for Alzheimer disease? Neurology;64;10-12.
Bennet, David2005Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. Neurology;64:834-841.
Cotman, Carl2005The role of caspase cleavage of tau in Alzheimer disease neuropathology. J Neuropathol Exp Neurol.
Cotman, Carl2005The Role of Neurotrophins in Brain Aging: A Perspective in Honor of Regino Perez-Polo. Neurochemical Research, vol. 30, no. 6-7.
Cotman, Carl2005Imaging Techniques- A Vision into the Future? Medicine & Science in Sports & Exercise. 37(5) Supplement:S415.
Cummings J. L.2005Neuropsychiatric and behavioral alterations and their management in moderate to severe Alzheimer disease. NEUROLOGY;65:S18-S24
Cummings J. L.2005Clinical evaluation as a biomarker for Alzheimer’s disease. Journal of Alzheimer’s Disease, vol. 8, pp. 327-337
Cummings J. L.2005Cholinesterase inhibitors for treatment of dementia associated with Parkinson’s disease. Journal of Neurology Neurosurgery and Psychiatry;76:903-904
DeCarli, Charles2005Anatomical Mapping of White Matter Hyperintensities (WMH): Exploring the Relationships Between Periventricular WMH, Deep WMH, and Total WMH Burden. Stroke;36:50
Doody R.S.2005Changing Patient Characteristics and Survival Experience in Alzheimer’s Center Patient Cohort. Dement Geriatr Cogn Disord;20:198-208
Fleisher A, Grundman M, Jack CR Jr, Petersen RC, Taylor C, Kim HT, Schiller DH, Bagwell V, Sencakova D, Weiner MF, DeCarli C, DeKosky ST, van Dyck CH, Thal LJ; Alzheimer's Disease Cooperative Study.2005Sex, apolipoprotein E epsilon 4 status, and hippocampal volume in mild cognitive impairment. Arch Neurol. 62(6):953-7
Galasko, Douglas2005Detailed assessment of activities of daily living in moderate to severe Alzheimer’s disease. Journal of the International Neuropsychological Society, 11:446-453
Jack, Clifford RJ2005Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI. NEUROLOGY;65:1227-1231
Karlawish, Jason2005The ability of persons with Alzheimer disease (AD) to make a decision about taking an AD treatment. NEUROLOGY;64:1514-1519
Knopman, DS2005Coronary artery bypass grafting is not a risk factor for dementia or Alzheimer disease. NEUROLOGY; 65:986-990
Marson, Daniel2005Impairment and partial recovery of medical decision-making capacity in traumatic brain injury: a 6-month longitudinal study. Arch Phys Med Rehabil. 86(5): 889-95
Mesulam, Marsel2005Imaging connectivity in the human cerebral cortex: the next frontier? Ann Neurol; 57(1):5-7
Mohs, Richard C.2005The clinical syndrome of Alzheimer’s disease: aspects particularly relevant to clinical trials. Genes, Brain & Behavior, vol. 4, no. 3, pp. 129-133(5)
Mueller SG, Weiner MW, Thal LJ, Petersen RC, Jack C, Jagust W, Trojanowski JQ, Toga AW, Beckett L.2005ADNI Neuroimaging Clinics of North America. 2005. PMID: 16443497 PMCID: PMC2376747.view
Mueller SG, Weiner MW, Thal LJ, Peterson RC, Jack CR, Jagust W, Trojanowski JQ, Toga AW, Beckett L.2005Ways Toward an Early Diagnosis in Alzheimer's Disease, ADNI Alzheimer's and Dementia. 2005. PMID: 17476317 PMCID: PMC1864941.view
Mulnard, Ruth A.2005Methodological Issues in Estrogen Treatment Trials for Alzheimer’s Disease. Ann. NY Acad. Sci. 1052: 173-181.
Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, Galasko D, Jin S, Kaye J, Levey A, Pfeiffer E, Sano M, van Dyck CH, Thal LJ.2005Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment. N Engl J Med, 352:2379-88View
Petersen RC.2005Aging, Memory, and Mild Cognitive Impairment. International Psychogeriatrics.
Schneider, Lon S.2005Risk of Death With Atypical Antipsychotic Drug Treatment for Dementia. JAMA; 294:1934-1943
Tariot PN, Raman R, Jakimovich L, Schneider L, Porsteinsson A, Thomas R, Mintzer J, Brenner R, Schafer K, Thal L; Alzheimer's Disease Cooperative Study; Valproate Nursing Home Study Group.2005Divalproex sodium in nursing home residents with possible or probable Alzheimer Disease complicated by agitation: a randomized, controlled trial. Am J Geriatr Psychiatry. 13(11):942-9View
Tractenberg RE, Aisen PS, Chuang Y-L.2005One trial 10-item free recall performance in Taiwanese elderly and near-elderly: implications for screening for memory impairment and cognitive decline. American Journal of Alzheimer’s Disease and Other Dementias, 20:239-247
Tractenberg, R. E.2005 Symptoms of sleep disturbance in persons with Alzheimer’s disease and normal elderly. Journal of Sleep Research, vol. 14, issue 2, p. 177.
Tractenberg, R. E.2005Benchmarking a Test of Temporal Orientation with Data from American and Taiwanese Persons with Alzheimer’s Disease and American Normal Elderly. Neuroepidemiology; 24:110-116
Whitehouse, Peter J.2005Antiaging medicine and mild cognitive impairment: practice and policy issues for geriatrics. J Am Geriatr Soc.; 53(8):1417-22
Whitehouse, Peter J.2005Anthropological contributions to the understanding of age-related cognitive impairment. Lancet Neurol.;4(5):320-6
Bennet, David2004Cerebral Infarctions and the Relationship of Depression Symptoms to Level of Cognitive Functioning in Older Persons. Am J Geriatr Psychiatry 12:211-219.
Cummings J. L.2004Reduction of Behavioral Disturbances and Caregiver Distress by Galantamine in Patients With Alzheimer’s Disease. Am J Psychiatry 161:532-538.
Cummings J. L.2004Dementia with Lewy Bodies: Moledcular Pathogenesis and Implications for Classification. Journal of Geriatric Psychiatry and Neurology, Vol. 17, No. 3, 112-119.
Cummings J. L.2004Searching for Methods to Detect, Prevent, and Treat Alzheimer’s Disease. Am J Psychiatry 162 (4): 645.
Cummings J. L.2004The one-minute mental status examination. Neurology;62;534-535
Cummings J. L.2004THE DIAGNOSIS AND MANAGEMENT OF DEMENTIA. Middle East Journal of Family Medicine; vol. 2 (5)
DeCarli, Charles2004Vascular factors in dementia: an overview. J Neurol Sci;226(1-2):19-23
DeCarli, Charles2004Memory impairment, but not cerebrovascular disease, predicts progression of MCI. NEUROLOGY;63:220-227
DeKosky, Steven T.2004Effects of post-injury hypothermia and nerve growth factor infusion on antioxidant enzyme activity in the rat: implications for clinical trials. Journal of Neurochemistry, vol. 90, issue 4, p. 998.
DeKosky, Steven T.2004 Time Course Analysis of Hippocampal Nerve Growth Factor and Antioxidant Enzyme Activity following Lateral Controlled Cortical Impact Brain Injury in the Rat. Journal of Neurotrama, vol. 21, no. 5: 491-500
Doody R.S.2004Specific Functional Effects of Memantine Treatment in Patients with Moderate to Severe Alzheimer’s Disease. Dementia and Geriatric Cognitive Disorders, vol. 18, no. 2.
Doody R.S.2004A Method for Estimating Duration of Illness in Alzheimer’s Disease. Dement Geriatr Cogn Disord; 17:1-4
Doody R.S.2004Refining treatment guidelines in Alzheimer’s disease. Geriatrics; Suppl:14-20
Farlow, Martin R.2004Impact of APOE in mild cognitive impairment. NEUROLOGY;63:1898-1901
Farlow, Martin R.2004NMDA receptor antagonists: a new therapeutic approach for Alzheimer’s disease. Geriatrics, vol. 59, no. 6, pp. 22-30
Farlow, Martin R.2004Differential qualitative responses to rivastigmine in APOE ?4 carriers and noncarriers. The Pharmacogenomics Journal, vol. 4, no. 5, pp. 332-335
Galasko, Douglas2004Galantamine Maintains Ability to Perform Activities of Daily Living in Patients with Alzheimer’s Disease. Journal of the American Geriatrics Society, volume 52, issue 7, page 1070.
Galasko, Douglas2004Biomarkers in non-Alzheimer dementias. Clinical Neuroscience Research, vol. 3, issue 6, pp. 375-381.
Grundman M, Petersen RC, Ferris SH, Thomas RG, Aisen PS, Bennett DA, Foster N, Jack C, Galasko D, Doody R, Kaye J, Sano M, Mohs R, Gauthier S, Kim HT, Jin S, Schultz AN, Schafer K, Mulnard R, van Dyck C, Mintzer J, Zamrini EY, Cahn-Weiner D, Thal LJ and 2004Mild Cognitive Impairment can be Distinguished from Alzheimer’s Disease and Normal Aging for Clinical Trials. Archives of Neurology, 61: 59-66
Jack, Clifford RJ2004In vivo visualization of Alzheimer’s amyloid plauques by magnetic resonance imaging in transgenic mice without a contrast agent. Magnetic Resonance in Medicine: vol. 52, issue 6, pp. 1263-1271.
Jack, Clifford RJ2004Comparison of different MRI brain atrophy rat measures with clinical disease progression in AD NEUROLOGY;62:591-600
Karlawish, Jason2004Donepezil Delay to Nursing Home Placement study is Flawed. Journal of the American Geriatrics Society, vol. 52, issue 5, p. 845.
Karlawish, Jason2004Competency in the age of assessment. The Lancet, vol. 364, issue 9443, pp. 1383-1384.
Karlawish, Jason2004Addressing the Ethical, Legal, and Social Issues Raised by Voting by Persons With Dementia. JAMA;292:1345-1350
Karlawish, Jason2004Silence Science: The Problem of Not Reporting Negative Trials. Alzheimer Disease & Associated Disorders; 18(4): 180-182.
Mesulam, Marsel2004The Cholinergic Lesion of Alzheimer’s Disease: Pivotal Factor or Side Show? LEARNING & MEMORY 11:43-49.
Mesulam, Marsel2004 Cholinergic nucleus basails tauopathy emerges early in the aging-MCI-AD continuum. Annals of Neurology, vol. 55, issue 6, pp. 815-828.
Mesulam, Marsel2004The cholinergic innervation of the human cerebral cortex. Prog Brain Res; 145:67-78
Mintzer, Jacobo E2004What are the challenges faced by psychiatrists in the management of Alzheimer’s disease? CNS Spectr ;9(7 Suppl 5):13-5
Mintzer, Jacobo E2004A comparison of extrapyramidal symptoms in older patients treated with quetiapine or riseperidone. Current Medical Research and Opinion, vol. 20, no. 9, pp. 1483-1491(9)
Morris, John C.2004Induction of cytotoxic T-lymphocyte responses to enhanced green and yellow fluorescent proteins after myeloablative conditioning. Blood, vol. 103, no. 2, pp. 492-499
Mulnard, Ruth A.2004Estrogen Replacement Therapy, Alzheimer’s Disease, and Mild Cognitive Impairment. Current Neurology and Neuroscience Reports, 4:368-373
Petersen RC.2004Challenges of Epidemological Studies of Mild Cognitive Impairment. Alzheimer Disease & Associated Disorders. 18(1):1-2, January/February/March
Raskind, Murray A.2004The Cognitive Benefits of Galantamine Are Sustained for at Least 36 Months. Arch Neurol. ;61:252-256
Raskind, Murray A.2004The Challenge of a PTSD Brain Bank. Psychiatry 67(4).
Sano M.2004Economic effect of cholinesterase inhibitor therapy: implications for managed care. Manag Care Interface; 17(8):44-9
Schafer KA, Tractenberg RE, Sano M, Mackell JA, Thomas RG, Gamst A, Thal LJ, Morris JC; Alzheimer's Disease Cooperative Study.2004Reliability of monitoring the clinical dementia rating in multicenter clinical trials. Alzheimer Dis Assoc Disord. 18(4):219-22
Schneider, Lon S.2004Long-term donepezil treatment in 565 patients with Alzheimer’s disease (AD2000): randomized double-blind trial. The Lancet, vol. 363, issue 9427, pp. 2105-2115.
Sperling, Reisa A.2004Metacognition and Self-Regulated Learning Constructs. Educational Research and Evaluation, vol. 10, no. 2, pp. 117-139
Tariot, P. N.2004Memantine Treatment in Patients With Moderate to Severe Alzheimer Disease Already Receiving Donepezil. JAMA; 291:317-324
Tariot, P. N.2004Memantine for Patients With Alzheimer Disease. JAMA, vol. 291, no. 14:1695
Tariot, P. N.2004Efficacy of atypical antipsychotics in elderly patients with dementia. J Clin Psychiatry; 65 Suppl 11:11-5
Van Dyck, Christopher2004Central Serotonin Transporter Availability Measured With [123 I]?-CIT SPECT in Relation to Serotonin Transporter Genotype. Am J Psychiatry 161: 525-531.
Weiner, Myron F.2004Legal and Ethical Issues for Patients With Dementia and Their Families. Geriatric Times, vol. 5, issue 1
Weiner, Myron F.2004Neuropsychiatry and Behavioral Neurosciences. Arch Neur vol. 61, pp 805-806
Whitehouse, Peter J.2004Breaking the diagnosis of dementia. Lancet Neurol.; 3(2):124-8
Whitehouse, Peter J.2004Paying attention to acetylcholine: the key to wisdom and quality of life? Prog Brain Res.;145:311-7
Yesavage, Jerome A.2004Use of VA Pharmacy Database to Screen for Areas at High Risk for Disease: Parkinson’s Disease and Exposure to Pesticides. Journal of Geriatric Psychiatry and Neurology, vol. 17, no. 1, 36-38
Yesavage, Jerome A.2004Sleep/Wake Disruption in Alzheimer’s Disease: APOE Status and Longitudinal Course. Journal of Geriatric Psychiatry and Neurology, vol. 17, no. 1, 20-24
Aisen PS, Berg JD, Craft S, Peskind ER, Sano M, Teri M, Mulnard R, Thomas RG, LJ Thal for the Alzheimer’s Disease Cooperative Study.2003Steroid-induced elevation of glucose in Alzheimer’s disease: relationship to gender, apolipoprotein E genotype and cognition. Psychoneuroendocrinology, 28:113-120
Aisen PS, Egelko S, Andrews H, Diaz-Arrastia R, Weiner M, DeCarli C, Jagust W, Miller JW, Green R, Bell K, Sano M.2003A Pilot Study of Vitamins to Lower Plasma Homocysteine in Alzheimer’s Disease. American Journal of Geriatric Psychiatry, 11: 246-9
Aisen PS, Schafer K, Grundman M, Pfeiffer E, Sano M, Davis KL, Farlow M, Jin S, Thomas R, Thal LJ for the Alzheimer’s Disease Cooperative Study.2003Effects of Rofecoxib or Naproxen vs Placebo on Alzheimer Disease Progression. Journal of the American Medical Association. 289:2819-2826View
Aisen PS, Schafer K, Grundman M, Thomas R, Thal LJ.2003NSAIDs and Hypertension. Archives of Internal Medicine, 12:1115
Grundman M, Capparelli E, Kim HT, Morris JC, Farlow M, Rubin EH, Heidebrink J, Hake A, Ho G, Schultz AN, Schafer K, Houston W, Thomas R, Thal LJ; Alzheimer's Disease Cooperative Study.2003A multicenter, randomized, placebo controlled, multiple-dose, safety and pharmacokinetic study of AIT-082 (Neotrofin) in mild Alzheimer's disease patients. Life Sci. 73(5):539-53View
Grundman M, Jack CR Jr, Petersen RC, Kim HT, Taylor C, Datvian M, Weiner MF, DeCarli C, DeKosky ST, van Dyck C, Darvesh S, Yaffe K, Kaye J, Ferris SH, Thomas RG, Thal LJ; Alzheimer's Disease Cooperative Study.2003Hippocampal volume is associated with memory but not monmemory cognitive performance in patients with mild cognitive impairment. J Mol Neurosci. 20(3):241-8
Singer C, Tractenberg RE, Kaye J, Schafer K, Gamst A, Grundman M, Thomas R, Thal LJ; Alzheimer's Disease Cooperative Study.2003A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease. Sleep. 26(7):893-901View
Thal LJ, Grundman M, Berg J, Ernstrom K, Margolin R, Pfeiffer E, Weiner MF, Zamrini E, Thomas RG.2003Idebenone treatment fails to slow cognitive decline in Alzheimer's disease. Neurology. 61(11):1498-502View
Aisen PS, Davis KL, Berg J, Schafer K, Campbell K, Thomas R, Weiner MF, Farlow MR, Sano M, Grundman M, Thal LJ for the Members of the Alzheimer’s Disease Cooperative Study.2000A Randomized Controlled Trial of Prednisone in Alzheimer’s Disease. Neurology, 54: 588-593View
Mulnard RA, Cotman CW, Kawas C, van Dyck CH, Sano M, Doody R, Koss E, Pfeiffer E, Jin S, Gamst A, Grundman M, Thomas R, Thal LJ.2000Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. JAMA. 283(8):1007-15View
Teri L, Logsdon RG, Peskind E, Raskind M, Weiner MF, Tractenberg RE, Foster NL, Schneider LS, Sano M, Whitehouse P, Tariot P, Mellow AM, Auchus AP, Grundman M, Thomas RG, Schafer K, Thal LJ; Alzheimer's Disease Cooperative Study.2000Treatment of agitation in AD: a randomized, placebo-controlled clinical trial. Neurology. 55(9):1271-8View
Thomas RG, Berg JD, Sano M, Thal L.2000Analysis of longitudinal data in an Alzheimer's disease clinical trial. Stat Med. 19(11-12):1433-40
Knopman DS, Berg JD, Thomas R, Grundman M, Thal LJ, Sano M.1999Nursing home placement is related to dementia progression: experience from a clinical trial. Neurology. 52(4):714-8
Apostolova LG, Morra JH, Green AE, Hwang KS, Avedissian C, Woo E, Cummings JL, Toga AW, Jack CR Jr, Weiner MW, Thompson PM;Alzheimer's Disease Neuroimaging Initiative.1998Automated 3D mapping of baseline and 12-month association between three verbal memory measures and hippocampal atrophy in 490 ADNI subjectsNeuropsychology. 1998. PMID: 20083211 PMCID: PMC2847034.view
Ferris SH, Mackell JA, Mohs R, Schneider LS, Galasko D, Whitehouse PJ, Schmitt FA, Sano M, Thomas RG, Ernesto C, Grundman M, Schafer K, Thal LJ.1997A multicenter evaluation of new treatment efficacy instruments for Alzheimer's disease clinical trials: overview and general results. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Discord., 1997; 11 Suppl 2:S1-12.View
Galasko D, Bennett D, Sano M, Ernesto C, Thomas R, Grundman M, Ferris S.1997An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. Alzheimer Dis Assoc Disord. 11 Suppl 2:S33-9
Galasko D, Bennett D, Sano M, Ernesto C, Thomas R, Grundman M, Ferris S.1997An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord. 1997;11 Suppl 2:S33-9. PMID: 9236950 [PubMed - indexed for MEDLINE] view
Koss E, Weiner M, Ernesto C, Cohen-Mansfield J, Ferris SH, Grundman M, Schafer K, Sano M, Thal LJ, Thomas R, Whitehouse PJ.1997Assessing patterns of agitation in Alzheimer's disease patients with the Cohen-Mansfield Agitation Inventory. Alzheimer Dis Assoc Disord. 11 Suppl 2:S45-50
Mackell JA, Ferris SH, Mohs R, Schneider L, Galasko D, Whitehouse P, Schmitt F, Sano M, Thal LJ.1997Multicenter evaluation of new instruments for Alzheimer's disease clinical trials: summary of results. Alzheimer Dis Assoc Disord. 11 Suppl 2:S65-9
Mohs RC, Knopman D, Petersen RC, Ferris SH, Ernesto C, Grundman M, Sano M, Bieliauskas L, Geldmacher D, Clark C, Thal LJ.1997Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. Alzheimer Dis Assoc Disord. 11 Suppl 2:S13-21
Morris JC, Ernesto C, Schafer K, Coats M, Leon S, Sano M, Thal LJ, Woodbury P.1997Clinical dementia rating training and reliability in multicenter studies: the Alzheimer's Disease Cooperative Study experience. Neurology. 48(6):1508-10
Patterson MB, Mack JL, Mackell JA, Thomas R, Tariot P, Weiner M, Whitehouse PJ.1997A longitudinal study of behavioral pathology across five levels of dementia severity in Alzheimer's disease: the CERAD Behavior Rating Scale for Dementia. Alzheimer Dis Assoc Disord. 11 Suppl 2:S40-4
Sano M, Ernesto C, Thomas R, Klauber M, Schafer K, Grundman M, Woodbury P, Growdon J, Cotman CW, Pfeiffer E, Schneider LS and Thal LJ for the members of the Alzheimer’s Disease Cooperative Study.1997A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer’s disease. New England Journal of Medicine, 336:1216-1222View
Sano M, Mackell JA, Ponton M, Ferreira P, Wilson J, Pawluczyk S, Pfeiffer E, Thomas RG, Jin S, Schafer K, Schittini M, Grundman M, Ferris SH, Thal LJ.1997The Spanish Instrument Protocol: design and implementation of a study to evaluate treatment efficacy Instruments for Spanish-speaking patients with Alzheimer's disease. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord. 1997;11 Suppl 2:S57-64. PMID:9236954view
Schmitt FA, Ashford W, Ernesto C, Saxton J, Schneider LS, Clark CM, Ferris SH, Mackell JA, Schafer K, Thal LJ.1997The severe impairment battery: concurrent validity and the assessment of longitudinal change in Alzheimer's disease. Alzheimer Dis Assoc Disord. 11 Suppl 2:S51-6
Schneider LS, Olin JT, Doody RS, Clark CM, Morris JC, Reisberg B, Schmitt FA, Grundman M, Thomas RG, Ferris SH.1997Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. Alzheimer Dis Assoc Disord. 11 Suppl 2:S22-32
Cummings J. L. The Role of Positron Emission Tomography in the Diagnosis of Alzheimer’s Disease. Journal of the American Geriatrics Society 52 (3), 467-468
DeCarli, Charles Measures of brain morphology and infarction in the Framingham heart study: establishing what is normal. Neurobiology of Aging, vol. 26, issue 4, pp 491-510
Knopman, DS Antemortem diagnosis of frontotemporal lobar degeneration. Annals of Neurology; vol. 57, issue 4, pp. 480-488
Weiner, Myron F. Early behavioral symptoms and course of Alzheimer’s disease. Acta Psychiatrica Scandinavica 111 (5), 367-371